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Abstract
Perinatal brain injury is a consequence of insufficient blood and oxygen supply to the brain
during labour or delivery and can lead to impaired neurodevelopment or mortality. Hypoxic-
ischemia triggers a chain of physiological reactions of the vasculature and measuring cerebral
blood flow (CBF ) has the potential to improve our knowledge of injury location and progres-
sion, as well as to deepen our understanding of the therapeutic processes involved in treatments.
Quantitative regional CBF can be measured non-invasively with a magnetic resonance imaging
technique called pseudo-continuous ASL (pCASL). However, the use of pCASL for neonatal
CBF assessment in research or clinical practice is still uncommon due to several challenges
specific to this patient group.
This thesis addressed some of the acquisition and quantification challenges and established
a clinically feasible ASL protocol and processing pipeline for neonates with presumed hypoxic-
ischemic encephalopathy (HIE). Specifically, a Bloch equation simulator was implemented to
estimate the labelling efficiency of pCASL in neonates. The robustness of pCASL efficiency was
investigated theoretically using the simulator and in vivo in a group of healthy adult volunteers.
A high robustness of the pCASL efficiency against the angulation of the labelling plane was
determined. Additionally, a problem of acoustic noise was studied theoretically and a method
was proposed which resulted in a 6dB reduction of the acoustic noise. This thesis also developed
an image analysis framework for robust motion correction and exclusion of corrupted datasets.
The framework enabled the inclusion of all the acquired datasets (compared to seven out of
twelve if no motion correction was used). Finally, the proposed developments and imaging
framework was applied in a clinical study of neonates with presumed HIE. The new information
provided by CBF was investigated separately and in combination with magnetic resonance
spectroscopy (MRS), which is used routinely in HIE outcome prediction. In neonates at high
risk of adverse outcome, lentiform nuclei and cingulate cortex were found to have elevated
CBF values compared to neonates at low risk.
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Chapter 1
Introduction
1.1 Motivation
Perinatal brain injury can result from insufficient delivery of oxygen (hypoxia) or blood (is-
chemia) to the brain during labor and/or delivery. A lack of oxygen or glucose delivered with
blood results in molecular cell injury, which in turn causes cell death. Hypoxic-ischemia trig-
gers a chain of physiological reactions of the vasculature in order to preserve sufficient blood
flow to the brain, such as luxury perfusion, delayed post-ischemic hypoperfusion and abolished
autoregulation. Different parts of the brain are susceptible to hypoxic-ischemic injury to a dif-
ferent extent; the most commonly affected are regions of the highest metabolic demand, such
as basal ganglia and cortex. The degree of damage also depends on the nature and duration of
hypoxic-ischemic event.
The best treatment available to date, that improves the outcome of neonates after hypoxic-
ischemia, is therapeutic cooling. However, it does not provide neuroprotection in all cases.
There is therefore a high demand for an effective treatment that would help prevent the brain
damage from developing. Having a sensitive biomarker of injury could speed up clinical trials
as well as aid prognosis of the outcome given to parents.
Measuring cerebral blood flow (CBF ) has a potential to improve our knowledge of injury
progression as well as deepen the understanding of the therapeutic processes involved in treat-
ments. One magnetic resonance imaging technique, called arterial spin labelling (ASL), is ca-
pable of providing quantitative CBF maps non-invasively and without the need for exogenous
contrast agents. It is therefore a good candidate to become a neonatal imaging biomarker.
The use of ASL for neonatal CBF assessment in research or clinical practice is still uncom-
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mon due to several challenges specific to this patient group. One of these challenges is the much
lower CBF values in neonates than that of healthy adults, which results in much lower signal-
to-noise (SNR) of ASL. Recently proposed pseudo-continuous ASL (pCASL) provides higher
SNR compared to previously used pulsed techniques. However, labelling efficiency of pCASL
depends on the velocity of protons flowing through the labelling plane, which is different in
neonates compared to that of healthy adults. Another challenge of using pCASL is acoustic
noise produced by the scanner during the labelling period. A further challenge in neonatal ASL
imaging is motion during the scan which might corrupt the scans. Elimination of motion is
crucial, as motion artefacts can lead to misinterpretation of results or reduce the success rate of
the technique.
This thesis develops a methodological framework that will address all these challenges and
optimise the process of pCASL for neonatal imaging.
1.2 Scope and Objectives
The aim of this thesis is to establish a clinically feasible ASL protocol and processing pipeline
for neonates with presumed hypoxy-ischemic encephalopathy (HIE) and investigate the new
information provided by CBF in combination with magnetic resonance spectroscopy (MRS).
Specific objectives are:
1. To find the appropriate labelling efficiency for neonates
2. To reduce the amount of acoustic noise
3. To reduce the effects of motion
4. To optimise the framework for neonates
5. To apply the framework to the study of neonates with presumed hypoxy-ischaemic en-
cepahlopathy
6. To investigate new information provided by CBF in combination with magnetic reso-
nance spectroscopy (MRS).
This thesis implements a Bloch equation simulator and estimates labelling efficiency for a
range of measured velocities in arteries supplying the neonatal brain. Additionally, other factors
influencing labelling efficiency, specifically angulation of labelling plane are considered. The
27 of 212
Chapter 1. Introduction
robustness of the pCASL efficiency is investigated theoretically using the simulator and in vivo
in a group of healthy adult volunteers. The problem of acoustic noise is studied theoretically and
a method, leading to the reduction of the acoustic noise is proposed. This thesis also develops
an image analysis framework for robust motion correction and exclusion of corrupted datasets.
Finally, the proposed developments and imaging framework is applied in the study of neonates
with presumed hypoxy-ischemic encephalopathy and investigates the new information provided
by CBF in combination with magnetic resonance spectroscopy (MRS), which is used routinely
in HIE outcome prediction.
1.3 Thesis outline
The material in this thesis is organised as follows:
Chapter 2: Neonatal encephalopathy: from pathophysiology to imaging gives a back-
ground of a healthy brain physiology and physiological changes following hypoxia-ischemia in
the neonatal brain.
Chapter 3: Introduction to magnetic resonance imaging and spectroscopy provides the
basic theory of magnetic resonance imaging and spectroscopy.
Chapter 4: Introduction to neonatal perfusion quantification with arterial spin labelling
introduces the concept of arterial spin labelling. It describes models that allow perfusion quan-
tification and discusses sources of potential quantification errors in adults and in neonates.
Chapter 5: pCASL simulator for labelling efficiency estimation contains the theory of
pseudo-continuous labelling and describes an implementation of a simulator which enables the
estimation of labelling efficiency in neonates based on measured velocities of blood in vessels
supplying the brain.
Chapter 6: Practical aspects of pCASL focuses on the practical aspect of the pCASL and
provides solutions to address existing drawbacks such as acoustic noise and incorrect planning,
which apply especially when scanning neonates. An effective method of acoustic noise reduc-
tion is given and the dependence of planning on labelling efficiency is investigated.
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Chapter 7: Development of in vivo imaging framework for neonatal pCASL describes
optimisation of the scanning protocol and development of an effective method for motion cor-
rection, resulting in a reduction of rejected datasets due to motion.
Chapter 8: Clinical application of pCASL in neonates with hypoxic-ischaemic encephalopa-
thy presents a detailed regional analysis of CBF maps acquired in neonates who experienced
a perinatal hypoxic-ischaemic event. This is additionally combined with brain MRS data to link
the physiological and biochemical changes after hypoxia-ischaemia in the neonatal brain.
Chapter 9: Summary and future work summarises the work presented in this thesis and
proposes future developments.
Appendix A: Renal pCASL: reproducibility study presents an application of pCASL quan-
tification of renal blood flow. Although this work is not directly motivated by investigation of
neonatal HIE at this stage, it benefits form the knowledge and experience gained during the
development of the neonatal imaging framework described in chapter 7.
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Neonatal encephalopathy: from
pathophysiology to imaging
2.1 Introduction
In this chapter a background of a healthy brain physiology and physiological changes following
insufficient blood or oxygen delivery to developing brain tissue will be reviewed. This will be
followed by description of the consequences of hypoxia-ischemia on the cellular level and its
presentation in clinical imaging.
2.2 Normal brain physiology
Viability of the brain tissue depends on the delivery of glucose and oxygen, and clearance
of the products of metabolism. High metabolic demand of the working brain means that it
requires a continuous supply of glucose and oxygen (O2) and, at the same time, clearance of
carbon dioxide (CO2) and other products of metabolism. This is provided by perfusion, which
is the process of delivery of the nutrients to a capillary bed in the tissue, with cerebral blood flow
(CBF ) defined as the rate of that delivery to a tissue volume. The high level of metabolism in
the case of brain is due to its primary role: the generation of electrical activity, which is required
for neuronal signalling. Since there is no reserve store of O2 and glucose, the continuous flow
of blood is crucial to guarantee continuity of brain function.
CBF reflects metabolic demand. The higher the metabolism, the higher need for nutrients
and therefore the higher CBF . This coupling between metabolism and CBF is reflected in the
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heterogenous distribution of blood flow within the brain, with the majority of the flow received
by grey matter (consisting mainly of the neuronal cell bodies), whereas white matter (consisting
mainly of the myelinated axons) has much lower metabolic demand and therefore lower CBF .
Within grey matter, delivery of fully oxygenated blood can change in response to stimulation,
as observed with functional brain imaging studies.
In healthy neonates, the metabolic demand and therefore CBF is very low [16],[17]. This
rapidly changes within the first days, weeks and years of life, during the time of the fastest
development, and peaks at approximately 4-10 years of age, with CBF exceeding that of adults
by 70% or more during this period [18], [19].
Brain is supplied by dense network of vessels. The high demand for blood flow to the brain
is supported by the brain vasculature. Figure 2.1 shows a maximum intensity projection an-
giogram, showing the main vessels delivering blood to the brain. The biggest arteries - the
common carotid arteries (CCAs) - derive from the aortic arch (left) and brachiocephalic artery
(right) and split into the internal and external carotid arteries (ICA and ECA respectively) at the
carotid bifurcation. The vertebral arteries originate from subclavian arteries, and combine to-
gether to form the basilar artery. The ICAs and vertebral system connect into the Circle of Willis
( 2.1 C ) - a communicating pathway, that provides redistribution of the blood supply in case of
vascular occlusion. The Circle of Willis is composed of anterior cerebral arteries (ACAs), and
middle cerebral arteries (MCAs) which are derived from ICAs and connected by the anterior
communicating artery, and posterior cerebral arteries (PCA), derived from the basilar artery,
connected to MCAs by the posterior communicating arteries.
The arterial cerebral circulation can be divided into perforating and leptomeningeal arteries
[20]:
• Perforating arteries arise from the Circle of Willis or from its immediate branches, and
run perpendicularly to them. Perforating arteries penetrate brain parenchyma supplying
blood to the basal ganglia, thalamus and deep white matter. Similar branches stemming
from the basilar artery supply the brain stem.
• Leptomeningeal arteries consist of terminating branches of ACA, MCA and PCA. They
travel across or in the depth of cortical sulci supplying blood to the cortex and subjacent
white matter. An anastomotic (reconnecting) network created from the confluence of
these terminating branches forms watershed zones, which protect the blood delivery to
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the cortex in case of occlusion of the ACA, MCA or PC. Watershed zones are illustrated
in figure 2.2.
Brain regions supplied by these arteries and their branches are presented in figure 2.3.
Figure 2.1: Maximum intensity projection (MIP) angiography: coronal (A), saggital (B),
Circle of Willis (C) 1
Figure 2.2: Watershed zones (purple) as seen in the coronal (left) and transverse (right) orientations 2
1http://radiopaedia.org/images/545665
2http://missinglink.ucsf.edu/lm/ids_104_cns_injury/response%20_to_injury/watershed.htm
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Figure 2.3: Vascular territories of the major cerebral arteries3
CBF is controlled by pressure and resistance. CBF depends on the net pressure gradient
driving the blood through the vascular tree, the cerebral perfusion pressure (CPP , [Pa]), and the
resistance that must be overcome along the way, the cerebrovascular resistance (CV R, [MPa ·
s · m 3 ] ). This relationship can be described by the following equation:
CBF =
CPP
CV R
(2.1)
CV R is determined by arteriolar and capillary tone. The arteriolar smooth muscle controls
CV R by relaxing (dilation, CV R #) and contracting (CV R "). The state of moderate contrac-
tion - muscular tone - ensures appropriate resistance for a given blood flow demand.
Arterial smooth muscles can be affected by a large number of factors. Some of the most
common factors, their workings and influence on CBF are summarised in the table 2.1. A
more detailed description of the cerebral blood flow regulation can be found in [21].
3http://radiopaedia.org/articles/cerebral-vascular-territories
33 of 212
Chapter 2. Neonatal encephalopathy: from pathophysiology to imaging
Agent Function Effect on
CV R
Mechanism Effect
on
CBF
Arterial oxygen
content CaO2
[22]
Substrate of ox-
idative glucose
metabolism
Vasodilatation
or vasocon-
striction
Low levels trigger in-
crease of CBF
CBF "#
Glucose Substrate of energy
metabolism in a cell
Low levels trigger in-
crease of CBF
CBF "
CO2 and H+
[22], [23]
Product of oxidative
glucose metabolism
Vasodilatation Change of the pH at the
arterial smooth muscle
CBF "
K+ [22],[23] Involved in neuronal
signalling
Vasodilatation Relaxes the muscle of
arterioles
CBF "
Adenosine [22],
[23]
Involved in energy
metabolism and neu-
ral activity
Vasodilatation Binds to the receptors
and inhibits the activity
release
CBF "
Nitric oxide
NO [23]
Produced locally
following glutamate
receptor activ-
ity; produced by
inflammatory cells
Vasodilatation,
maintenance
of vascular
tone
Produces intracellular
second messenger
CBF "
Arachidonic
acid and its
derivatives [23]
Involved in inflam-
mation, fever and
pain
Vasodilatation
or vasocon-
striction
Complex via hormones
and enzymes
CBF "#
Sympathetic
pathway [23]
Neural pathway Vasoconstriction Via transmitters CBF #
Parasympathetic
pathway [23]
Neural pathway Vasodilatation Via transmitters CBF "
Table 2.1: Summary of different mechanisms controlling CBF
Autoregulation sustains constant CBF . Figure 2.4 shows the relationship between CBF
and CPP together with vessel diameter. Constant CBF values can be sustained within a broad
range of CPP by appropriate vasculature response: this is known as autoregulation. An in-
crease in blood pressure triggers vessel constriction and therefore increase of cerebrovascular
resistance, up to the point where any further constriction is impossible. Additional CPP in-
crease may cause passive dilatation, resulting in linear increase of CBF with CPP and pro-
duces vasogenic edema [1],[4]. Similarly, if the CPP decreases beyond the limits of phys-
iological vasodilatation, any further decrease in resistance is impossible and CBF decreases
linearly with CPP , leading to ischemia. This passive link between CBF and CPP is called
vasoparalysis.
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Figure 2.4: Cerebral Blood Flow in relation to Blood Pressure and artery lumen diameter. Dotted lines
represent the lower and upper limits of CBF auto regulation. Red circles represent cerebral arteries
(figure 2 from [1])
Two ischemicCBF thresholds have been identified [24] and quantified using positron emis-
sion tomography (PET) in adults with cerebral ischema [25]. The first is a flow threshold of elec-
trical failure in the cerebral cortex (⇠)20 ml/100g/min. The second one, is a threshold for cell
membrane failure and cell death (⇠)15 ml/100g/min [25]. The condition of the ischemic brain
with flow between the two thresholds is called penumbra [26] and is correlated with reversible
neurological deficits [25]. It has been suggested, that the area of penumbra can be identified
by imaging from the diffusion-perfusion mismatch area, i.e. the mismatch in the abnormality
volume between diffusion and perfusion weighted MRI [27]. When the autoregulatory range
is exhausted, the blood flow declines first in the most peripheral branches of the brain arteries
(watershed zones).
Pre-term and neonatal autoregulation plateau is narrower compared to adults. Based
on data acquired in neonatal lamb it was concluded that the autoregulation plateau is already
present in the lamb foetus, but covers a narrower blood pressure range than in more mature
animals, at the upper limit in particular [28]. Additionally, the mean arterial blood pressure is
only slightly higher than the lower limits of autoregulation, meaning that the buffer provided
by autoregulation is much smaller compared to adults. This indicates that the risk of ischemic
injury is increased with minor hypotension, particularly within the watershed regions. In hu-
man neonates, this lower threshold has not been identified; CBF values associated with cell
membrane failure in adults have been associated with subsequent normal outcome [3].
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Glucose metabolism provides energy for neural activity. Metabolism of glucose and O2
can be divided into four steps, illustrated in figure 2.5:
1. Glycolysis. In the first instance, glucose is taken up from the blood and undergoes glycol-
ysis, in which the glucose is broken down into two pyruvate molecules. The free energy
released in this process is used to form high-energy compounds: adenosine triphosphate
(ATP ) and reduced nicotinamide adenine dinucleotide (NADH). For each glucose
molecule undergoing glycolysis two ATP and two NADH are formed. Most of the
pyruvate is transported into the mitochondria, where it is further metabolised by means of
the Krebs Cycle. When the rate of pyruvate production by glycolysis is higher than that
of pyruvate and O2 metabolism, pyruvate is converted to lactate (reversibly), which then
diffuses out of the cell and is carried away in the blood.
2. Krebs Cycle. The Krebs Cycle (or trans-carboxylic acid (TCA) cycle) is a complex chem-
ical reaction pathway, in which pyruvate, a product of glycolysis, is further broken down
to form CO2 with the storage of energy in the form of NADH .
3. Electron transfer chain (ETC). In this step the electrons are transferred from NADH to
O2 to form water and protons (H+) are transferred across an inner mitochondrial mem-
brane. The transfer of H+ is against the electrochemical gradient and therefore storing
the energy in H+ gradient.
4. ATP synthesis. The ATP synthesis is driven by the proton gradient resulted from ETC.
The overall process of glucose metabolism can be written as:
Glucose+ 6O2 ! 6CO2 + 6H2O + 38ATP
where 2 ATP compounds are gained from step 1 and 36 from steps 2-4. ATP is used by the cells
to maintain their activity, by sustaining the chemical (neurotransmitters) and ionic gradients.
A more complex picture of glucose metabolism and a key role of neuron-astrocyte metabolic
interactions, can be found in [29].
2.3 Vascular pathophysiology during hypoxia - ischemia
Insufficient supply of oxygen (hypoxia) within the uterus following acute reduction of the uter-
ine or umbilical circulation (ischemia) triggers a physiological reaction of the vasculature, which
can be divided into two phases: during and after hypoxia-ischemia.
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Figure 2.5: Major steps of energy metabolism: glycolysis (cys-
tol), Krebs cycle, electron transfer chain and ATP synthesis (mi-
tochondria) (figure 1.5 from [2])
2.3.1 Brain vasculature physiology under hypoxia - ischemia
Activation of sympathetic - adrenergic system. The sympathetic - adrenergic system ac-
tivation redistributes the cardiac output to preserve blood flow in favour of the central organs:
brain, heart and adrenal gland, at the expense of flow to the less vital organs (i.e. kidneys,
intestine, muscle) [3]. Increased CO2 and decreased O2 partial pressure lead to vasodilation
of the cerebrovascular bed causing hyperperfusion, according to table 2.1. Increase of CBF
by vasodilatation is least effective in the white matter. Persisting deficit of oxygen drains the
anaerobic energy reserves, which in turn reduces the cardiac output and blood pressure. If blood
pressure falls below the lower level of autoregulation, a decrease in CBF is observed [3]. This
CBF decrease mostly affects parasagittal watershed region of cerebrum and the white matter.
A summary of cardiovascular reaction to asphyxia (severe deficit of oxygen supply to the body)
is shown is figure 2.6.
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Figure 2.6: Schematic representation of the cardiovascular response to asphyxia (figure 1 from [3]).
2.3.2 Brain recovery from hypoxia - ischemia
Early post-ischemic deficit. The ’no-reflow’ phenomenon is a failure of re-perfusion early
after a period of cerebrovasculatory arrest and results from mechanical obstruction of the mi-
crocirculation by post-ischemic edema, observed in animal models [4]. The brain tissue volume
of the no-reflow depends on the length and severity of ischemia: the longer and more severe is-
chemia, the greater the no-reflow volume. In case of complete ischemia, no-reflow is prominent
after only 7 minutes of occlusion; this time extends to 3-7 hours for incomplete ischemia.
Luxury perfusion syndrome. Luxury perfusion syndrome (hyperaemia) is characterised by
increasedCBF relative to the metabolic needs of the brain. It lasts longer than would be needed
to reoxygenate the brain (1-2 hours in dogs), indicating that the syndrome is most likely initiated
by abnormal metabolism i.e. acute metabolic acidosis caused by accumulated lactate and CO2
[30], as well as complete loss of tone in vessels [17] ( see figure 2.7).
Figure 2.7: Luxury perfusion and postischemic hypo perfusion of gerbil brain after 10 min bilateral
carotid artery occlusion (figure 2 from [4])
This phenomenon was also observed in asphyxiated term infants using Doppler ultrasonog-
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raphy [5] (see figure 2.8). Here, however, the increased blood velocities indicating high CBF
were observed from 12 hours after birth and increased over the course of the period of measure-
ment in the neonates with the most severe hypoxic-ischemic encepalopathy (HIE) (see table 2.2
for details of HIE grading).
Figure 2.8: Mean cerebral blood flow velocity in anterior (left) and middle (right) cerebral arteries
in asphyxiated infants with different development of perineonatal hypoxic-ischemic encepalopathy and
controls showing significant increase in measured velocities for most severe cases of HIE (figures 1 and
2 from [5])
Delayed post-ischemic hypo-perfusion. Postischemic hypo-perfusion syndrome is a func-
tional disturbance that develops due to increased arterio-artreriolar vascular tone. In the absence
of no-reflow, it follows directly the luxury perfusion phase (see figure 2.7). It develops after
about 5 min of ischemia (focal, complete or incomplete) and does not depend on the ischemia
duration. At this time, the auto regulation, but not CO2 reactivity begins to recover, and CBF
stabilises at subnormal level [4],[31].
Abolished autoregulation andCO2 reactivity. Abolished autoregulation andCO2 reactivity
is manifested by the pressure passive CBF and implies that CBF does not adjust to changes
in cerebral metabolic demand. The lack of auto regulation i.e. no vascular response stimulated
by hypercapnia or hypoxia, can be presumed to relate to the fact that the maximal vasodilatation
has already developed as a result of asphyxia. Therefore further vasodilatation is impossible,
regardless of the decrease in blood pressure. Abolished auto regulation has been observed in
asphyxiated fetal sheep [32] and distressed newborn infants [33]. In neonates with extensive
hypoxic-ischemic brain damage and isoelectric electroencephalogram (EEG), abolished CO2
reactivity accompanying vasoparalysis was detected. In infants with signs of brain damage and
burst suppression EEG, the pressure-flow autoregulation was abolished, whereasCO2 reactivity
was preserved. In the neonates with pressure-passive CBF , the average CBF was additionally
increased (proportionately to the brain damage) compared to controls or mildly affected infants
[17],[34].
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2.4 Cellular injury
Lack of glucose and oxygen cause molecular cell injury. Neuronal cell death happens in two
phases following a reversible global insult.
Primary cell death is related to a lack of O2, which leads to disturbance in high energy
oxidative glucose metabolism (’primary energy failure’) and chemical imbalance and terminal
depolarisation of the cell. As a result, the cell osmolality rises, causing a shift of water from the
extracellular into the intracellular compartment [35]. The detailed description of this process
can be found in [36]. This injury is established within a few minutes after the onset of hypoxia.
However, primary cell death triggers a cascade of pathologic processes, but on its own doesn’t
contribute to large number of neuronal deaths.
Secondary/delayed cell death becomes apparent from about 1-100 hours after the injury. The
mechanisms contributing include: excitotoxicity (damage and death of neurones by excessive
stimulation by neurotransmitters, primarily glutamate) and apoptosis (programmed cell death).
It is associated with hyperaemia, increased seizure activity cytoxic oedema, NO synthesis, ac-
cumulation of excitotoxins and mitochondrial failure. Mitochondrial failure is a key step leading
to delayed cell death.
It has been demonstrated using a piglet model with continuous phosphorous-31 MRS mon-
itoring [37], that the pattern of energy failure during and after hypoxic ischemia comes in
two phases. Following an acute energy depletion in which some cells undergo primary cell
death, the latent phase begins. This phase is characterised by the apparent recovery of ox-
idative metabolism. The second phase known as secondary energy failure, in which oxidative
metabolism deteriorates leading to the secondary or programmed cell death. The latent phase,
or the phase of pseudo-normalisation, is considered to be a "therapeutic window" for treatments,
such as brain cooling.
2.5 Factors influencing the type and location of neural damage: an-
imal models
The reaction of the brain under hypoxic-ischaemic conditions depends on the severity, pattern
and type of the insult, as well as neonate’s gestational age. [36]. As the origin of brain damage
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in neonates is un-controllable and often unknown, the majority of the research on hypoxia-
iscahemia and its impact on the brain has been carried out using animal models.
Figure 2.9: Neuronal damage in nine brain regions of neonatal sheep following increasing durations
of ischemia. These are ranked in order of total damage scores: The parasagittal cortex was the most
severely damaged (bottom), whereas the thalamus (top) showed the least damage. The damage scores
are on a linearised scale. 0 to 100:0, no neuronal lo.is; 100. total necrosis (figure 2 from [6])
Duration of ischemia. Depending on the duration of ischemia, cell damage happens in dif-
ferent brain regions with different extent. This is illustrated in figure 2.9, which shows neuronal
damage in nine brain regions of the developing sheep brain after partial ischemia, whereas acute
near-total hypoxic ischemia of 10 minutes duration to the umbilical blood flow in lamb fetus
produces damage to the nuclei of basal ganglia and the thalami [6].
Gestational age. If the baby is premature, it is more likely that the neurological disturbance
will involve white matter (see section 2.7).
Temporal sequencing. Temporal sequencing appears to affect both the severity and the re-
gional nature of the injury. Three repeated episodes of 10 min of ischeamia, repeated at 1h and
5h intervals, resulted in neuronal damage in striatum, but less in the cortex [38].
2.6 Clinical HIE grading
HIE grading system helps to diagnose, assess and aid prognosis of neonates after perinatal
insult. It uses clinical observation like level of consciousness, muscle tone and complex reflexes
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to assign one of the stages: mild (I), moderate (II) and severe (III). HIE stages are closely related
to the outcome. The first grading system was proposed by Sarnat and Sarnat [13] (given in table
2.2).
Mild HIE (I) Moderate HIE (II) Severe HIE (III)
Level of consciousness Hyperalert Lethargic Flaccid
Muscle tone Normal Mild hypotonia Severe hypotonia
Complex reflexes:
Suck Normal/Weak Weak/Absent Absent
Moro Strong Weak/Incomplete Absent
Seizures Absent Common Frequent/difficult
to control
Table 2.2: HIE grading according to Sarnat and Sarnat [13]
2.7 Neonatal neuropathology
Thalamus
Caudate	
nucleus
Cerebellum
Putamen	and	
globus pallidus
PLIC
Cingulate	cortex
Figure 2.10: T1 weighted image of a typical neonate showing anatomies most often affected by hypxix-
ischemia
According to Inder et al. [36] the neuropathology of hypoxic-ischaemic encephalopathy in
term neonates can be divided into 3 categories:
1. Selective neuronal necrosis. This is the most common neural injury in term infants result-
ing from HI. The brain regions injured the most often are: CA1 region of hippocampus,
deeper layers of the cerebral cortex, putamen and thalamus.
2. Parasagittal cerebral injury is an injury of the cerebral cortex and subcortical white matter
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in parasagittal and supermedial aspects of the cerebral convexities (i.e. the aspect of
the cerebral hemisphere that lies in contact with the flat bones of the skull). The most
prominent areas of neuronal necrosis are watershed regions of the cerebral cortex (border
zones between the major cerebral arteries) and in the depths of sulci.
3. Basal ganglia and thalamic lesions. The basal ganglia consists of the lentiform nucleus
(consisting of the globus pallidus and the putamen) and the caudate nucleus (as shown at
the image 2.10). Together with the thalamus, they are extremely vulnerable to damage
following acute near-total hypoxic ischemia. Often, the peri-Rolandic cortex is affected
at the same time. In extreme cases, the damage to deep grey matter is termed ’Status
Marmoratus’. Status Marmoratus initially involves basal ganglia and thalamus and is
characterised initially by neuronal loss, gliosis and hypermyelination. This is apparent
from about 8 months of age and characterised by marbled appearance of the basal ganglia.
It is observed in only 5% of children with HI brain lesions [39].
Additionally, the most common lesions found in pre-term neonates are [36]:
1. Periventricular leucomalacia, which is a necrosis of white matter in a characteristic distri-
bution, i.e. near the lateral ventricles.
2. Periventricular haemorrhage. Perilventricular haemorrhagic infarction is a haemorrhagic
necrosis of periventricular white matter that is usually large and asymmetric.
3. Germinal matrix haemorrhage.
2.8 MR imaging findings and its relation to the neurodevelopmen-
tal outcome
MR imaging has been widely used for early evaluation of perineonatal hypoxic-ischemic en-
cepalopathy. The most commonly used techniques are T1, T2 and diffusion weighted imaging.
MRI allows determination of the type and severity of the insult and guides outcome progno-
sis. The most common imaging findings include brain swelling, abnormal signal/lesions in the
basal ganglia and thalami, abnormal signal intensity in the posterior limb of the internal capsule
(PLIC) and cortex, loss of gray/white matter differentiation [7]. Examples of abnormal images
are shown in figures 2.11 to 2.14. The loss of normal signal intensity within PLIC is caused
by edema or infarction and is associated with abnormal neurodevelopment outcome. Abnormal
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signal in deep grey matter is linked to cerebral palsy, memory defects and feeding difficulties.
The outcome depends on the severity and exact location of the damage [7]. Loss of gray/white
matter differentiation can result from cytotoxic edema, with the outcome depending on the ex-
tent and location of the damage. Cortical involvement defined as abnormal highlighting on T1
weighted images may represent ischemia and is usually accompanied by other lesions within
the brain.
Figure 2.11: T1 (A) and T2 (B) weighted images
showing loss of gray/white matter differentiation
in the posterior parietal and occipital lobes4.
Figure 2.12: T2 (A) and diffusion weighted (B)
images showing cortical and subcortical white
matter abnormalities4.
Figure 2.13: T1- weighted images showing pos-
terior limb of the internal capsule. A - normal
signal intensity (arrow) from myelin. B - loss
of normal high intensity signal (arrow) in severe
HIE. Also, there is abnormal high signal inten-
sities in the thalamus and lentiform nuclei either
side of the PLIC (figures 1a and 4c from [7])
Figure 2.14: MRI pattern suggestive of acute
near total asphyxia. A - T1-weighted image does
not show a normal signal within the posterior
limb of the internal capsule, but areas of in-
creased signal intensity within thalami and basal
ganglia. DWI (B-D) shows restricted diffusion in
the ventrolateral thalami, lentiform nuclei, cere-
bral peduncles, and in the perirolandic cortex.
Also note involvement of the hippocampi (figure
2 from [8])
4http://www.mrineonatalbrain.com/
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A summary of the above information of the injury type, affected brain region and the out-
come is provided in table 2.3.
Time
course
Typical site of
brain injury
Disability
Acute,
near-
total
Moderate Basal ganglia and
thalami
Athetoid or dystonic CP, intact
or mildly impaired cognitive de-
velopment
Severe
or pro-
longed
Cerebral cortex
added to basal gan-
glia and thalami
Severe, spastic quadriplegia,
cortical visual impairment,
microcephaly, cognitive deficit
Prolonged,
partial
Moderate Watershed regions Moderate, spastic quadriplegia,
variable cognitive deficit
Severe Extensive cortical
pathology
Spastic quadriplegia, severe
cognitive impairment, cortical
visual impairment, micro-
cephaly
Table 2.3: Relationships between time course of asphyxial insult, site(s) of brain injury and
type of disability [14]
2.9 Neuro-imaging scoring system
One of the ways to evaluate the radiological findings is by a scoring system. The scores are based
on the image intestines and contrast of the main brain areas affected by hypoxia-ischemia: deep
grey matter and the intravascular zones. The more extensive injury, the higher the score is given.
The scores can then be compared to clinical outcomes and use to help in outcome prediction.
One example of such a scoring system was introduced by Barkovich et al. [15] and is shown in
table 2.4.
2.10 Treatment
To date, a single, fully effective treatment for HIE has not yet been determined. This is due to
the vast complexity of the biochemical and physiological processes and interactions, which are
still not fully understood. However, as pointed out in section 2.4, there is a therapeutic win-
dow between reperfusion and secondary energy failure, in which a treatment should be most
effective by blocking the path to cellular death. Recently, it has been shown that therapeutic
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Score Description
Basal ganglia (BG)
0 Normal or isolated focal cortical infarct
1 Abnormal signal in thalamus
2 Abnormal signal in thalamus and lentiform nucleus
3 Abnormal signal in thalamus, lentiform nucleus, and perirolandic cortex
4 More extensive involvement
Watershed (W)
0 Normal
1 Single focal infarction
2 Abnormal signal in anterior or posterior watershed white matter
3 Abnormal signal in anterior or posterior watershed cortex and white matter
4 Abnormal signal in both anterior and posterior watershed zones
5 More extensive cortical involvement
Basal ganglia/watershed (BG/W)
0 Normal
1 Abnormal signal in basal ganglia or thalamus
2 Abnormal signal in cortex
3 Abnormal signal in cortex and basal nuclei (basal ganglia or thalami)
4 Abnormal signal in entire cortex and basal nuclei
Table 2.4: Barkovich scoring system [15]
cooling improves neurocognitive outcomes in early [40] and middle childhood [41]. Thera-
peutic hypothermia is a deliberate and closely controlled reduction of the body temperature to
33-34  for 72 hours, started within 6 hours after delivery. Hypothermia is currently the only
treatment that has been recommended and introduced to the standard clinical care by the NICE
interventional procedures guidance (IPG347)5. However, it does not provide neuroprotection in
all cases. Therefore many other potential treatments are currently being investigated [42]. A
combination of cooling and inhalation of Xenon gas has shown promising results in pre-clinical
research [43], but its effectiveness hasn’t been confirmed in a first clinical trial trial6 [44].
5http://www.nice.org.uk/guidance/ipg347
6https://www.npeu.ox.ac.uk/toby-xe
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2.11 Summary
This chapter presented anatomical, physiological and clinical background necessary to under-
stand the origin and consequences of hypoxia-ischemia. Currently, none of the imaging tech-
niques used in standard clinical practice evaluate perfusion, which could be beneficial to im-
prove the knowledge of injury progression as well as deepen the understanding of the therapeu-
tic processes involved in treatments. A review of research results measuring perfusion is given
in chapter 4, section 4.2.
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Introduction to magnetic resonance
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3.1 Introduction
This chapter gives an overview of the basics physical principles of nuclear magnetic resonance
(NMR), formation of an image using NMR principles and magnetic resonance spectroscopy.
It provides the basis for the imaging and spectroscopy techniques used and described in the
subsequent chapters.
3.2 Physical principles of nuclear magnetic resonance
The nuclear magnetic moment µ is the foundation for MR spectroscopy and imaging. When
put into an external magnetic field ~B0, the magnetic moment vector ~µ experiences a torque
~N = ~µ ⇥ ~B. Nonzero torque implies that the system’s total angular momentum ~J changes
according to d ~J/dt = ~N . On the other hand, the relationship between the magnetic moment
µ and angular momentum ~J is given by : ~µ =   ~J , where   is the gyromagnetic ratio and for
protons of water it is equal to 42.6 MHz/Tesla (or 2.68 ⇥108 rad/s/Tesla). Putting the above
together yelds:
~N =
d ~J
dt
= ~µ⇥ ~B ! d~µ
dt
=  
d ~J
dt
=  ~µ⇥ ~B (3.1)
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which is the equation of motion for the magnetic moment µ of an isolated spin in the classical
mechanics view. The solution to the above equation is of the form:
µx(t) = µx(0)cos( B0t) + µy(0)sin( B0t) (3.2)
µy(t) =  µx(0)sin( B0t) + µy(0)cos( B0t)
µz(t) = µz(0)
or using rotation matrix notation:
~µ(t) = Rz( B0t)~µ(0) (3.3)
The angular frequency that µ precesses about B0 is called the Larmor frequency:
!0 =  B0 (3.4)
The magnetic moment vectors of all protons contained in a unit volume (population) sum up
and give a net magnetisation vector ~M =
Pn=Np
n=1 ~µn . If there is no phase coherence between
~µ within the population, then ~M is aligned with the direction of the main magnetic field. ~M is
several orders of magnitude lower compared to B0 (M0 per unit volume at B0 = 3 T is⇡ 0.04 µ
T/ml [10]), therefore in order to detect ~M , it needs to be tipped away from its equilibrium direc-
tion. This can be achieved by applying a short magnetic field of radio frequency (RF pulse). If
the frequency of theRF pulse is equal to the Larmor frequency, the rotation is most efficient and
it is said that the RF pulse is on resonance and it provides a continuously synchronised torque.
The changes in the net magnetisation vector orientation can be then measured throughout the
interaction of the protons’ magnetic field with a coil detector.
3.2.1 Mathematical description: laboratory and rotating frames
The rotating frame is often used to simplify the description of ~M rotation compared to that of
the laboratory frame, both mathematically and conceptually. Both the laboratory and rotating
frames are right handed Cartesian coordinate systems (denoted by (x0, y0, z0) and (x, y, z) in
laboratory and rotating frame respectively), with z0 and z axis of both systems aligned with
main magnetic field direction ~B. However, the xy plane of the rotating frame rotates around z
slowing down the rotation of ~M and if the rotation frequency of the rotating frame is equal to
Larmor frequency, ~M appear to be stationary. The biggest benefit of using the rotating frame is
when considering the motion of ~M as a result of interaction with RF pulse.
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Mathematical description of the frames. A time-dependent vector ~m(t) can be written in
terms of its (x0, y0, z0) components as:
~m0(t) = mx0(t)xˆ0 +my0(t)yˆ0 +mz0(t)zˆ0 (3.5)
where (xˆ0, yˆ0, zˆ0) are unit vectors in a laboratory frame. In the rotating reference frame, ~m can
be expressed as:
~m(t) = mx(t)xˆ+my(t)yˆ +mz(t)zˆ (3.6)
where (xˆ, yˆ, zˆ) are unit vectors in a rotating frame. The three components of ~m(t) in the rotating
frame relate to those in a laboratory frame by:2666664
mx
my
mz
3777775 =
2666664
cos!frt   sin!frt 0
sin!frt cos!frt 0
0 0 1
3777775
2666664
mx0
my0
mz0
3777775 = R ~m0 (3.7)
where R is a rotation matrix, and !fr is the angular frequency of the rotating frame. Knowing
the components in one frame allows computation of the components in the other frame:2666664
mx0
my0
mz0
3777775 =
2666664
cos!frt sin!frt 0
  sin!frt cos!frt 0
0 0 1
3777775
2666664
mx
my
mz
3777775 = R 1 ~m = RT ~m (3.8)
where RT is a transpose of the matrix R.
The relation of the rate of change of the vector in time in two frames is given by:
✓
d~m(t)
dt
◆
lab
=
✓
d~m(t)
dt
◆
rot
+ ~⌦⇥ ~m(t) (3.9)
where ⌦ is a rotational angular velocity vector and subscripts ’lab’ and ’rot’ refers to the lab-
oratory and rotating reference frames, respectively. The magnitude of ⌦ is equal to !fr and
it points along the negative z axis: ~⌦ =  !frzˆ ( ~m rotates around z clockwise, the direction
of the angular velocity vector is defined by right-hand rule - if the fingers points towards the
direction of the rotation, the thumb points towards the direction of the velocity vector). The
above equation says that the rate of change of a vector seen in the laboratory frame is equal to
the vector sum of rate of change of this vector seen from a rotating frame perspective and a cross
product of angular velocity of one rotation frame (seen in laboratory frame) and vector ~m.
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Spin precession in rotating frame. The mathematical description of the net magnetisation
~M of spins in phase rotating in the laboratory frame with Larmor frequency !0 is similar to the
equation of motion for a single magnetic moment ~µ, equation 3.1, and is given by: 
d ~M
dt
!
lab
=   ~M ⇥ ~B0 = ~M ⇥ (!0zˆ) (3.10)
Therefore, if the rotating frame rotates with the angular velocity ~!fr, using equation 3.9 it can
be rewritten as:
 
d ~M(t)
dt
!
rot
=
 
d ~M(t)
dt
!
lab
  ~⌦⇥ ~M
= ~M ⇥ (!0zˆ) + ~M ⇥ ( !frzˆ) (3.11)
= (!0   !fr) ~M ⇥ zˆ (3.12)
If the frame rotates clockwise around z at Larmor frequency !0, then (d ~M/dt)rot = 0, indicat-
ing that from the point of view of the rotating frame, there is no change in time of ~M , i.e. M is
stationary in this frame.
RF pulse representation in the rotating frame
Radiofrequency (RF) pulses, oscillating at the same frequency as spins, are used to deliver an
external energy and drive the spin system away from its equilibrium. AnRF pulse of frequency
!RF applied along x axis can be represented in the laboratory frame by the equation:
~B1(t) = xˆ
0B1(t) cos!RF t  yˆ0B1(t) sin!RF t (3.13)
B1(t) is called the envelope and !RF = 2⇡fRF is the pulse carrier frequency.
By matrix multiplication with the rotation matrix R, the RF pulse can be transformed to the
rotating frame:2666664
B1x(t)
B1y(t)
B1z(t)
3777775 =
2666664
cos!frt   sin!frt 0
sin!frt cos!frt 0
0 0 1
3777775
2666664
B1(t) cos!RF t
 B1(t) sin!RF t
0
3777775 =
2666664
B1(t) cos (!fr   !RF )
B1(t) sin (!fr   !RF )
0
3777775
(3.14)
If the angular frequency of the rotating frame !fr is equal to the carrier frequency !RF , then
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B1(t) reduces to: 2666664
B1x(t)
B1y(t)
B1z(t)
3777775 =
2666664
~B1(t)
0
0
3777775 (3.15)
The representation of the RF pulse in the rotating frame is much simpler than in the laboratory
frame, and has proven to be very popular in describing the MR experiment.
3.2.2 The Bloch Equations
The Bloch equations describe a time dependent behaviour of ~M in the presence of applied
magnetic fields and relaxation. In general form it is given by:
d ~M
dt
=   ~M ⇥ ~B   Mxxˆ
0 +Myyˆ0
T2
+
(M0  Mz) zˆ0
T1
(3.16)
where T1 and T2 are spin-lattice and spin-spin relaxation times and describe the return of the
system to its equilibrium after perturbance,M0 is a fully relaxed ~M .
Excitation. The overall magnetic field is the sum of the static magnetic field B0 and RF B1
field:
~B = ~B1 + ~B0
where ~B1 is given by equation 3.13. Therefore equation 3.16 can be written as (ignoring relax-
ation processes): 
d ~M
dt
!
lab
=   ~M ⇥
⇣
xˆ0B1 cos!RF t  yˆ0B1 sin!RF t+ zˆ0B0
⌘
and after conversion to the rotating frame: 
d ~M
dt
!
rot
=   ~M ⇥

B1 (xˆ cos(!RF   !fr)t  yˆ sin(!RF   !fr)t) + zˆ
✓
B0   !fr
 
◆ 
=   ~M ⇥ ~Beff (3.17)
where ~Beff is called the effective magnetic field. From the above equation it can be seen that
in the rotating reference frame the magnetisation vector always precesses about ~Beff .
At resonance (i.e. !RF =  B0 = !fr ) the effective field reduces to xˆB1(t) and the magneti-
sation precesses about the applied B1 field. If the frequency of the rotating frame is identical
to the frequency of RF pulse, i.e. !fr = !RF , B1 is demodulated. This is so called " RF
reference frame". Another special case is when the frequency of the rotating frame is equal to
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the Larmor frequency (i.e. !fr = !0). In this frame B0 disappears and therefore this frame is
called "B0 rotating frame".
In the RF rotating frame the equation 3.17 simplifies to: 
~dM
dt
!
rot
=   ~M ⇥

B1xˆ+ zˆ
✓
B0   !RF
 
◆ 
(3.18)
Defining frequency offset  ! as a difference between frequency of the spins and frequency of
the RF pulse:
 ! =  B0   !RF (3.19)
equation 3.18 can be expressed as:
dMx
dt
=  !My
dMy
dt
=  B1(t)Mz   !Mx
dMz
dt
=   B1(t)My (3.20)
or, equivalently, in a matrix representation:
d ~M
dt
=
2666664
0  ! 0
  ! 0  B1
0   B1 0
3777775 (3.21)
On resonance, the RF frequency is equal to Larmor frequency and  ! = 0. With the initial
conditionsMx = 0,My = 0 andMz = M0, the closed-form solution to the above equation is
given by:
Mx(t) = 0
My(t) = M0 sin
✓
 
Z ⌧RF
0
B1(t)dt
◆
Mz(t) = M0 cos
✓
 
Z ⌧RF
0
B1(t)dt
◆
(3.22)
and therefore the RF flip angle FA can be defined as:
FA(t) =  
Z ⌧RF
0
B1(t)dt =
Z ⌧RF
0
!(t)dt (3.23)
where ⌧RF is the duration of the RF pulse. Off resonance,  ! 6= 0, the ~Beff has two compo-
nents: B1 along xˆ axis and !/  pointing along zˆ and therefore magnetisation ~M will precess
around ~Beff with angular frequency !eff :
!eff =  Beff =
q
 !2 +  2B21 (3.24)
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~Beff makes the angle ✓ with zˆ axis:
✓ = arctan
✓
 B1
 !
◆
(3.25)
Relaxation. The general Bloch Equation in the rotating frame takes the form: 
d ~M(t)
dt
!
rot
=   ~M ⇥ ~Beff   Mxxˆ+MyyˆT2 +
(M0  Mz) zˆ
T1
(3.26)
When Beff = 0, equation 3.26 can be expressed in the rotating frame as:
dMx
dt
=  Mx
T2
dMy
dt
=  My
T2
dMz
dt
=
M0  Mz
T1
(3.27)
The solution to 3.27, with initial condition: ~M(0) = Mx(0) +My(0) +Mz(0) is:
Mx(t) = Mx(0) exp( t/T2)
My(t) = My(0) exp( t/T2)
Mz(t) = Mz(0) exp( t/T1) +M0 (1  exp( t/T1)) (3.28)
which, in the matrix representation takes form:
~M(t) =
2666664
exp( t/T2) 0 0
0 exp( t/T2) 0
0 0 exp( t/T1)
3777775 ~M(0) +
2666664
0
0
M0 [1  exp( t/T1)]
3777775
(3.29)
An illustration of the evolution x, y and z components of the magnetisation after excitation
pulse in the laboratory and rotating frames is presented in figure 3.1, computed for T1 = 200
[ms] and T2 = 50 [ms].
3.2.3 Signal detection
Precessing magnetisaton in the xy plane can be detected by measuring the voltage V (t) it in-
duces in a receive coil in accordance with Faraday’s law of electromagnetic induction. The law
states that a time-varying magnetic flux through a loop of wire,  , generates a voltage whose
amplitude is proportional to the (negative of the) time rate of change of the flux [45]:
V (t) =  d 
dt
(3.30)
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Figure 3.1: Relaxation in laboratory and rotating frame.
The magnetic flux can be written as:
  =
Z
object
~Br(r) · ~M(r, t)dr (3.31)
where ~Br(r) is the receive coil B1 field at the location r. The full detailed derivation of the
above equation can be found in [45]. Therefore the signal, S(t), can be expressed as:
S(t) / V (t) =   @
@t
Z
object
~Br(r) · ~M(r, t)dr (3.32)
After introduction of some assumptions and simplifications, of which details can be found in
[45] and [9], the above can be rewritten as a signal expression:
S(t) =
Z
object
Mxy(r, 0) exp( t/T ⇤2 (r)) exp ( i!(r)t) dr (3.33)
whereMxy is a complex representation of the transverse magnetisation in the rotating frame, i.e.
Mxy = Mx+ iMy = Mxy exp(i ), and !(r) is spatially dependant resonance frequency. T ⇤2 is
called an apparent T2 and it given by: 1/T ⇤2 = 1/T2 +1/T 02, where T 02 is inversely proportional
to the magnetic field inhomogeneity. By introducing a spin spectral density function ⇢(!) to
characterise the frequency distribution of a spin system:
dM(!) = ⇢(!)d! (3.34)
and
M =
Z 1
 1
⇢(!)d! (3.35)
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where M(!) = Mx(!) +My(!) +Mz(!), it can be shown that the signal generated can be
expressed as [9]:
S(t) /
Z 1
 1
⇢(!) exp( t/T ⇤2 (r)) exp( i!t)d!. (3.36)
On the other hand, the frequency spectrum ⇢ˆ of the time signal S(t) is:
S(t) =
1
2⇡
Z 1
 1
⇢ˆ(!) exp( i!t)d!. (3.37)
Therefore the frequency spectrum of the time signal is directly linked to the spin spectral density
function when T2 relaxation is omitted.
3.3 Image formation
To obtain spatial localisation of the signal in the sample, the frequency of spins needs to be
controlled. This can be achieved by augmenting the homogenous magnetic field with magnetic
field gradients and creating a position dependant resonance frequency of the spins. The depen-
dency of the spin frequencies on the spatial location can be used together with an RF pulse,
which leads to a selective excitation, as only the spins at resonance with an RF pulse will ex-
perience excitation. If the field gradient is used to make an RF pulse spatially selective, it is
called a slice selective gradient. The spatial encoding within a slice relies on creating a position
dependant resonance response of the spins after excitation. The encoding can be employed in
two forms: frequency and phase encoding, which is then decoded using a Fourier transform. If
the gradients are used for spatial encoding, they are referred to as frequency and phase encoding
gradients. The details of how slice selective and encoding gradients are used to form an MR
image is described below.
3.3.1 Imaging gradients
Magnetic field gradient G is the linear variation of the z component of the magnetic field Bz in
space and time, where z is the direction of the main magnetic field B0. Since Bz can vary in
any of the three orthogonal directions, the field gradient can be expressed as a vector:
~G(t) =
@Bz(~r, t)
@x
xˆ+
@Bz(~r, t)
@y
yˆ +
@Bz(~r, t)
@z
zˆ ⌘ Gxxˆ(t) +Gyyˆ(t) +Gz yˆ(t) (3.38)
whereGx,Gy andGz are the three orthogonal components of ~G, ~r is a displacement vector from
the gradient isocenter, xˆ, yˆ and zˆ are the unit vectors of the Cartesian coordinate system. The
gradient amplitudes are given in mT/m (or G/cm). If the field gradient is applied, the additional
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magnetic field at the position described by ~r is equal to ~G(t) · ~r and the total magnetic field at
this location is given by:
~B(~r, t) =
⇣
B0 + ~G(t) · ~r
⌘
zˆ = (B0 +Gxx(t) +Gyy(t) +Gzz(t)) zˆ (3.39)
3.3.2 Spacial selectivity
Selective excitation and refocusing. To obtain spatial selectivity (slice selection), an RF
pulse is played out concurrently with a magnetic field gradient. In the presence of a gradient
Gz , the Larmor frequency at the position z is given by:
f(z) =
 
2⇡
B0 +
 
2⇡
~G(t) · ~r = f0 +  
2⇡
Gzz (3.40)
where f0 is the Larmor frequency of the spins at the isocenter. To select spins at the position  z
away from a isocenter, the carrier frequency of the RF pulse needs to be adjusted, from that at
the isocenter, by the offset  fRF given by:
 fRF =
 
2⇡
Gz z (3.41)
The RF pulse contains a bandwidth of frequencies  fRF which translates into a band of loca-
tions:
 z =
2⇡ fRF
 Gz
(3.42)
where  z is the width of the selected region. This dependency and its utilisation for offsetting
the slices or controlling the slice width is illustrated in figure 3.2 and 3.3, respectively. The RF
bandwidth fRF is given by the full width at half maximum (FWHM) of the frequency profile,
which, for small angles, can be approximated by the Fourier Transform of the pulse envelope.
Apart from spatial selection, the slice selection gradient causes a phase variation across the
slice. To compensate for this phase dispersion, a slice refocusing gradient is applied after the
RF excitation pulse. The maximal possible extent of the refocus of the phase dispersion across
the slice is calculated based on the isodelay parameter  tI , which is the dephasing time that
results in phase dispersion. The phase introduced by the slice selective gradient is given by:
 (z) =  Gzz tI (3.43)
Across the slice this equals to:
  (z) =  Gz z tI (3.44)
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Substituting  z with equation 3.42, the above simplifies to:
  (z) = 2⇡ fRF tI (3.45)
which states that the phase dispersion (in cycles) across the slice is approximately given by the
product of the RF bandwidth and the isodelay [12].
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Figure 3.2: RF carrier frequency offset
 fRF is used to offset the centre of the slice
by a distance  z from the gradient isocenter.
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Figure 3.3: The stronger gradient Gz1 pro-
duces a thiner slice z1 compared to a weaker
gradient Gz2 for s given band width  fRF
3.3.3 Spatial encoding
Frequency encoding. Frequency encoding relies on the linear dependency of the spins’ fre-
quency on their spatial location, as illustrated in figure 3.4. This is achieved by applying a
linear gradient field. In the presence of such a gradient applied in the x direction, the Larmor
frequency at the position x is given by:
 !(x) =  Gxx (3.46)
and the signal generated at the infinitesimal interval dx is (from equation 3.36):
dS(x, t) = ⇢(x) exp( t/T ⇤2 ) exp(i xGxt)dx (3.47)
In general case, the total signal from the sample is:
S(t) =
Z
object
⇢(r) exp( t/T ⇤2 ) exp(i GFEr · tdr) (3.48)
where frequency encoding gradientGFE = (Gx, Gy, Gz).
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Phase encoding. To achieve phase encoding, a linear gradient field is applied for a duration
TPE and turned off before data acquisition (see figure 3.5). Therefore, at the position x:
dS(x, t) =
8><>:⇢(x) exp( t/T
⇤
2 ) exp(i xGxt)dx 0  t  TPE
⇢(x) exp( t/T ⇤2 ) exp(i xGxTPE)dx TPE  t
(3.49)
As a result of the first interval the spins accumulate different phases, depending on the frequency
at which they oscillated. Therefore, after the first period of Gx, the phase will equal to:
 (x) =  GxxTPE (3.50)
In general, this can be written as:
 (r) =  GPErTPE (3.51)
where frequency encoding gradient GPE = (Gx, Gy, Gz). The total received signal is the sum
of all the local phase-encoded signals and it’s given by:
S(t) =
Z
object
⇢(r) exp( t/T ⇤2 ) exp(i GPEr · TPE)dr (3.52)
Comparing the above expression with 3.48 it can be appreciated that both phase and fre-
quency gradients encode the signal by spatially varying the frequency of the spins. The main
difference lies in the acquisition time: while the PE gradient is applied before the acquisition
begins, the FE gradient is applied during the acquisition.
k-space To spatially encode a 2D plane, the phase and frequency encoding gradients are ap-
plied in perpendicular directions. The signal from spins at position x, y following both fre-
quency and phase encoding is given by:
dS(t) = ⇢(x, y) exp( t/T ⇤2 ) exp(i xGFEt) · exp(i yGPETPE)dxdy (3.53)
With a substitution: 8><>:kx(t) =
 
2⇡GFE · t
ky(t) =
 
2⇡GPE · t
(3.54)
equation 3.53 becomes:
S(kx, ky) =
Z Z
⇢(x, y) exp( t/T ⇤2 ) · exp(i2⇡(kxx+ kyy)) · dxdy (3.55)
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Figure 3.4: Example of signal at 3 different
locations in the presence of a frequency encod-
ing gradient. Acquired signal is a composition
of all frequencies (figure 5.7 from [9]).
Figure 3.5: Example of signal at 3 different
locations after applying phase encoding gra-
dient for a duration of TPE (figure 5.9 from
Liang2000).
which, with the exemption of the T ⇤2 , term is the inverse Fourier transform of the spin density
⇢(x, y):
⇢(x, y) =
Z Z
S(kx, ky) · exp( i2⇡(kxx+ kyy)) · dkxdky (3.56)
Position (x, y) and spatial frequency (kx, ky) are said to constitute a Fourier transform pair. The
signal data matrix filled is called k-space. A Fourier transform of k-space data yields an image.
3.3.4 Echo formation
A signal measured in an MR experiment is called an echo. Echoes are created when magneti-
sation, tilted away from the equilibrium with an excitation RF pulse, first dephases and then
gets refocused. There are two ways of refocusing the spins: (i) using refocusing gradient, or
(ii) using a 180  refocusing RF pulse. Depending on the refocusing type, the echo is called
gradient or spin echo.
Gradient Echo. A gradient echo (or field echo) is created by rapid dephasing and rephasing
of the transverse magnetisation, by changing spins precession frequencies. However, since the
rephasing gradient can only compensate dephasing caused by the dephasing gradient, dephasing
due to main magnetic field inhomogeneities or T2 relaxation is not refocused. The amplitude of
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the echo, acquired at the echo time, TE, is therefore given by:
SGE = S0 exp
✓
 TE
T ⇤2
◆
(3.57)
An example of a gradient echo sequence is shown in figure 3.6.
Spin Echo. A spin echo is created by applying a 180  refocusing RF pulse, which refocuses
the spins that naturally dephased after 90  excitation pulse. The 180  refocusing RF pulse
reverses the accrued phase, therefore the amplitude of the echo will not depend on inhomo-
geneities:
SSE = S0 exp
✓
 TE
T2
◆
(3.58)
An example of a spin echo sequence is shown in figure 3.7.
Figure 3.6: Example of gradient echo. An
echo is formed by first dephasing and then
rephasing of the spins, achieved by rapid
switching of the gradient (figure 8.9a from
[10])
Figure 3.7: Example of spin echo. After
dephasing, the spins are refocused by a 180 
pulse (figure 8.10a from [10])
3.3.5 Pulse sequence
A pulse sequence is a series of events including RF pulses, gradients and data acquisition,
with precisely defined timing. First, an RF pulse is played out together with a slice selective
gradient, causing an excitation of a two-dimensional plane (a slice). Next, phase encoding is
applied orthogonal to the slice selection direction. The frequency encoding gradient is applied
in the third orthogonal direction and the signal is acquired. The sequence is then repeated for
each phase encoding steps until k-space is filled. Fast Fourier Transform (FFT) of the k-space
data yields an image. The pulse sequence is usually visualised using a pulse sequence diagram,
with time on the horizontal and amplitude on the vertical axis. An example the gradient-echo
pulse sequence diagram is shown in figure 3.8.
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Figure 3.8: Example of a simple gradient-echo pulse sequence and k-space path. After a selective RF
pulse (A), phase encoding rephrasing gradients are applied (B). Next, an echo is formed and recorded
during frequency encoding gradient (B-D). This is repeated for each phase encoding step till a full k-
space is filled in. (Figures 7.19 and 7.23 from [10])
The number of acquired points,M and phase encoding steps, N is dictated by the required
field of view (FOV ): 8><>:FOVFE = M · x =
2⇡
 GFE t
FOVPE = N · y = 2⇡  GPETPE
(3.59)
3.4 Fast imaging: Echo Planar Imaging
One of the fastest MRI techniques is Echo Planar Imaging (EPI) [46]. EPI is capable of pro-
ducing a 2D image in tens of milliseconds, and it is therefore broadly used in applications that
benefit from such acquisition speed (e.g. arterial spin labelling). In EPI, the full k-space is ac-
quired after a single RF excitation pulse by using bipolar readout gradients and ’blipped’ phase
encoding gradients, which generate a train of echoes (as illustrated in figure 3.9). Due to the
speed of acquisition, EPI suffers from a range of artefacts like ghosting, chemical shift artefacts,
distortions and blurring. More details on the EPI artefacts and their prevention can be found in
[12].
3.5 Imaging moving spins: Phase Contrast
Phase contrast is an imaging method which enables quantification of the velocity of moving
spins by applying flow encoding gradients. Spins moving in the direction of the flow encoding
62 of 212
Chapter 3. Introduction to magnetic resonance imaging and spectroscopy
Figure 3.9: Echo-planar sequence and the k-space path (figures 16a and 16b from [10]).
gradient field G of duration T with velocity v accrue a phase  v:
 v =  
Z T
0
Gvt · dt =

1
2
 vGt2
 T
0
=
1
2
 vGT 2 (3.60)
where GT 2 is referred as the first moment of the gradient M1. Typically, a bipolar gradient
waveform is used, which is composed of two flow encoding gradients with the same amplitude
but opposite polarity (applied in the time from T to 2T ), therefore the total phase shift is:
 v =   vM1 (3.61)
To avoid contribution to the phase from external factors, like B0 inhomogeneities, the scan is
usually performed with the inverted polarity of the bipolar gradient. The subtraction of the phase
images on pixel-by-pixel basis yields:
  v =  v M1 (3.62)
The dynamic range of  v is limited to±⇡ and it is therefore only possible to reliably determine
the flow velocity for phase values within this range, unless unwrapping algorithms are used
in post processing. The maximum velocity that produces a phase shift of ⇡ radians is called
V ENC (Velocity ENCoding) and is given by:
V ENC =
⇡
|  M1| (3.63)
and the velocity can be calculated from:
v =
 v
⇡
V ENC, where   V ENC < v < V ENC (3.64)
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3.6 Magnetic Resonance Spectroscopy
3.6.1 Principles
Magnetic resonance spectroscopy (MRS) is a MR technique that allows non-invasive measure-
ment of selected biochemical compounds in-vivo. MRS is possible owing to a phenomenon
called chemical shift, in which protons in different molecular environments experience different
amounts of shielding of the magnetic field by the electron clouds of neighbouring atoms. There-
fore the effective magnetic field, B0,eff is different to that applied, B0, and can be expressed in
terms of a shielding parameter,  :
B0,eff = B0 (1   ) (3.65)
and the resonance frequency becomes:
!0,eff =  B0,eff = !0 (1   ) (3.66)
Chemical shift enables differentiation of different chemical environments based on their reso-
nance frequencies.   is very small and the resulting frequency offset depends on B0, therefore
the chemical shift is usually defined in parts per million (ppm) of the resonance frequency mea-
sured relative to a reference compound (!ref ): 106 (!eff   !ref/!ref ) ppm.
In addition to chemical shift effect, protons in liquid samples usually experience the mag-
netic field of their nuclei through polarisation of the electrons in the molecular bonds between
them. The effective magnetic field experienced by one nucleus depends on the spin state of the
neighbouring coupled nucleus. This is so called J-coupling and the effect is B0 independent.
Since the technique is relatively insensitive only compounds present in millimolar concentra-
tions are detectable using clinical in vivo MRS.
Although many studies have investigated nuclei such as phosphorous-31 (31P) and some
carbon-13 (13C), proton (1H) spectroscopy is by far the most popular, given its natural abun-
dance and higher SNR, and no need for specialised hardware which allows performance of
proton spectroscopy on most commercial MRI scanners. Therefore the rest of this section will
focus on 1H MRS.
3.6.2 Information content
An example spectra obtained from a phantom containing the main brain metabolites acquired at
different TE are shown in the figure 3.10. The most important compounds detectable by proton
64 of 212
Chapter 3. Introduction to magnetic resonance imaging and spectroscopy
MRS in the human brain are listed below, together with their chemical shifts:
Lactate (Lac) 1.3 ppm. In the normal human brain the concentration of lactate methyl is very
low, therefore it is not usually detected. However, lactate is increased, and therefore detectable,
in pathological conditions resulting from hypoxia or ischemia, when glucose metabolism by the
means of the Krebs cycle is no longer sustained (see chapter 2 for more details on the Krebs
cycle). Lactate can be also elevated in pathologies such as tumours and mitochondrial diseases,
in which Krebs cycle is inefficient.
N-acetyl aspartate (NAA), 2 ppm. NAA is the most abundant amino acid in the central ner-
vous system; its decrease can represent neuronal loss, and increase is observed in neuronal
development. However, the exact functions and roles of this amino acid are unclear.
Creatine (Cr) 3 ppm & 3.9 ppm. Creatine is a compound involved in energy metabolism.
Cr is converted to phosphocreatine , which is the short-term energy storage form of the tissue.
Therefore the total measured Cr (sum of PCr and Cr) may reflect the energy potential available.
Choline (Cho) 3.2 ppm. The Cho peak consists of free choline, phosphocholine and glyc-
erophosphocholine. These compounds are involved in membrane synthesis and degeneration,
and their levels can be elevated in diseases like tumours, where increased membrane turnover is
involved.
Figure 3.10: Example of MR spectroscopy obtained in a phantom containing the main brain metabolites
in normal concentrations plus lactate.TE = 30 ms (a), 135 ms (b) and 270 ms (c) (figure 15.1 from [10]).
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3.6.3 Acquisition
The spatial localisation of a single voxel is achieved by applying three slice selective pulses in
mutually orthogonal directions. This is illustrated in figure 3.11 [11], where black, green and
red represent slice selection in x, y and z direction, respectively. Two most commonly used
sequences for spatial localisation are: STimulated Echo Acquisition Mode (STEAM) and Point
RESolved Spectroscopy (PRESS).
1. STimulated Echo Acquisition Mode - STEAM. The STEAM sequence consists of three
90  orthogonal slice selective pulses, which produce a stimulated echo. Spin-echoes from
the second or third pulse are dephased by large crusher gradient applied between the sec-
ond and third pulse. Any other undesired coherence is also removed using crusher gradi-
ents applied during the echo time. An example of the STEAM pulse sequence (without
crusher gradients) is given in figure 3.12.
2. PRESS - Point RESolved Spectroscopy. The PRESS sequence uses one 90  and two re-
focusing 180  pulses to generate a spin echo in the localised volume. Additional crusher
gradients are applied around the refocusing pulses to dephase any undesired coherence
pathways and therefore select only the desired spin-echo signal. An example of the
PRESS pulse sequence (without crusher gradients) is given in figure 3.13.
PRESS is characterised by higher SNR compared to STEAM, but STEAM can be performed
with shorter TE. However, the performance of the two sequences is comparable in clinical brain
spectroscopy, and the choice of sequence depends on the availability from the MRI vendor or
the particular application that is required [11].
3.6.4 Processing and analysis
The main goal of MRS analysis is to measure the concentration of the compounds present in
the spectra. Metabolite concentrations are proportional to their respective peak areas, however,
measuring them in vivo can be challenging due to resonance overlap, baseline distortions, and
poor approximation of conventional models such as Gaussian or Lorentzian functions as line-
shapes. Therefore many studies report relative amounts (ratios) of each metabolite, for example
Lac/NAA in the case of HIE neonates.
The following steps are performed to obtain a readable spectrum:
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Figure 3.11: Voxel localisation (figure 1a from [11])
Figure 3.12: Example of STEAM pulse se-
quence (figure 1b from [11])
Figure 3.13: Example of PRESS pulse se-
quence (figure 1c from [11])
1. Fourier transform data from time to frequency domain to represent the data as spectral
intensity as a function of frequency.
2. Correction of phase and timing error, associated with the scanner receiver pathway and
the start of recording the data
3. Correction of frequency errors resulting from subject’s motion
4. Spectral fitting in time or frequency domain.
3.7 Summary
This chapter presented a basic theory of magnetic resonance imaging and spectroscopy. It de-
scribed the magnetic resonance phenomenon, how field gradients and RF pulses are used for
MR image formation and quantification of moving spins. It also illustrated how chemical shift
of different molecular environments is used to identify the brain metabolites.
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The aim of this chapter was to provide background of the mathematical formalism, image
formation, basic imaging techniques and spectroscopy for the following chapters, in which these
concepts will be used.
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Introduction to neonatal perfusion
quantification with arterial spin
labelling
4.1 Introduction
This chapter begins with a short overview of the neonatal cerebral blood flow measurement
methods. It then provides an introduction to a concept of the arterial spin labelling, describes
models that allow perfusion quantification and discusses sources of potential quantification er-
rors. It finished with a review of the recent work on perfusion measurement in neonates, which
provides the basis for in-vivo protocol development described in chapter 7.
4.2 Motivation
Cerebral circulation in preterm and high risk infants has been a subject of numerous studies,
aiming to determine pathological mechanism of cerebral damage as well as evaluate maturation
in developing brain. In normal developing preterms, cerebral blood flow (CBF ) was found to be
much lower than in adults and changed rapidly during first weeks of life, reflecting first low and
then increasing brain activity and metabolism [47],[48],[49]. In premature infants with intraven-
tricular haemorrhage and hemorrhagic intracerebral involvement, abnormalities in CBF were
observed, [50] indicating the role of impaired CBF in brain damage [51]. Term and preterm
infants, as well as infants with HIE, were also found to have much lower CBF compared to
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adults [16]. Additionally, different patterns of HI brain injury emerged from CBF maps [52]:
watershed, basal ganglia and total cortical pattern.
A variety of different methods has been employed to study neonatal brain perfusion. CBF
in high risk and normal neonates has been investigated using radioisotopes: Xenon clearance
[47], positron emission topography (PET) [50], [53], [16], and single-proton emission computer
tomography (SPECT) [54], as well as non-invasive Doppler ultrasonography and near- infrared
spectroscopy (NIRS) [55], [56]. Magnetic resonance imaging (MRI) methods have also been
used: phase contrast (PC) [57], arterial spin labelling (ASL)[58],[49] and dynamic bolus track-
ing [59], [52], requiring an injection of a gadolinium contrast agent. Table 4.1 sums up the
quantification of CBF derived from different methods in neonates with different pathological
conditions. However, the direct comparison of CBF values provided might be difficult, as each
of the method has its own limitations and different accuracy.
Method N GA Weight
at
birth(g)
Postnatal
Age (d)
Condition CBF Range
mL/100g/min
Xe clearance [47] 42 28-33 1510 0-5 preterm 5.6-36.8
Xe clearance [56] 16 27-39 1753 9-74h preterm 7.2-22.0
PET [16] 16 26-36 1355 2.0-39 preterm 5.0-23
14 term 3180 2.0-40 HIE or
ECMO
9.0-73
NIRS [55] 9 25-44 1.0-10.0 12.0-33
NIRS [56] 16 27-39 1753 9-74h preterm 6.21-21.0
PC MRI [57] 13 27-38 - 33-97 mild HIE 18-30
7 term - 45-49 mild HIE 25-60
MRI ASL [58] 23 28-34 - 63 (median) preterm 21.3 (± 5.1)
6 37-42 - 2 (median) normal 16.6 (± 5.9)
Table 4.1: Summary of measured CBF values in studies using different techniques; ECMO - status after
common carotid ligation and extracorporeal membrane oxygenation; HIE - hypoxic-ischemic encephalopa-
thy, GA - gestational age
ASL is a method of choice for CBF measurement in neonatal population. It is truly
non-invasive as it does not require injection or inhalation of radioisotopes (as opposed to Xenon
clearance, PET, SPECT) or other contrast agents (like dynamic bolus tracking MRI), therefore
allowing CBF quantification and repeated measurements safely as many times as required.
Additionally, it capable is of providing regional CBF maps, in contrast to ultrasound, NIRS
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or phase contrast MRI. However, ASL protocol and CBF quantification needs to be carefully
designed to reflect neonatal physiology, which in turn requires an understanding of underlying
model assumptions and potential quantification errors.
4.3 Introduction to arterial spin labelling
Arterial spin labelling is capable of imaging and quantifying CBF non-invasively by using
water as an endogenous, freely diffusible tracer. The principle behind ASL is to measure the flow
rate of arterial blood delivered to imaging voxels within the slice of interest. This is achieved by
magnetically labelling blood water protons with one or several RF pulses applied to the arterial
input of the imaging slice. Such prepared water molecules then travel with the blood and reach
the tissue at a rate proportional to the local CBF . The image is acquired after a delay, sufficient
to allow labeled spins to reach the imaged slice. The presence of labelled blood water and
unlabelled tissue water within a voxel gives rise to the MR signal change. An analogous image is
then acquired without the labelling and subtraction of the two yields a perfusion weighted image.
Since the signal from the static tissue in both control and label images is identical, it subtracts
out leaving only the signal of labelled arterial blood water delivered during the delay time. The
signal-to-noise ratio (SNR) of a single subtraction image is very low; the signal change due
to the perfusion is in the order of 0.5-1.5% of the full signal [60]. Therefore usually multiple
repeats of labelled and control conditions are performed and averaged in a post processing step,
resulting in a mean perfusion weighted image (PWI).
The feasibility of the ASL concept was demonstrated by Williams et al. [61] and Detre
et al. [62] in 1992. Williams used adiabatic fast passage (AFP) for flowing spin inversion,
whereas Detre used a train of pulses to saturate arterial spins in the neck. Williams method gave
rise to continuous ASL methods (CASL), in which the labelling is carried out by using a long
(2-4s) continuous radiofrequency (RF) pulse while applying a magnetic field gradient in the
flow direction. However, due to specialist hardware requirements of AFP (i.e. gradient and RF
amplifier duty cycle), there was a limited usage of this method in the clinical setting. A different
approach to labelling was proposed by Edelman et al. [63] in 1994, called EPISTAR. He applied
pulsed adiabatic inversion to a slab of arterial blood proximal to the imaging slice. Additionally,
he used Echo Planar Imaging (EPI [46]), a fast imaging technique, which significantly increased
the time resolution between control and label experiments. As a consequence, motion artefacts
were reduced and multiple signal averages were acquired to compensate for the low SNR of
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pulsed approach. Also, the power deposition of such a scheme was lower than that of the long
pulse in CASL. Introduction of pulsed labelling in ASL (PASL) allowed for more common
usage of ASL in clinics, since no additional hardware was required. This also accelerated ASL
development: since EPISTAR, a number of other PASL schemes were proposed to enable better
and more accurate quantification as well as reduction of confounding effects like magnetisation
transfer (MT). However, PASL suffers from lower SNR compared to CASL label due to lower
signal difference between control and label [64].
Recently, pseudo-continuous ASL (pCASL) was introduced by Dai et al. [65]. Here, a train
of pulses accompanied by gradients is used to invert flowing spins in a "pseudo-continuous"
manner. pCASL has the advantages of CASL, namely the higher SNR, but can be easily realised
on common clinical scanners without additional hardware. Since the main difference between
CASL and pCASL is only in the implementation of the inversion of the flowing spins most of the
considerations of CASL are the same in pCASL. In the descriptions below, pCASL will be used
to represent both CASL and pCASL. In case of any differences between these two methods,
they will be considered separately.
4.4 Perfusion quantification with ASL
Quantification of perfusion from ASL data requires a theoretical model, which accounts for the
label delivery and wash out as well as the relaxation of the label. Two main approaches are used
to derive such a model: modification of the Bloch equations and the General Kinetic Model.
4.4.1 Bloch Equation
In their original work, Detre et al. [62] proposed modification of the Bloch Equation to account
for delivery and clearance of protons, proportional to the local flow:
dMt(t)
dt
=
M0t  Mt(t)
T1t
+ f (Ma(t) Mv(t)) (4.1)
where f is the flow in ml / (g · s), T1t relaxation time of the tissue in the absence of flow or ex-
change between blood and brain water,Mt is the longitudinal magnetisation of brain tissue,M0t
is fully relaxed Mt and Ma and Mv are the longitudinal magnetisation of arterial and venous
blood water, respectively. The first part of equation 4.1 describes the return of theMt to equilib-
rium after a perturbation, as given in detail in chapter 3, section 3.27. Term f (Ma(t) Mv(t))
represents the delivery of the label into the tissue and its clearance by the venous outflow. As-
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suming a single compartment model, the water, a freely diffuseable tracer, exchanges rapidly
across the capillary walls and the magnetisation of water leaving the voxel (Mv(t)) is propor-
tional to the average magnetisation of the whole voxel. Since the volume of the water in the
tissue differs from that in the blood Mv(t) = Mt(t)/  where   is the blood/brain partition
coefficient (concentration of the tracer in brain tissue relative to that of the blood). This very
simple model was later expanded to account for inversion efficiency ([61]), spin relaxation dur-
ing the transit time ( time delay between blood labelling and its arrival to the acquisition plane)
([66],[67]) as well as different relaxation times for water protons in the blood and tissue [68]
and restricted capillary water permeability [69].
4.4.2 General Kinetic Model
Buxton et al. [64] proposed a general kinetic model for ASL perfusion quantification. In this
model, he considered the difference of control and label signals to be a measure of how much of
the original label, created by the inversion pulse, has been delivered to the voxel and survives at
the time of the measurement. Therefore the difference in magnetisation  M becomes a bolus
of an agent delivered by cerebral blood flow and kinetic modelling used in tracer kinetics can be
rewritten as:
 M = 2 ·Ma,0 · f ·
Z t0
0
c (t) · r  t0   t  ·m  t0   t  dt (4.2)
whereMa,0 is the equilibrium magnetisation of arterial blood that fills up the voxel, c(t) is the
delivery function (normalised arterial concentration of magnetisation arriving at the voxel at
time t ), r (t0   t) is the residue function describing the wash out of labelled spins from a voxel,
andm (t0   t) accounts for longitudinal magnetisation relaxation effects. With the assumptions
of (i.) uniform plug flow of arterial blood, (ii.) single compartment model i.e. rapid exchange
between the protons of arterial blood arriving into the voxel and tissue, (iii). blood relaxation
time T1a during arterial transit time ATT until exchange into the tissue and T1t after reaching
the extravascular space, the model can be summarised using the following equations:
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c(t) =
8>>>>>>>>><>>>>>>>>>:
0, t  ATT
↵ · e t/T1a , (PASL) ATT < t  ATT + ⌧
↵ · e ATT/T1a , (pCASL) ATT < t  ATT + ⌧
0, ATT + ⌧ < t
(4.3)
m(t) = e t/T1t (4.4)
r(t) = e f ·t/  (4.5)
where ⌧ is bolus width (PASL) or labelling duration (pCASL) and ↵ - inversion efficiency,
describing the fraction of the maximum possible change in longitudinal relaxation between the
label and control. The above can be solved by applying equations 4.3 - 4.5 to 4.2 for PASL:
 M =
8>>>>>>>>><>>>>>>>>>:
0 t  ATT
2Ma,0 · ↵ · f
 R e
 R1a·t ·  1  e  R(t ATT )  ATT < t  ATT + ⌧
2Ma,0 · ↵ · f
 R e
 R1a·(ATT+⌧)
·  1  e  R(t ATT ) · e R1app·(t ATT ⌧)  ATT + ⌧ < t
(4.6)
and for pCASL:
 M =
8>>>>>>>>><>>>>>>>>>:
0 t  ATT
2Ma,0 · ↵ · f
R1app
e R1a·ATT ·  1  e R1app(t ATT )  ATT < t  ATT + ⌧
2Ma,0 · ↵ · f
R1app
e R1a·ATT · e R1app(t ⌧ ATT )
·  1  e R1app·⌧  ATT + ⌧ < t
(4.7)
where  R = R1a   R1app, R1app = R1t + f/ , R1a = 1/T1a and R1t = 1/T1t. Terms: 
1  e R1app(t ATT )  and  1  e R1app·⌧  describes the approach to the steady state. For
pCASL, t=0 represents the beginning of the labelling.
The above form of function m(t) assumes that the protons start relaxing with tissue relax-
ation time T1t immediately after arriving at the imaging voxel. A more realistic description
of the exchange is to assume that the water proton spend time Tex in the vasculature before
exchanging [70]:
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Figure 4.1: Kinetic Model: theoretical curves of pulsed and pseuo-continuous ASL signal. A - variable
flow rates, B - variable transit times, C - variable bolus durations. Other parameters: T1a = 1.7s,
T1t = 1.3s, ↵ = 1,   = 0.9, ⌧ 1.5s (pCASL) and 1s (PASL), ATT = 0.5s.
m(t) =
8><>:e
 t/T1a t < Tex
e Tex/T1ae (t Tex)/T1t t   Tex
(4.8)
Using equations 4.6 and 4.7 (i.e. assuming a rapid exchange), theoretical curves of the ASL
signal M are plotted in the Figure 4.1 for PASL and pCASL: A - for variable flow rates f , B -
variable arterial transit times ATT , and C - variable bolus length ⌧ . Other parameters used for
the simulation were T1a = 1.7s, T1t = 1.3s, ↵ = 1,   = 0.9, ⌧ = 1.5s (pCASL) and 1s (PASL),
ATT = 0.5s. For PASL, time t = 0 is the time of the inversion pulse, whereas for pCASL t = 0
is the beginning of the labelling train.
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Recently, a simplified solution to equation 4.2 was proposed [71] for use in the clinical
setting for PASL:
CBF =
6000 ·   · M · e
TI
T1,a
2 · ↵ · TI1 ·Mt,0 (4.9)
and for pCASL:
CBF =
6000 ·   · M · e
PLD
T1,a
2 · ↵ · T1,a ·Mt,0
✓
1  e
 ⌧
T1,a
◆ (4.10)
where CBF is given in units of ml/100g/min by multiplication of f by a factor of 6000.
4.4.3 Quantification errors
To obtain quantitative CBF values, T1a, T1t M0a,   and ↵ need to be estimated or measured.
With the use of the kinetic model it can be easily visualised, how a particular systematic error
can affect the quantification of the perfusion for PASL and pCASL approaches and how they
differ in terms of bolus delivery. The most significant quantification errors will now be discussed
together with the potential solutions.
Arterial transit time ATT . Arterial transit time ATT is the time taken by the labelled blood
to travel from the labelling region to the imaging voxel. It differs across brain regions [72]. If
the transit time is unknown, quantification and interpretation of the ASL signal can be incor-
rect, especially in the presence of large transit time differences between the regions within one
imaging slice. This is shown in the figure 4.1 B, in which  M is plotted for 3 different ATT
values. If the acquisition is performed at Tacq1 immediately after the end of the labelling in
pCASL, three different perfusion signals  M would be recorded, even though the value of the
perfusion is the same for these three cases. A solution to this problem was proposed by Alsop
et al. [67]. They introduced a delay time between the labelling and acquisition, termed post
labelling delay, PLD (in case of pCASL). If this delay is longer than the longest transit time:
PLD > ATT , all the labelled spins will be delivered to the imaging voxel before the start of
acquisition ( Tacq2 in figure 4.1 B). This way the dependence on the transit delay of the ASL
experiment is greatly reduced. The labelled spins, that took longer to reach the tissue voxel,
would, indeed, experience less relaxation, since they would spend more time relaxing with the
blood T1b, which is usually longer than than that of the tissue T1b > T1t. However, this is a
small effect for grey matter. Another approach to minimise uncertainty of transit delay is to
acquire data at the multiple time points [64] and fully characterise the inflow of labelled signal.
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Arterial transit artefact. In the case of very big differences in the transit times between dif-
ferent brain regions or very short post labelling delays, the measured signal might be a mixture
of signal arising from the water perfused to the tissue and the arterial blood signal, which is
still in the large vessels at the time of the measurement. This problem can be partially removed
by assuring appropriate PLD or by applying appropriate bipolar crushing gradients to reduce
vascular ASL signal by dephasing the moving spins [73]. However, this increases the effective
echo time, which will introduce T2 (or T ⇤2 ) contrast and result in reduction in SNR.
Unknown bolus duration and dispersion. Under the assumption of plug flow, i.e. the flow
with the constant fluid velocity across any cross-section, the duration of the bolus in pCASL
is equal to the duration of the labelling pulse. In PASL, the width of the labelled bolus can
be controlled with the use of the QUIPSS II (Quantitative Imaging of Perfusion with a Single
Subtraction II) technique [74], [75]. This technique produces a well defined bolus by saturation
of the arterial blood after time TI1, which also gives the bolus a well defined edge. In reality,
however, the blood travels with the range of velocities, which can be different in different parts
of the arterial tree and causes bolus dispersion. To account for that, models of bolus dispersion
have been proposed [76], [77].
Labelling efficiency ↵. The blood exposed to labelling flows in the vessels with mean velocity
ranging from 40 to 60cm/s [78]. This does not present a problem for PASL, since all the spins
are uniformly inverted with a single inversion pulse and inversion efficiency is usually assumed
to be the same for all velocities and equal to the efficiency of the inversion pulse for static
spins. In the case of CASL and pCASL, on the other hand, the inversion efficiency depends
heavily on the blood velocity. For laminar flow, i.e. the flow where the velocities are distributed
across the crossection, the degree of inversion will be different for the blood traveling with
different velocities within an artery. Additionally, if the labelling plane is not perpendicular to
the direction of the flow, the efficiency might be also decreased. This, in the context of pCASL
will be investigated and discussed in details in the chapter 5.
Fully relaxed magnetisation of arterial blood Ma,0. Ma,0 can be measured directly in the
posterior sagittal sinus [60], however most commonlyMa,0 is estimated fromM0 of the tissue
and dividing by  .
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Control for Magnetisation Transfer effects. All ASL techniques, pulsed or continuous, rely
on perfect cancellation of the static tissue signal after subtraction of labeled from control images.
For this to be fulfilled, Magnetisation Transfer (MT) effects in both images must be the identical.
MT is the exchange of longitudinal magnetisation between protons in two pools: the free water
pool and pool of protons bounded to macromolecules. Protons in macromolecules, due to very
short T2 have a very broad resonance frequency compared with free water protons. Therefore
the RF pulse on resonance at the labelling plane, when applied with gradients, will saturate
longitudinal magnetisation in the macromolecular pool at the imaging plane. Next, the saturated
protons bound to macromolecules exchange with those in free water and reduce its MR signal
[79]. If the MT effect is different for control and label images, the resulting difference image
will mis-represent the signal change due to the perfusion and yield incorrect quantification.
Balancing magnetisation transfer in control/label experiments has been a consideration since the
first ASL experiments and prompted the development of labelling/control designs of continuous
and pulsed ASL.
MT in CASL. In the first CASL experiment the control image was created with a pulse
similar to the labelling RF pulse, but with the labelling plane placed distal to the imaging slice
[61], which was well above the brain. The major drawback of this approach is that only one
imaging plane experiences identical saturation effects due to applied gradients during labelling
and therefore MT effects in other slices are not appropriately balanced. A solution to this prob-
lem was proposed by Zhang et al.[80] by using a small, separate labelling coil. This has been
shown to enable multi slice CASL imaging in humans [81]. It is also possible to compensate MT
effects using a single coil, as demonstrated by Alsop et al.[82] by employing a double inversion
during the control imaging (double adiabatic inversion, DAI). During the passage through the
first plane, flowing spins get inverted, however, this process is reversed within the second plane
and the spins are returned to the original magnetisation direction. By assuring that the power
in the control and label experiments are matched, the MT effects are balanced. In practice,
however, it is difficult to satisfy the adiabatic conditions for double inversion, and therefore this
solution suffers from reduced effectiveness of spin labelling.
MT in PASL. In the original single slice EPISTAR [63], the thick, labelling slab was
positioned about 1cm below the imaging plane. The gap was designed to reduce the effect of
imperfect profiles of the inversion slab. For the control, an identical slab was positioned on the
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other side, above the imaging slice with 180   flip angle was used with identical bandwidth, and
total RF irradiation as the inversion pulse. This ensured that the MT effects (already reduced
compared to CASL by using a short RF pulse) are the same in both label and control images.
However, true compensation is present only for a single slice. What is more, the venous blood
inverted in the control can enter the imaging slice and produce artefacts, which would manifest
themselves as negative perfusion signal. A variation of EPISTAR is PICORE (proximal inver-
sion with a control for off-resonance effects) proposed by Wong et al. [75]. PICORE label is
performed in the same way as in EPISTAR, but the inversion pulse in control is performed non-
selectively, with the same frequency offset. This assures the identical MT effects on the imaging
slice and at the same time reduces the inflow artefact seen in EPISTAR. However, the gradients
played out during control and label experiments are different and therefore eddy-current effects
may differ. An improved version of EPISTAR [83] consisted of a labelling pulse, identical
as in the previous version, and two inversion pulses at the same location as the labelling slab,
rather than a single pulse above imaging slice as in the original version. This allowed multislice
acquisition as the MT effects were identical in both label and control pulses.
Another alteration to EPISTAR, TILT (Transfer Insensitive Labelling Technique) introduced
by Golay et al. [84] enabled multislice acquisition by splitting one inversion pulse into two
pulses for labelling. For the control, the second pulse is phase shifted by 180  , which brings the
magnetisation back to its relaxed state. The efficiency of this approach is low in the presence
of inhomogeneities of RF pulses. In PULSAR (Pulsed Star Labelling or Arterial Regions) [85],
the inversion was done with a single adiabatic pulse, whereas in control, double inversion pulses
of half of the power were applied, as in EPISTAR.
A different approach was presented by Kwong et al. [66] and Kim, which was named
by Kim: Flow-Sensitive Alternating Inversion Recovery, FAIR [86]. Here, selective and non-
selective pulses are employed to produce control and label, respectively. Provided, that both
pulses have identical effects on static spins in the imaging plane, the difference image is free
from MT artefact and represents only the inflowing spins. The blood entering the imaging
slice is inverted by nonselective RF (label), but fully relaxed if selective RF was applied. The
problem with this approach is to produce as sharp inversion pulse over the entire slice to match
the nonselective inversion.
The most common designs of ASL experiment are presented in the figure 4.2.
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!!!!!!!!A.!CASL/pCASL! !!!!B.!PASL!(EPISTAR)! !!!!C.!PASL!(FAIR)!
Imaging!slices! Label! Control!
Figure 4.2: ASL designes for CASL/pCASL (A), PASL (B) and FAIR (C). The colour
boxes represent: the imaging slices (green), label (yellow) and control (red) pulses
position.
4.5 Considerations in neonatal ASL experiment design and CBF
quantification
4.5.1 Cerebral blood flow rate and perfusion signal
CBF in the neonates is low, which means that the perfusion signal  M is correspondingly
lower than that found in adults. This is presented in figure 4.3, which shows the signal change
for two CBF values: 60 ml/100g/min (red line, adult) and 20 ml/100g/min (blue line, neonate),
simulated using the general kinetic model (equations: 4.2, 4.3 - 4.4). Each of the flow values was
also used to plot perfusion signal of two labelling schemes: pseudo-continuous ASL (pCASL,
solid line) and pulsed ASL (PASL dashed line) for comparison. As expected, the pCASL tech-
nique provides higher perfusion signal compared to PASL and therefore pCASL is a method
of choice for neonatal perfusion imaging [87]. A consequence of low CBF in neonates is re-
duction in SNR, which means that more repetitions of control/label pairs are needed to reliably
quantify perfusion.
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Figure 4.3: Buxton Model: theoretical curves  M for pCASL and PASL. Other parameters for the
simulations were: T1a = 1.7 s, T1t = 1.3s for adults (red), T1a = 1.5 s, T1t = 2s for neonates (blue),
↵ = 1,   = 1, ⌧ = 1.5s for pCASL and 1s for PASL
4.5.2 Labelling duration
In pCASL, the labelling duration is controlled by the operator and can depend on hardware lim-
itations. Figure 4.4 shows the implications of changing the labelling duration in pCASL: the
longer ⌧ the greater the signal. To understand further the reason for increased signal for longer
labelling, the dependency of labelling duration vs approach to the steady state is plotted in the
figure 4.5. It shows the term related to the approach to the steady state: 1  exp ( ⌧/T 01) where
1/T 01 = 1/T1t + f/  (equation 4.7 for ATT + ⌧ < t). Steady state is the level at which the
perfusion signal is maximum for given flow f and T 01. Prolonging the labelling duration brings
the state closer to the steady state. It can be seen from the Figure 4.5 that the steady state is
reached more slowly in case of neonates, with lower CBF values, than for adults. In order to
match the level of steady state in neonatal group with that of adults with 1.5s labelling duration,
⌧ of 2.4s would have to be used. However, the longer duration of labelling means longer ac-
quisition times which in turn reduces the temporal resolution of the method and its efficiency
i.e. number of averages which can be acquired in a given scan time. Longer acquisition might
be also more prone to motion artefact. Also, long labelling duration might be not feasible due
to hardware limitations (CASL RF amplifier or gradient duty cycle) or SAR limits (pCASL) as
well as decay of the label. Therefore the labelling duration of 1.5s is commonly used in practice.
Moreover, in the case of neonates and young infants with long T1a, the flowing blood might not
fully relax before the control condition and therefore create negative voxels after subtraction
of the label and control images, which has been reported by [88]. In their PASL experiment,
the labelling slab covered almost the whole infant body. Additionally, the infants imaged had a
heart condition causing the mixing of the blood from systematic and pulmonary circulation and
cross-contamination of the label and control acquisitions. The amount of negative voxel was
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much reduced by reduction of the labelling slab width. When using a labelling method with a
thin labelling plane, i.e. pCASL in babies without any heart disease, the mixing and negative
voxels, however, should not be an issue.
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Figure 4.4: Buxton Model: the effect of la-
belling duration ⌧ on the pCASL signal. Other
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Figure 4.5: Buxton Model: the approach to
the steady state for pCASL. Other parameters for
the simulations were: CBF = 60 ml/100g/min,
T1t = 1.3s and   = 0.9 for adults (red), CBF
= 30 ml/100g/min, T1t = 2s and   = 1 for
neonates (blue)
4.5.3 Arterial blood relaxation time T1a.
Arterial blood relaxation time T1a depends on the haematocrit (Hct). Haematocrit is the volume
of the blood occupied by the red blood cells and can vary hugely in the neonatal population
(28-67%), with significant changes within days [89]. It has been shown for a narrow range of
Hct levels of healthy adults, that the relationship between haematocrit and T1a can be described
as [90]:
1
T1a
= a ·Hct+ b (4.11)
Varela et al. [89] found a similar dependency in a neonatal population: a = 0.5 s  1 and
b = 0.37 and the range of T1 of the venous blood T1v to be 1393ms to 2035 ms.
The kinetic model of  M for a range of T1a and T1t in adults and in neonates is plotted in
Figure 4.6 and 4.7. This clearly shows, that the T1a has a significant effect on  M as opposed
to T1t and therefore the knowledge of T1a is crucial for appropriate CBF quantification.
4.6 Findings and limitations of neonatal ASL studies
ASL in neonates has proven feasible and useful by a number of groups. Licht et al. [91] used
ASL to assess CBF in 23 term neonates with severe congenital heart defect. They used PASL
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that had been previously validated in children [88]. They confirmed the previous findings of
much lower CBF compared to healthy adults (mean of 19 ml/100g/min ranging from 7 to 43
ml/100g/min vs 40-60 ml/100g/min in healthy adults [82]) and found association between low
CBF baseline and poor CO2 reactivity with periventricular leukomalacia (PVL). There were
two major limitations of the study. First, the absence of a control group. Second, the assumption
of a constant value of blood T1 for adults and neonates (1.2s at 1.5T). It has been shown by Lu et
al. [90], that blood T1 is dependent on haematocrit. This finding was also confirmed in neonates
by Varela et al. [89]. Since the values of haematocrit in neonates can range from 0.27 to 0.7
[89], this results in a range of T1 of blood between 1.4 and 2s at 3T, which has a significant
effect on CBF quantification.
Miranda et al. [58] looked atCBF in healthy, unsedated term and preterm neonates at term-
equivalent age. Apart from global CBF in the whole brain (WB) they also reported regional
values of CBF in basal ganglia (BG) cortical grey matter (GM) and white matter (WM), which
were found higher at pre-terms than term infants. In both groups, CBF was the highest in BG
(39 and 30 ml/100g/min for pre terms and terms respectively), and was approximately twice
of that in cortical GM (19.3 and 15.8 ml/100g/min for pre terms and terms respectively). WM
perfusion was the lowest (14.8 and 10.3 ml/100g/min for pre terms and terms respectively). WB
perfusion was lower in term controls (16.6 ml/100g/min) compared to preterm infants (21.3
ml/100g/min). This was the first imaging study carried out in heathy infants, permitted by the
non-invasive nature of ASL MRI. However, a similar limitation in this study was present, i.e. a
fixed T1 of the blood equal to 1.5s.
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Wintermark et al. [92] investigated changes in CBF before, during and after therapeu-
tic hypothermia in asphyxiated neonates. Three groups were enrolled to the study: 11 HIE
neonates that received hypothermia, 7 neonates who were not cooled and 4 controls without
brain injury. They found that CBF values in the first week of life were significantly different
in neonates developing brain injury compared to the ones that did not indicating that the sever-
ity of the encephalopathy has an effect on brain perfusion, regardless of hypothermia. Also,
despite hypothermia, some asphyxiated cooled neonates (that later exhibited injury) displayed
hyperperfusion in brain areas (up to 78 ml/100g/min in BG, 19 ml/100g/min in WM and 64
ml/100g/min in GM injury), similarly to infants that were not cooled and also developed BG,
WM or GM injury (up to 88 ml/100g/min in BG, 15 ml/100g/min in WM and 88 ml/100g/min
in GM). For comparison, in controls, the mean CBF was 28, 3 and 39 ml/100g/min in BG,
WM and GM respectively.
Pienaar et al. [93] used the pseudo-continuous method of labelling in ASL to study the
correlation between abnormal perfusion and diffusion weighted images (DWI) in non-cooled
HIE infants. Diffusion weighted images are used to identify the areas of metabolic stress or
evolving necrotic injury. Decrease in apparent diffusion coefficient (ADC) is associated with
complete energy failure in adult ischaemic stroke. The main finding of their work was the
correlation between regions of increased perfusion and low ADC intensity on DWI. The WB
CBF ranged from 13 to 33 ml/100g/min in healthy controls (2 days to 4 weeks of life at the
scan) and from 10 to 70 ml/100g/min in HIE babies (0 to 4 days of life at the scan, with regional
CBF ranging from 70 to 160 ml/100g/min). However, the post labelling delay of 1s might
have skewed the results of CBF quantification, as it is likely that not all the labelled blood has
reached the imaging slice by the time of imaging. Additionally, the labelling duration of 1.2s
might not have been enough to reach the required steady state.
Massaro et al. [94] aimed to correlate the injury seen on conventional MRI and that on ASL
images. Reported CBF was: in WB 24 and 19 ml/100g/min, in BG 52 and 31 ml/100g/min,
in thalamus 52 and 29 ml/100g/min and in WM 12 and 10 ml/100g/min in HIE and control
group respectively. The HIE infants and controls were scanned in the second week of life. They
found increased CBF in BG and thalamus in infants with HIE and no qualitative injury on
conventional MRI compared with healthy controls. The quantification, however, might have
been affected by the choice of short PLD of 1.025s as well as choosing a fixed tissue and blood
T1 of 1.2s and 1.6s respectively.
Recently, Boudes et al. [87] compared the performance of pulsed and pseudo-continuous
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ASL in asphyxiated newborns. The authors found that both methods were feasible and the
quantifiedCBF with each technique was strongly correlated. MeanCBF quantified in a single
slice was highest in the most affected neonates (33.51 ±16.73 and 32.41 ± 14.43 ml/100g/min
for PASL and pCASL respectively) and lower in lest affected neonates (27.48 ±8.21 and 24.65
± 8.82 ml/100g/min for PASL and pCASL respectively) as well in the control group (27.22 ±
8.23 and 24.27± 5.83 ml/100g/min for PASL and pCASL respectively). The authors used blood
T1 of 1.8s for all neonates. In addition, the pCASL images were characterised by significantly
superior image quality compared to PASL, which was quantified using an image quality score.
4.7 Summary
This chapter provided a motivation for choosing pCASL for neonatal perfusion measurements,
reviewed arterial spin labelling techniques, CBF quantification and model limitations result-
ing in quantification errors. Also, a short summary of the recent work on neonatal perfusion
measurement was given. This gave the motivation for detailed analysis of pCASL labelling
that follows in chapter 5 and theoretical background for the protocol optimisation presented in
chapter 7.
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Chapter 5
pCASL simulator for labelling
efficiency estimation
5.1 Introduction
In this chapter, a detailed theory of continuous and pseudo-continuous labelling will be intro-
duced, together with the theoretical basis for labelling efficiency changes due to magnetic field
inhomogeneity and orientation of the flow direction to the labelling plane. Next, a method for
efficient numerical simulation of the Bloch equations for labelling efficiency estimation will be
given, which will be then used to investigate the changes of labelling efficiency for a range of ve-
locities, inhomogeneities and orientations. Following the simulations, in-vivo validation of the
simulator will be described. Finally, the simulator will be used to estimate labelling efficiency
in neonates. An additional application of the simulator for renal blood flow quantification in
healthy adults is given in an appendix.
5.2 Theoretical background
5.2.1 Labelling efficiency
In the previous chapter the perfusion signal of pseudoontinuous Arterial Spin Labelling (pCASL)
was modelled and it was shown that accurate quantification of CBF depends heavily on accurate
estimation of labelling efficiency ↵ (equations 4.7 and 4.10 in chapter 4). Labelling efficiency
is defined as the maximum difference in longitudinal magnetisation Mz after control and label
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pulses:
↵ =
Mz,C  Mz,L
2M0
(5.1)
whereMz,C ,Mz,L are the longitudinal magnetization after the control and label pulses, respec-
tively and M0 is fully relaxed magnetisation. For perfect inversion after labelling ( Mz,L =
 M0) and perfect non-inversion after control ( Mz,C = M0), ↵ = 1. Therefore to estimate
labelling efficiency, knowledge of Mz,C and Mz,L is necessary. Mz,C and Mz,L can be calcu-
lated theoretically from the solution of the Bloch equations, described in detail in section 3.2.2
of chapter 3.
5.2.2 Continuous ASL (CASL)
Magnetic labelling in CASL is achieved through velocity-driven adiabatic inversion [61]. A
constant RF pulse B(t) = B1 exp( i!RF t) with amplitude B1 is applied concurrently with
a field gradient G in the direction of the flowing spins. The frequency offset of this pulse is
chosen to define labelling plane at position r0 (with respect to the gradient isocenter) according
to equation 3.41:  !RF = r0 G. The moving spins will experience variable angular frequency
offset, which in the reference frame rotating at frequency !RF =  B0 +  !RF is defined,
similarly to 3.19, as:
 !(t) =  B0 +  Gr(t)  !RF =  G [r(t)  r0] (5.2)
where r(t) is position of the spin in relation to the magnet isocenter. The effective magnetic
field Bˆeff will have zˆ component equal to  !(t)/  and xˆ component given by the magnitude
of the RF pulse:
~Beff =
zˆ !(t)
 
+ xˆB1 (5.3)
As the spins flow through the field gradient the zˆ component of Beff changes from parallel
to anti-parallel and so does the direction of the ~Beff (Figure 5.1 (a - f)). If the adiabatic condition
is met, the spins magnetisation will nutate around ~Beff and therefore follow its direction. The
adiabatic condition for spins flowing with velocity v is given by:
1
T2b
⌧ G · v| ~Beff |
⌧  
2⇡
| ~Beff | (5.4)
where T2b is the T2 relaxation time of the arterial blood. At low velocities, the inversion effi-
ciency is reduced, as the T2 relaxation dominates. If the velocity of the spins is too high, then the
change of Beff is too rapid for the magnetisation to follow and the efficiency is also reduced.
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Figure 5.1: Flow driven adiabatic passage (figure 17.6 from [12])
5.2.3 Pseudo-Continuous ASL (pCASL)
Pseudo-continuous ASL [65] was designed to perform flow driven inversion in a way that does
not require a long RF pulse and therefore additional hardware, as in case of CASL. To achieve
this, the inversion of flowing spins is realised by using a train of short RF pulses and gradients.
To understand the principles of the pCASL labelling train design, firstly, the rectangular train
of pulses is considered in the presence of a constant gradient. RFr pulse train with rectangular
width  t and spacing  t can be mathematically represented as a convolution of comb and rect
functions:
RFr(t) =
1
 t
comb
✓
t
 t
◆
⇤ rect
✓
t
 t
◆
(5.5)
where ⇤ is the convolution and comb and rect functions are given by:
comb t(t) =
P1
n= 1   (t  n t) = 1 tcomb
 
t
 t
 
and
rect (t/ t) =
8><>: 1 |t| <
 t
2
0 otherwise.
The Fourier transform of such defined RFr(t) is given by:
F{RFr (t)} = comb (f t) ·  tsinc (⇡ tf) (5.6)
since F{comb t (t)} = 1 tcomb 1 t (f), and
1
 tcomb 1 t
(f) =
P1
N= 1  
 
f  N 1 t
 
=
P1
N= 1   (f  N f) = comb(f t).
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Therefore, RFr will result in a number of aliased (repeated) frequencies: N t with their Fourier
response modulated by broad sinc function. In a presence of a constant gradient G applied dur-
ing RFr train, these frequencies will correspond to labelling planes positioned at ra,N = 2⇡N G t ,
where   is the gyromagnetic ratio.
The presence of these undesired aliased labelling planes can be reduced by choosing a RF
pulse with its Fourier response dropping more rapidly, for example Hanning pulse. The train of
Hanning pulses RFh(t) can be written as a convolution ⇤ of comb and Hanning function:
RFh(t) =
1
 t
comb
✓
t
 t
◆
⇤H
✓
t
 t
◆
(5.7)
where Hanning function is defined as: H(t) =
8><>: 0.5 + 0.5 cos (2⇡t) |t| <
1
2
0 otherwise.
and its Fourier transform given by:
F{RFh(t)} = comb (f t) ·  tsinc (⇡ tf) 1
2
 
1   2t f2
  . (5.8)
The Fourier response of Hanning pulse train drops quadratically faster than that of a square
pulse, however it is too broad to supress all aliased planes. The spatial selectivity of the RF
train can be further improved by increasing the gradient amplitude Gmax during each of the
Hanning pulses in relation to the average gradient Gave played out between the consecutive
pulses  t (Figure 5.2).
This way the position of the first aliased labelling plane ra,1 = 2⇡ Gave t
will fall outside
the excitation profile of RFh pulse frequency response (the half width of Hanning pulse can
be approximated to rhw = 2⇡ Gmax t
). Hence, in order to avoid aliased labelling planes the
condition:
r   rhw ) GmaxGave  
 t
 t
(5.9)
needs to be fulfilled. To achieve the position-dependent frequency offset  ! (5.2) during the
time between the pulses, the average gradient between the pulses (Gave) needs to be compara-
ble to G used in CASL. Additionally, an average B1 over the same period of time should be
comparable to that of CASL.
There are two variations of control experiment: ’balanced’ [95], and ’unbalanced’ [96].
’Balanced’ scheme has a control gradient train identical to that of label. In the ’unbalanced’
variation, Gave is equal to zero for control condition. Additionally, for both methods, the phase
of every otherRF pulse in the control pulse train is ⇡ shifted, reversing the effect of the previous
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 t
GmaxRF duration
spacing
Gave
Figure 5.2: A single module of pCASL labelling train
pulse. For labelling planes located at r0 outside scanner isocenter, the frequency offset of the
RF pulses is given by:
 !RF =  Gmaxr0 (5.10)
and the phase increment between consecutive pulses at the location r0, sometimes referred to as
’tracking phase’ [97]:
   =  Gaver0 t (5.11)
and for the control condition, the phase of the n-th pulse of the train:
  n =  Gaver0 t+ ⇡ · (1 + ( 1)
n)
2
(5.12)
On the other hand, if the proton moves through the gradient field, with its initial position r0 and
velocity v0, the true phase accrued between the pulses is given by:
r(t) = r0 + v0t;   =  (t0, t)
  true =  
Z  t
0
G(t) · r(t)dt
  true =  
Z  t
0
G(t) · (r0 + v0 · t) dt
  true =   ·Gave · r0 · t+ 1
2
·  v0Gave t2
(5.13)
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The velocity dependant component 12 ·  vGave t2 is small and therefore there is usually no
need to account for in the in    calculations. However, for high v0 or for large gradient in-
homogeneities the velocity dependant phase accrual might become a source of discrepancies
between   true required to track the spins phase and that subscribed,  .
Pseudo-Continuous ASL (pCASL) in a presence of B0 inhomogeneities and correction
methods
Two types of magnetic field inhomogeneities can influence the labelling efficiency:  B0 and
position dependent inhomogeneities,  Ginh.
B0 inhomogeneities. The presence of B0 inhomogeneities,  B0, changes of the resonance
condition which shifts the labelling plane by  r = r0   r00, as illustrated in the image 5.3. The
new position of the labelling plane can be found from:
  B0
 r
=
 Gmaxr0
r0
) r00 = r0  
 B0
Gmax
(5.14)
Additionally, the true phase accrued between two consecutive pulses of the pCASL RF train
becomes:
   =  Gaver0 t+
1
2
·  v0Gave t2 +  error (5.15)
where:
  error =   B0 t+
1
2
·  v0 B0 t2 (5.16)
Ginh inhomogeneities. The position dependent inhomogeneities,  Ginh, can influence the
labelling efficiency in two ways: affecting the phase increment between two pulses, similarly to
the  B0 and by changing the rate of the frequency sweep required for pseudo-adiabatic inversion
(see equations 5.2 and 5.4 with G = Gave +  Ginh) and therefore the phase accrued between
the pulses. Similarly to  B0, the true phase accrued between the pulses is given by 5.15 with:
  error =   Ginh(rGinh   r0) t+
1
2
·  v(Ginh) t2 (5.17)
where rGinh is the point of crossing of the Ginh with ! axis. Changes of the position and the
thickness of the labelling plane are given by:
 !RF =  Gmaxr0 +   Ginh(rGinh   r0)) r0 =
 !RF    Ginh
 (Gmax +  Ginh)
(5.18)
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Additionally,  Ginh might further deteriorate the efficiency by changing GmaxGave fraction:
G0max
G0ave
=
Gmax +  Ginh
Gave +  Ginh
(5.19)
which might mean that 5.9 is no longer met and the aliased labelling planes are not appropriately
separated from the main labelling plane.
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 r
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xGma
x
+  
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Figure 5.3: The shift of the labelling
plane as a result of  B0
r0r
 
0
 !
 !RF
Gma
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+
 G
in
h
rGinh
Ginh
Figure 5.4: The shift of the labelling
plane and thickness change as a result of
 Ginh
Methods of   correction. The methods for B0 inhomogeneity correction rely on finding an
additional phase increment,  add can be added to    to minimise the effect of  error:
|  error    add| = 0
so that the corrected phase increment is equal to:
  corrected =  Gmaxr0 +  error    add (5.20)
Several methods of finding  add has been proposed. In multiphase pCASL (MP-PCASL) [97],
images are acquired with eight-phase tagging cycle, with   add ranging from 0 to 7⇡/4 every
⇡/4. Then, multiple signal averages are fitted to the function of expected inversion response
to the phase changes (modified Fermi function, or more recently a cos function [98] at 7T) to
yield the PWI and   error on a per-voxel basis. A modification of this approach is to acquire
images with two different   add values and determine the   error from a look-up table [99].
Both approaches rely on an accurate definition/prediction of the response function.
An extension to MP-PCASL is optimised pCASL (OptPCASL) [100],[98]. In OptPCASL
method,   error is found at each main artery location from a pre scan and a mask of perfusion
territories, and compensated for with the use of additional gradients in xy plane.
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A different approach is to find  B0 and  Ginh from a B0 map acquired at the level of the
labelling plane [101]. From the map,  error as well as an additional gradient can be calculated
and added to the refocusing gradient of the pCASL train. The advantage of the last approach is
that it does not require any assumption related to inversion response function and corrects for
velocity dependent phase accrual, as stated in the equation 5.17, and has greater SNR efficiency
compared to MP-PCASL, in which multiple acquisitions are repeated with sub-optimal   add.
However, it does require an additional scan, and therefore, similarly to OptPCASL, requires
more scanning time.
pCASL for spins traveling through labelling plane not perpendicular to the flow direction
The usual assumption made for pCASL is that the spins flow through the labelling plane posi-
tioned perpendicularly to the direction of the flow. However, this might not be always the case
for all feeding arteries simultaneously, given their anatomy and relative position/orientation to
each other. Since the normal to the labelling plane designates the direction of the pCASL gra-
dients, any deviation from the normal means that the rate of change of the spins’ position in the
gradient field (with the respect to the labelling plane) is different to that of the spins velocity
along the direction of the artery (see image 5.5).The new value of effective velocity will be equal
to:
veff = |~v| · cos (⇠) (5.21)
Figure 5.5: Spins traveling though the labelling plane within an artery perpendicular to the labelling
plane (A) and in one that makes an angle ⇠ with the normal to the labelling plane (B)
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5.3 Bloch equation simulator
To estimate the theoretical labelling efficiency for spins moving with a range of velocities in
different scenarios, a Bloch equation simulator was implemented in Matlab. A particle with
starting magnetisation vector ~M0 aligned with the direction of the main magnetic field B0, was
moving with a velocity   through a total distance r, in the presence of RF pulses and field
gradients. After each time interval dt, the location of the particle was updated according to:
rn+1 = rn +   · dt. To find ~M at each location ri, the Bloch equation was solved using
the matrix representation [102]. In this representation, the solution of the Bloch equations is
equivalent to rotation around ~Beff in theBeff rotating frame. Since ~Beff is not constant during
adiabatic inversion, the numerical solution is found by integration of small, finite rotations of
the magnetisation vector ~M . During each time step dt, ~M will process about ~Beff by the angle:
' = 2⇡ | ~Beff |dt (5.22)
In the case of pCASL, the selective pulses are interleaved with refocusing gradients. During an
RF pulse, ~Beff is considered in !RF rotating frame, and therefore equal to:
| ~Beff | =
s✓
zˆ !(t)
 
◆2
+B21 (5.23)
where  !(t) is defined by equation 5.2 and the angle ✓ that ~Beff makes with zˆ direction of
the !RF rotating frame is equal to ✓ = arctan
⇣
B1
 !/ 
⌘
. In the absence of the RF pulse, the
~Beff frame rotates with the frequency at the isocenter, equal to  B0, and therefore  ! and
| ~Beff | reduces to  Gr(t)zˆ and  !(t)  respectively. The angle that the !RF frame rotates about
the isocenter frame within the duration of the pulse  t can be found from:  =  !RF . All the
above can be combined into one rotation matrix R: and applied to magnetization vector ~M for
each time point dt:
R = Rz( )
 1Rz( ) 1Ry(✓) 1Rz(')Ry(✓)Rz( ) (5.24)
where:
Ry(✓) =
2666664
cos ✓ 0   sin ✓
0 1 0
sin ✓ 0 cos ✓
3777775 Rz(') =
2666664
cos' sin' 0
  sin' cos' 0
0 0 1
3777775
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Rz, =
2666664
cos sin 0
  sin cos 0
0 0 1
3777775
which can be seen as changing the coordinate system to one aligned with the phase   of applied
RF pulse Rz( ) (changing in accordance to 5.11 and 5.12 ), next from !RF frame to the
one where ~Beff is aligned with zˆ: Ry(✓), then rotation around the direction of Beff Rz(')
and return to the original reference frame by inverse transformations Rz( ) 1 and Ry(✓) 1.
Finally, Rz( ) 1 accounts for the rotation of !RF rotating frame with respect to the isocentre
frame after each pulse.
In the case of CASL, the RF pulse is applied constantly and therefore R simplifies to:
R = Ry(✓)
 1Rz(')Ry(✓) (5.25)
The effect of T1 and T2 relaxations are accounted for by 3.28:
W (t) =
2666664
exp( dt/T2) 0 0
0 exp( dt/T2) 0
0 0 exp( dt/T1)
3777775 (5.26)
and
Q(t) =
2666664
0
0
M0 · [1  exp( dt/T1)]
3777775
Therefore for each iteration, a new orientation of ~M was found as a result of the rotations
and relaxations:
~Mn+1 = WR ~Mn +Q (5.27)
5.3.1 Methods
Velocities and B1. Simulations were performed for spins moving through the labelling plane
with a range of velocities (1-100cm/s), over a distance of 20 cm. The time step was 4e 6s. The
pCASL RF pulse and gradient trains were matched to that implemented on the Philips scanner
(’balanced’ variety): Gmax = 6mT/m,Gave = 0.6 mT/m, Hanning shaped RF pulses with mean
B1 = 1.175 µT for  t = 0.5ms and  t = 1ms (FA =18 , max B1 = 4.7µT) and B1 = 0.65 µT
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Figure 5.6: Mz simulation results plotted against the location r. Labelling plane was set at r = 0 and
T1b and T2b were set to 1.65s and 0.2s respectively. Scanner default settings of the pCASL train was
used: FA = 18 , Gmax = 6 mT/m, Gave = 0.6 mT/m ,  t = 1ms,  t = 0.5ms
(FA = 10 , max B1 = 2.6µT) to illustrate the effect of the mean B1 on the labelling efficiency
for a range of velocities. The matrix R was pre-computed for each spin location using explicit
solutions of matrix multiplications.
A realistic distribution of flow velocities in the arteries can be modelled by a laminar flow.
This ensures an appropriate weighting by velocity, as the higher flow velocity the greater volume
of the blood delivered by this velocity:
↵weighted( max) =
1
2 2max
Z  max
0
 ↵( )d  (5.28)
where ↵( ) is the efficiency for the particle moving with the velocity  .
Inhomogeneities.  B0 and  Ginh were considered separately:
1. The influence of  B0 was tested in two steps: For the first step, a constant filled of 0.0352
[Gauss] (150 [Hz], estimated from field inhomogeneity at the level of labelling plane in
[101]) was added to the pCASL gradient train.   add was calculated from equation - 5.16
to compensate for the   error and added    with accordance to equation 5.15. For the
second step, theMz for labelled and control conditions was obtained for  error ranging
from  ⇡ to ⇡ and the efficiency calculated according to 5.1.
2. To study the influence of  Ginh, additional linear gradient of 0.02 [Gauss/cm] (similarly
to [101]) was added to the pCASL gradient train.  Ginh gradient was centred at isocenter
for simplicity (i.e. rGinh = 0.) To illustrate the correction with the additional gradient,
the refocusing part of the pCASL gradient train was re-computed to compensate for the
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phase accrued in  Ginh ( Gadd).   error was calculated based on equation 5.17 and
compensated for with  add, ignoring the velocity dependant component.
The pCASL train parameters were matched to the scanner default with FA =18  and the velocity
of moving spins was 50 [cm/s].
Alignment. To quantify the labelling efficiency loss due to imperfect alignment with the vec-
tor normal to the labelling plane, the simulations were performed for angles ⇠ equal from 0
(i.e. flow perpendicular to the labelling plane) to 80  (i.e. flow almost parallel to the labelling
plane). This was done for the velocities ranging from 1 to 80 cm/s with a step size of 5 cm/s.
Additionally, the weighted efficiency was also estimated, as described in 5.3.1.
5.3.2 Results
Velocities and B1. The results of the Bloch equation simulations of Mz inversion for spins
flowing with a range of velocities are shown in the figure 5.6. The calculated efficiencies ↵( )
and weighted efficiencies ↵weighted( max) for two different mean B1 are shown in figures: 5.7
and 5.8. It can be noticed in figure 5.7, that the efficiency rapidly increases with the velocity
up to about 22cm/s and then slowly decreases. This is consistent with the adiabatic condition
prediction 5.4 for slowest and fastest spins and additionally, increasing tracking error   error
for the fastest spins. For more realistic laminar flow model, the weighted efficiency reaches
its maximum for velocities around 38cm/s and the maximum is flat within a broad range of
velocities. Changing the average B1, as seen in the figure 5.8, improves the efficiency of the
slower spins. However, this compromises the efficiency of the spins flowing with the higher
velocities. In a cardiac cycle, a range of velocities are expected. Therefore the best parameter
choice should provide as little dependency of labelling efficiency on velocity as possible.
Inhomogeneities. The shift of the labelling plane and influence of  error as a result of  B0
is shown in the figure 5.9. The direction of the shift depends on the sign of the additional  B0,
in the accordance with equation 5.14. The additional phase  add almost perfectly corrects for
the shift of the labelling plane and the deterioration of theMz inversion. In case of the  Ginh,
the additional gradient in a combination with   add also produce a very good correction. On
its own,   add corrects for the labelling plane shift, but only some inversion loss, as shown in
figure 5.10. This is due to the velocity dependant part or the true phase accrual between the
pulses: 12 · v(Gave+Ginh) t2 that withGinh became a significant component of the true  .
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Figure 5.7: pCASL Labelling efficiency for FA
= 18 , Gmax = 6 mT/m,Gave = 0.6 mT/m, t
= 1ms,   = 0.5ms
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Figure 5.8: pCASL Labelling efficiency for FA
= 10 , Gmax = 6 mT/m,Gave = 0.6 mT/m, t
= 1ms,   = 0.5ms
The results of the Bloch equation simulations ofMz inversion for spins flowing with a range
of velocities and phase offsets  error are shown in the figures 5.11 and 5.12 with the labelling
efficiency in the figure 5.13. It can be clearly seen, that spins traveling at different velocities
are affected differently. For the slowest spin, the efficiency is preserved for the broadest range
of   error. The higher the velocity, the quicker deterioration of the efficiency with the in-
creased phase offset. Again, the velocity dependant part or the true phase accrual between the
pulses: 12 ·  v0 (Gave +  B0) t2 became a significant component of the true  , which is not
compensated for if  B0 is unknown.
A very important observation is that for   error = 180 , control and label conditions are
swapped, as predicted by equation 5.2.3, and the labelling efficiency is equal to 0 for  error =
90 .
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Figure 5.9: Mz simulation results for  B0=150
[Hz] (blue),with additional   add = 54  (pink)
and inhomogeneity free (black). Other parameters
were set to the scanner default, with v = 50 [cm/s]
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Figure 5.10: Mz simulation results for
 Ginh=0.02 [G/cm] (blue), with additional
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(lilac) and inhomogeneity free inversion (black).
Other parameters were set to the scanner default,
with v = 50 [cm/s]
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Figure 5.11: Mz simulation
results for a range of veloc-
ities as a function of phase
offsets; label condition
−200 −150 −100 −50 0 50 100 150 200
−1
−0.8
−0.6
−0.4
−0.2
0
0.2
0.4
0.6
0.8
1
Phase offset [degree]
M
z
 
 
10 [cm/s]
20 [cm/s]
30 [cm/s]
40 [cm/s]
50 [cm/s]
60 [cm/s]
70 [cm/s]
80 [cm/s]
Figure 5.12: Mz simula-
tion results for a range of
velocities as a function of
phase offsets; control condi-
tion
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Aligment. Figures 5.14 and 5.15 show labelling efficiency and weighted labelling efficiency,
respectively as a function of the angle ⇠. Overall, the inversion process is remarkably robust
to the angle between the labelling plane and the flow direction for the flow velocities. This is
especially the case for velocities greater than 20 cm/s. For the highest velocities, improvement
of efficiency can be observed for high values of ⇠ as higher ⇠ reduces cos(⇠) and therefore,
according to equation 5.21, this shifts towards the lower v0, for which the efficiency is at its
highest. However, for the velocities in the lower range (i.e. less than 20cm/s), the lower the
velocity, the quicker reduction of the labelling efficiency with ⇠.
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Figure 5.14: Efficiency as a function of ⇠ for
a range of velocities
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5.3.3 Discussion
Different aspects affecting the labelling efficiency were described and simulated: the field in-
homogeneities and angulation of the labelling plane in respect to the vessel. This was done
for a range of velocities and different B1 values. The simulation results are consistent with
those presented in the literature [65],[99],[101], which reflects the reliability of the presented
implementation.
The labelling efficiency increases with proton velocity till around 25-30 cm/s and does not
change till velocity reaches 50-55cm/s, which is the range of the velocity values most commonly
present in feeding arteries in adults. Also, in presence of inhomogeneities, the efficiency of the
fastest protons decreases the fastest, as true phase accrual between the pulses changes with
velocity (see equations 5.16 and 5.17). However, for velocities in the range between 25-55cm/s
and small inhomogeneities, this is a small effect. Therefore many studies in which pCASL is
employed, assume a single value of ↵ for all subjects to be 0.85 [71]. This is likely to be a good
estimation for adult volunteers and for patients, for which mean velocities in the main feeding
arteries do not deviate significantly from the normal range. However, this is not the case for
the neonates, for which the velocities are much lower and might be dependant on the pathology.
Therefore the labelling efficiency in neonates will be investigated later in section 5.5 of this
chapter.
An important finding here is that the labelling efficiency is sustained for large miss-aligment
of labelling plane with the plane perpendicular to the flow, apart from the spins traveling with
the slowest velocities. This indicates, that the poisoning of the labelling plane is especially
important in the neonatal group.
5.4 Validation of pCASL simulator
5.4.1 Motivation
In order to use the simulator for labelling efficiency estimation for clinical studies, it needs to
be validated. The validation was performed by changing the labelling plane angulation ⇠ and/or
flip angle of the Hanning pulses, as this was easily achievable on the scanner and did not require
any changes in the sequence code, making the validation process more robust.
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5.4.2 Methods
Simulations. The change of labelling efficiency ↵ with the angulation of the labelling plane ⇠
(⇠ = 0 represents flow perpendicular to the labelling plane) was first investigated using Bloch
Equation simulations, similarly to those described in section 5.3.1. Angulation of the labelling
plane was modelled by calculating the effective velocity that spins experience with respect to the
vector perpendicular to the labelling plane according to the equation 5.21: veff = |~v| · cos (⇠)
(see section 5.2.3 for more details). ⇠ was varied from 0 to 80 ; the input velocities ranged
from 1 to 100 cm/s over a distance of 20 cm with a step size of 1 cm/s. Laminar flow was
assumed (see equation 5.28). The pCASL gradient (Gmax = 6mT/m, Gave = 0.6 mT/m) and RF
pulse train (Hanning shaped RF pulses of 0.5ms/1ms duration/spacing, flip angle FA=18 ) were
matched to that implemented on our Philips 3T scanner. To provide predictions of the relative
change in labelling efficiency large enough to be detectable in vivo, a pCASL train with FA=8 
was also simulated. FA=8  was chosen based on the previous simulations (see section 5.3.2).
T1/T2 of the blood was assumed to be 1.65s/0.2s.
In vivo experiments. Two healthy volunteers (1 female, mean age 26yrs) underwent pCASL
scans on a 3T Philips Achieva scanner. The pCASL labelling plane was carefully positioned
using a vessel survey scan. In addition to the standard pCASL acquisition (⇠= 0 , FA=18 ),
two different angles were chosen for ⇠: 30  and 60  with FA=18  (volunteer 1) and FA=8 
(volunteer 2). An example scan plan for ⇠ = 30  is shown in the figure 5.16. The center of
the labelling plane was positioned on the right carotid artery (CA) to keep the same distance
between the labelling plane and the imaging slices for each ⇠. Each scan was repeated twice in a
randomized fashion. pCASL protocol was: 30 control/label pairs, labelling duration: 1.65s, post
labelling delay: 1.8s, GE-EPI readout: FOV 240x240, acq. matrix 64x64 TR/TE 4000/15ms,
BS, 20 slices. An M0 image was also acquired with the readout identical to that of pCASL but
without background suppression.
Processing. All datasets were motion corrected (DTI-TK 1), pairwise subtracted and averaged
before correction for blood T1 relaxation and registration to a study template. M0 images were
chosen to manually draw a mask in the cortex of the right hemisphere to minimize the effect
of the saturation artifact caused by overlap of the labelling plane in the left hemisphere in the
angulated cases (bright stripe in figures 5.17 showing the scan plan and 5.21 showing the final
1http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
101 of 212
Chapter 5. pCASL simulator for labelling efficiency estimation
Figure 5.16: Example of the planning of the scan with ⇠ = 30  on coronal scout,
coronal and sagittal vessel survey. The yellow line and white slab is the position of
the centre and thickness of the labelling plane; red lines indicate the position of the
imaging slices.
Figure 5.17: Example of the planning of the scan with ⇠ = 60  on axial perfusion weighted
image, axial and coronal T1 slices. The white slab is the position of the labelling plane;
bright stripe in perfusion weighted image is caused by the labelling plane cutting through the
brain tissue.
CBF map). The mean perfusion weighted signal within the mask for a given ⇠ and labelling
efficiency ↵, PWI⇠,FA , was then used to estimate the labelling efficiency from the data:
↵⇠,FA = ↵0,18 · PWI⇠,FA/PWI0,18 (5.29)
where PWI0,18 is the mean perfusion weighted signal for the standard acquisition, i.e. ⇠=0
and FA = 18 , for which ↵0,18 was assumed to be 0.89, based on the simulation results for an
average flow of 40cm/s. The ratios between ↵0,18 and ↵⇠,FA were also compared to the results of
simulations to find vmax that best explained the data. Additionally, cerebral blood flow (CBF )
was calculated using a standard equation using ↵0,18 in all cases to demonstrate potential CBF
estimation error.
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Figure 5.18: Simulated efficiency for different ⇠ and flip angles for a range of vmax. Labelling plane
was set at r = 0 and T1b and T2b were set to 1.65s and 0.2s respectively. Scanner default settings of the
pCASL train was used: Gmax = 6 mT/m, Gave = 0.6 mT/m ,  t = 1ms,  t = 0.5ms
5.4.3 Results
The results of the Bloch Equation simulations for ⇠ values of 0 ,15 , 30  and 60  and 2 flip
angles plotted against the maximum velocity of the laminar flow distribution are presented in
figure 5.18. Figures 5.19 and 5.20 show the measured and simulated labelling efficiencies for
volunteer 1 and 2 respectively. The error bar for measured efficiency is the uncertainty assuming
15% error in PWI measurement, and for the simulated efficiency it was estimated from the
simulations for a broad range of velocities. In both cases, the  ⇠,FA/PWI0,18 ratios, and
therefore estimated ↵⇠,FA, follow the prediction of the simulations. CBF was measured at
54.6 (⇠ = 0 ), 58.1 (⇠ = 30 ) and 60.3 (⇠ = 60 ) [ml/100g/min] for volunteer 1 and 21.7
(⇠ = 0 , FA = 8 ), 22.6 (⇠ = 30 , FA = 8 ), 30.1 (⇠ = 60 , FA = 8 ) and, 41.5 (⇠ = 0 , FA
= 18 ), [ml/100g/min] for volunteer 2, which is in agreement with expected values in this age
group. Figure 5.21 illustrates the CBF maps computed for volunteer 1, showing good grey
matter contrast for all 3 values of ⇠. The data was best explained by the v = 60 and v = 60
cm/s for volunteer 1 and 2 respectively.
5.4.4 Discussion
The Bloch Equation Simulator predicted changes in the labelling efficiency which were con-
firmed by in vivo experiments. This proved the validity of the simulator and assumptions made
to model labelling plane angulation.
Additionally, this work confirmed high robustness of the pCASL efficiency against angu-
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Figure 5.19: Results of measured and simulated
labelling efficiency for different ⇠ and flip angles
for volunteer 1 (FA = 18 )
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Figure 5.20: Results of measured and simulated
labelling efficiency for different ⇠ and flip angles
for volunteer 2 (FA = 8 )
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Figure 5.21: CBF maps computed for volunteer 1 acquired
with ⇠ = 0  (first column), ⇠ = 30  (second column) and
⇠ = 60  (third column); top row - coronal view, bottom row -
transverse view. Green arrows point to the artefact caused by
the labelling plane cutting through the brain tissue.
lation of the labelling plane when using the standard 18  pulse train, as predicted by Bloch
Equation simulations. FA=8  was used here to better demonstrate the agreement of the simula-
tions with in-vivo data, as this predicts much larger changes, bearing in mind that this is not a
part of a standard, recommended protocol. In this study, the center of the labelling plane was
positioned on the right CA for consistency. If centered mid-way between the carotid arteries, it
would have caused a difference in the distance between the labelling plane and imaging slices
of 3.6cm/10cm for ⇠ 30 /60  and therefore introduce differences in the arterial transit time for
left and right hemisphere.
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5.5 pCASL labelling efficiency estimation in neonates
5.5.1 Motivation
The average velocity in the feeding arteries in neonates is much lower than in adults [47], [57]
and can be even lower in neonatal pathology [5]. The aim of this section is to obtain labelling
efficiency for neonatal group, based on blood velocities measured in this cohort, described in
details in chapter 8.
5.5.2 Methods
To obtain the velocity, quantitative phase contrast (QFlow, see section 3.5 in chapter 3) images
were acquired in 10 neonates at the level of the labelling plane. A detailed description of this
cohort can be found in chapter 8. Two protocols have been used with the following parameters:
TR/TE = 12/6.1ms, FA =10 , FOV = 100x100x4mm, 20 averages and VENC = 60 cm/s (in
agreement with [57] ) for 4 neonates , and TR/TE = 13/7ms, FA =10 , FOV = 120x120x4mm,
20 averages and VENC = 20 cm/s (in agreement with [103] ). Both protocols were optimised
for neonates in their respective studies. The change of protocol was dictated by the low range
of velocities measured in the studied cohort, which was much lower than 60 cm/s and therefore
reduction of VENC was appropriate, to improve the accuracy of velocity measurement (the
accuracy of velocity measurement is the highest, for VENC just above the expected velocity.
See 3.5 in chapter 3)
Figure 5.22: Magnitude (left) and phase (right) images acquired with QFlow se-
quence with overlaid manual segmentations of four arteries.
The QFlow data was acquired without cardiac gating with 20 averages, therefore the mea-
sured velocities represent the mean value within a cardiac cycle. Right and left common carotid
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arteries (RCA, LCA), and right and left vertebral arteries (RVA,LVA) were manually segmented
using ITK-SNAP2. An example segmentation is shown in the figure 5.22. These segmentations
were used to find mean and maximum velocities, as well as the lumen (the interior of a vessel)
of each artery (i.e. number of segmented voxels times voxel size in mm2). The mean from all 4
ROI were then added to estimate the total flow:
Ftotal =
4X
i=1
vmean,i · si (5.30)
where si is the artery lumen. Bloch equation simulations were performed using the simulator for
velocities ranging from 1 to 40 cm/s every 0.2 cm/s. The maximum velocity found in each ROI
was used to estimate efficiency assuming laminar flow. The mean efficiency was then calculated
as a sum of efficiencies weighted by the amount of flow they contribute:
↵total =
1
Ftotal
4X
i=1
vmean,i · si · ↵weighted(vmax,i) =
4X
i=1
wi · ↵weighted(vmax,i) (5.31)
where ↵weighted is defined by equation 5.28. Using the weighting additionally addresses the
issue of reliability of the velocity measurement with smallest areas due to the partial volume,
i.e. the accuracy of velocity estimation is lower for smaller vessels.
Comparsion to other methods of efficiency estimation
For comparison, the method of Aslan et al. [104] was also used for ↵ estimation. First, the total
flow to the brain was calculated, according to equation 5.30. High resolution anatomical scans
were segmented automatically, as described in methods section of chapter 8. The grey, white
and deep grey matter, cerebellum and brain stem segmentations were summed up and binarised,
and the total volume of brain, V , calculated. To obtain the total CBF in ml/100g/min from PC
measurement, tCBFPC , the brain tissue density ⇢ 1.06 [g/ml] [105] was assumed:
tCBFPC =
Ftotal
V · ⇢ (5.32)
Next, the total tCBFPC was equated to the brain CBF measured with ASL, tCBFASL (cal-
culated with ↵ = 1) and ↵ was found from:
tCBFPC =
1
↵PC
· CBFASL,↵=1 ) ↵PC = CBFASL,↵=1/tCBFPC (5.33)
The agreement between methods of efficiency estimation was assessed using Bland-Altman plot
and limits of agreement (2 · SD).
2http://www.itksnap.org/pmwiki/pmwiki.php
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Figure 5.23: Bland-Altman plot of agreement between two efficiency estimation methods: based on
simulations, ↵total and Aslani, based on phasc-contrast flow, ↵PC . The solid line represents bias and
the dashed lines limits of agreement (2 · SD)
5.5.3 Results
The results for each ROI are presented in the table 5.1. The mean velocity for all neonates
measured in CCAs was 9.55 [cm/s], ranging from 2.7 [cm/s] to 27.2 [cm/s] and 7.3 [cm/s] for
VSs ranging from 3.2 [cm/s] to 25.7 [cm/s], which is in a broad agreement with the literature
[57]. The labelling efficiency, estimated based on these measurements, was 0.77, ranging from
0.58 to 0.88.
Comparsion to other methods of efficiency estimation
The mean and total efficiencies based on the simulations as well as the total flow are presented
in table 5.2. The Bland-Altman plot and limits of agreement between ↵total and ↵PC are shown
in the figure 5.23. The mean difference between the two methods (solid line) is greater than
zero, indicating that ↵total gives on average higher results, compared to ↵PC . The agreement
between the two methods is overall poor, as indicated by very broad limits of agreement (dashed
lines in figure 5.23).
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Left CCA Right CCA
N vmax
[cm/s]
vmean
[cm/s]
s
[cm2]
↵w vmax
[cm/s]
vmean
[cm/s]
s
[cm2]
↵w
1 15.6 9.5 0.055 0.80 24.3 12.5 0.068 0.86
2 10.7 6.2 0.088 0.73 10.7 5.7 0.110 0.73
3 15.5 8.0 0.094 0.80 14.4 7.3 0.094 0.79
4 23.6 12.3 0.056 0.86 21.3 8.5 0.079 0.85
5 32.4 27.0 0.076 0.89 33.9 27.2 0.040 0.89
6 10.4 6.2 0.076 0.73 8.4 5.0 0.040 0.68
7 5.3 2.9 0.117 0.57 4.7 2.7 0.065 0.53
8 18.1 9.0 0.108 0.82 16.8 8.6 0.055 0.81
9 19.8 9.1 0.108 0.84 17.1 9.2 0.056 0.81
10 8.5 5.4 0.061 0.68 7.9 4.5 0.037 0.78
11 18.5 12.0 0.041 0.83 16.5 11.1 0.018 0.81
Mean 16.2 9.8 0.080 0.78 16.0 9.3 0.060 0.78
SD 7.6 6.4 0.025 0.09 8.4 6.6 0.027 0.10
Left VA Right VA
N vmax
[cm/s]
vmean
[cm/s]
s
[cm2]
↵w vmax
[cm/s]
vmean
[cm/s]
s
[cm2]
↵w
1 9.7 7.2 0.012 0.71 10.7 8.4 0.012 0.73
2 5.9 3.5 0.026 0.60 9.6 5.9 0.033 0.71
3 5.7 3.6 0.021 0.59 8.6 6.1 0.018 0.69
4 10.4 1.1 0.037 0.73 15.4 10.3 0.021 0.80
5 26.3 24.0 0.012 0.87 28.7 25.7 0.014 0.80
6 5.7 4.4 0.008 0.58 7.1 4.3 0.027 0.64
7 10.0 4.0 0.012 0.72 7.4 3.8 0.015 0.65
8 10.3 6.7 0.018 0.72 16.6 7.7 0.026 0.81
9 11.4 6.5 0.018 0.74 14.7 7.5 0.021 0.79
10 4.4 3.2 0.012 0.65 4.5 3.4 0.012 0.65
11 12.7 8.6 0.014 0.76 9.3 5.7 0.012 0.70
Mean 10.2 6.6 0.017 0.70 12.1 8.1 0.019 0.72
SD 6.0 6.2 0.008 0.09 6.7 6.2 0.007 0.07
Table 5.1: Blood velocity and labelling efficiency measurements from the carotid and vertebral arteries in
neonatal subjects. vmax - maximum blood velocity, vmean - mean blood velocity, s - artery lumen, ↵w -
efficiency assuming laminar flow distribution of velocities.
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N ↵mean ↵total Ftotal
[ml/min]
V
[cm3]
tCBFPC [ml/
100g/min]
tCBFASL,↵=1
[ml/
100g/min]
↵PC
1 0.78 0.82 94.0 402 22.0 18.8 0.85
2 0.69 0.72 87.5 289 28.5 12.2 0.43
3 0.72 0.78 98.3 369 25.1 18.1 0.72
4 0.81 0.84 97.6 422 21.8 12.5 0.57
5 0.86 0.88 226.3 381 56.0 8.2 0.15
6 0.66 0.70 49.2 384 12.1 12.3 1.02
7 0.62 0.58 37.1 346 10.1 9.8 0.97
8 0.79 0.81 106.1 357 28.0 19.6 0.70
9 0.80 0.82 106.8 380 26.5 20.0 0.75
10 0.69 0.70 34.4
11 0.77 0.80 52.9
Mean 0.74 0.77 90.005 370 25.6 14.6 0.68
SD 0.07 0.09 53.101 38 13.2 4.5 0.27
Table 5.2: Results of estimated labelling efficiency in neonatal subjects. ↵mean - labelling efficiency
averaged for four vessels, ↵total - total simulated labelling efficiency, Ftotal - total flow of blood based
on phase-contrast measurement of velocities, V - brain volume, tCBFPC - total CBF based on phase-
contrast flow estimation, tCBFASL,↵=1 -CBF based on ASL, ↵PC - labelling efficiency based on Aslani’s
method using phase-contrast flow.
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5.5.4 Discussion
This section presents an estimation of labelling efficiency in neonates using simulator and quan-
titative flow measurement for arterial blood flow velocities estimation.
1. No gating was used due to technical restrictions (incubator monitoring), which could
produce more accurate results if efficiency in the cardiac phases was included. However,
using 20 averages, the measured velocity should be equal to the mean velocity in the
cardiac cycle [57]
2. Manual segmentation of the arterial cross-section was used. This could influence the
estimation of the total flow Ftotal
3. The B0 field map was not acquired, and therefore there was no information available
about the amount of B0 inhomogeneities in the neck area of neonates. This could af-
fect the simulation estimation of efficiency, ↵total. However, given the small size of the
neonate, the expected inhomogeneities are less than in adults. Additionally, in the current
implementation on Philips scanner, additional shimming is performed on the level of the
labelling plane, reducing B0 inhomogeneities.
4. Velocity estimation for each artery might have been underestimated due to the partial
volume effects, i.e. the spins flowing fastest share the same voxels with the slower spins.
This could have given a rise to an underestimation of labelling efficiency, especially for
the velocities in the lower range, accordingly (see figure 5.7).
5. The Bland-Altman plot shows that the two methods of ↵ estimation are not in a good
agreement. ↵PC results are characterised much larger distribution compared to methods
using simulation. Aslan’s method relies on a reliable CBF quantification using pCASL
as well as accurate brain volume estimation. This, however, might not be the case in HIE
neonates, as discussed later in this thesis.
6. The simulations show a dependency of the labelling efficiency on velocity, which is es-
pecially apparent in the flow range measured in neonates. Therefore, ideally the blood
velocity at the level of labelling plane should be measured and used to compute ↵ on a
subject-by-subject basis. This will ensure more reliable CBF quantification. In this work,
a single average efficiency value is used.
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5.6 Summary and conclusions
This chapter describes the theory, implementation, validation and usage of the Bloch equation
simulator for pCASL labelling. The simulator provides the flexibility to estimate the labelling
efficiency for any design of RF and gradient train. Moreover, it allows inclusion of the mag-
netic field inhomogeneities (static and gradient) to study the effects of compensation for these
inhomogeneities. It therefore helps to understand the influence of changes in the train design
on the labelling efficiency as well as different real-life scenarios, such as imperfect positioning
of the labelling plane or an inhomogenous B0 field, for a range of velocities and realistic model
of the laminar flow. The results of the simulations presented here are consistent with the results
in the literature and were confirmed in-vivo, demonstrating their reliability and robustness. The
knowledge and experience gained from implementation of the simulator was later used in de-
signing the acoustic noise reduction strategies described in Chapter 6.3. The pCASL parameters
used for simulations are kept consistent with those used by the Philips scanners, as both pCASL
studies were carried out using these scanners and therefore the results for the ’unbalanced’ va-
riety of pCASL was not presented here. However, it is available on the simulator.
The Bloch equation simulator is an important tool in estimation of labelling efficiency in
new applications, as presented in this chapter and in appendix A, for which it has not been
estimated and reported. Also, it enables quantification of efficiency on subject-by-subject basis.
Another important area of usage for the simulator is pre-clinical research, where high magnetic
(B0) fields are used. The simulator described here was used for estimation of labelling efficiency
in rats kidneys and liver (see the third position in the list below). The simulator will be made
publicly available after publishing the PhD thesis.
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Practical aspects of pCASL
6.1 Introduction
The previous chapter described the theory of pCASL. This chapter focuses on the practical
aspect of the methods and provides some solutions to address the existing drawbacks. In section
6.2, an investigation into the effect of angulation of the labelling plane on spin tagging efficiency
is presented, which is an extension of work of the previous chapter. Section 6.3 discusses the
acoustic noise properties of the pCASL labelling train and methods for its reduction.
6.2 Effect of labelling plane angulation on pCASL labelling effi-
ciency
6.2.1 Motivation
pCASL, introduced in detail in chapter 5, is emerging as the method of choice for non-invasive
measurement of tissue perfusion in research and clinical practice [71]. The labelling efficiency
↵, knowledge of which is essential for accurate CBF quantification as discussed in chapters 4
and 5, usually takes a value based on the idealistic model that assumes spins flowing perpendic-
ularly to the labelling plane. In practice, it might not be always possible to meet this assumption
for all feeding arteries at the same time, either due to anatomical variation, lack of appropriate
anatomical scans or lack of angulation flexibility in the pCASL implementation. In chapter 5,
the theoretical background for the effect of the angulation on efficiency was given and it was
found that, even for large offsets of the labelling plane from desired perpendicular position, ⇠,
the labelling efficiency was preserved, which was then confirmed in vivo in two healthy vol-
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unteers. This is a very important finding in the context of clinical practice, clinical trials and
research, as it reassures users of the easiness of its application. The work presented here is ex-
tended to a larger group of volunteers, and other sub optimal positions of the labelling plane, that
could arise in a clinical setting, are also tested. Additionally, a more detailed characterisation of
↵ with increase of ⇠ for spins at different velocities is explored.
6.2.2 Methods
Simulations. The method of the labelling efficiency estimation using Bloch Equation simu-
lations was described in detail in chapter 5 section 5.4.2. The definition of the angle ⇠ here is
consistent to that introduced in chapter 5 section 5.2.3, (see figure 5.5). As previously described,
pCASL gradient amplitudes, as well as RF amplitudes and durations were consistent with the
Philips scanner implementation: Gmax = 6mT/m,Gave = 0.6 mT/m, Hanning shapedRF pulses
of 0.5ms/1ms duration/spacing, flip angle FA = 18 .
The initial results revealed, that even large labelling plane offsets from perpendicularity
result in a small change in labelling efficiency (see figure 5.18). Given relatively low test-retest
reproducibility of pCASL (reference), a larger ⇠, i.e. ⇠ > 15  and reduced flip angle of the
pCASL labelling train provides a detectable difference and therefore is more informative about
the limits of ⇠ that ensure sustained labelling efficiency.
Imaging protocol. 8 healthy volunteers underwent scans (4 females, mean age 28 years) after
providing a written consent. The scans were performed on a 3T Philips scanner, using the 32
channel head coil and standard pCASL vendor implementation (unless indicated otherwise).
The flow chart representing the protocol is shown in figure 6.1.
The core protocol included: T1 MPRAGE ( TI 812ms, TR/TE 6.8/3.1ms, TFE factor 230,
FOV 200x200x180mm, 1x1x1mm SENSE 2, scan duration 5min), phase contrast (PC QFlow,
VENC = 60 cm/s, non-gated), proton density image (TR=9s) and pCASL with three labelling
plane angles, chosen based on the work presented in the previous chapter: ⇠ = 0 , 30  and
60 , performed twice with 20 repetitions in a pseudo-randomised fashion. The labelling plane
was always carefully positioned on the vessel survey and centred on the right carotid artery to
maintain the same distance of the labelling plane from the imaging slices for each ⇠. Other
pCASL parameters were: labelling duration: 1.65s, post labelling delay: 1.8s, GE-EPI readout:
FOV 240x240, acq. matrix 64x64 TR/TE 4000/15ms, BS, 20 slices. The second part of the
protocol consisted of two scans with reduced flip angle of the labelling train (FA = 8 ) and
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Figure 6.1: Flow chart of the study protocol
Figure 6.2: The position of the labelling plane for ⇠ = 30  (A), 60  (B) and parallel
to the vertebral arteries: top kink (C) and bottom kink (D)
two labelling plane angles (⇠ = 0  and 60 ) (5 volunteers) or standard FA = 18  but labelling
plane positioned parallel to the flow direction on the parts of the vertebral artery. The position
of the labelling plane for ⇠ = 30  and 60  and parallel to the vertebral arteries (top and bottom)
are shown in figure 6.2. PC and proton density images were acquired three times, distributed in
time equally during scan duration.
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Post-processing. All datasets were motion corrected by registering all raw images to the vol-
unteer template (i.e. a mean of data acquired with FA = 18  and ⇠ = 0 ) using DTI-TK1
software. Each dataset was then pairwise subtracted, averaged (all acquired repetitions for given
⇠ and FA), corrected for blood T1 relaxation during the labelling delay with T1,a assumed to be
1.65s and divided by the proton density image. Cortical voxels were defined using FSL FAST
segmentation algorithm [106] and after converting to a binary map and restricting to only cover
right hemisphere, carotid and vertebral territories were segmented manually using ITK-SNAP2,
based on anatomical knowledge.
For vascular territories, the watershed regions were avoided. An example of segmentation
into cortex, carotid and vertebral territory is presented in figure 6.3. Mean signal in such defined
regions were then calculated for each acquisition and a paired two-sided Student’s t-test was
used to test the significance of the signal change between different labelling plane orientations
and F-test to test differences in the variance (p < 0.05 was considered statistically significant for
both tests).
Efficiency estimation For each combination of labelling plane angulation and pCASL flip
angle (⇠, FA) a relative labelling efficiency was calculated by dividing the mean signal from
each post-processed acquisition by the signal from the standard acquisition where FA = 18 
and the labelling plane is perpendicular to the arteries:
↵rel,⇠,FA = PWI⇠,FA/PWI0,18 (6.1)
This calculation was done for all segmented regions: cortex and both CA and VA segmented
territories. Additionally, the mean velocity of the blood was measured in CA and VA, using PC
Qflow scans, as shown in figure 6.4. Simulated relative labelling efficiencies were calculated
for these velocities using the results obtained in previous chapter 5 for each acquisition type
(section 5.4.3).
6.2.3 Results
Figure 6.5 shows results of relative labelling efficiency estimated based on the Bloch Equation
simulations and in vivo imaging data, plotted for a range of measured velocities. ↵rel from CA
and VA territories were calculated based on the velocity measured in the respective arteries.
1http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
2http://www.itksnap.org/pmwiki/pmwiki.php
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Cortex' VA'CA'
Figure 6.3: Example segmentation of voxels within cortex, carotid
artery (CA) and vertebral artery (VA) for a single slice.
VA#
CA#
PC#QFlow#
Figure 6.4: Segmentation of feeding arteries for velocity measurement
Although the range of relative labelling efficiencies in the in-vivo data is larger than expected
from simulations, the general trend and predicted order of the acquisitions are similar: the
highest ↵rel was measured for ⇠ = 30  (close to 1), then ⇠ = 60  both with the standard
FA = 18  followed by the ⇠ = 60  and ⇠ = 30  with reduced FA = 8 . This confirms the
model prediction, that for pCASL FA = 8 , the labelling efficiency improves with increase of
⇠.
Mean and standard deviation of ↵rel computed across all volunteers for different regions is
presented in table 6.1. On average, there is no change of the relative labelling efficiency for
⇠ = 30 , and only a small decrease for ⇠ = 60 , especially in the VA territory. For ⇠ = 60 , the
standard deviation is also higher, indicating bigger spread of the data. When comparing PWI
between acquisitions, no statistical significant difference was found between means or variances
of PWI for ⇠ = 0  and ⇠ = 30  or ⇠ = 60  for any of the regions of interest (p ranged from
0.16 to 0.96 for t-test and 0.07 to 0.69 for F-test). A large reduction of ↵rel is observed for the
least desired position, i.e. along the blood direction in the higher ’kink’. Although there is no
average ↵rel change for the bottom ’kink’, the standard deviation for that acquisition is elevated
in VA territory, similar to that of the top ’kink’ location. To better visualise the spread of the
data for each acquisition type, the results of ↵rel for all volunteers are shown in figure 6.6.
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Figure 6.5: Relative efficiency estimated based on simulations and in vivo data (carotid and
vertebral territories) for a range of measured velocities
ROI ⇠ = 30  ⇠ = 60  bottom ’kink’ top ’kink’
Cortex 1.01 (0.08) 0.98 (0.16 ) 1.00 (0.11) 0.87 (0.09)
CA 1.02 (0.08 ) 0.97 (0.13 )
VA 0.99 (0.10) 0.93 (0.12) 0.99 (0.19) 0.84 (0.18)
Table 6.1: Mean relative labelling efficiency for four different positions of the labelling plane.
Standard deviation is given in brackets.
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Figure 6.6: Relative efficiency for four different positions of the labelling plane (⇠ = 30 , ⇠ = 30  bottom and
top ’kink’) and different territories: cortex (blue), carotid artery (CA, yellow), vertebral artery (VA, red). The
boxes represent the 25th and 75th percentile, the line across is the median and whiskers are the spread of the
data (FA = 18 )
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6.2.4 Discussion and conclusions
This study confirmed high robustness of the pCASL efficiency against the angulation of the
labelling plane, even as high as 30  in larger number of volunteers. It also found, that labelling
plane positioned on parallel part of vertebral arteries resulted in a large data variation. Therefore
the highest attention while positioning the labelling plane should be given to ensure accurate
position on the vertebral arteries.
The findings presented here are important in the context of neonatal protocol development
for two reasons. Firstly, the lower velocities of blood in supplying arteries found in neonates,
especially in posterior circulation, are more susceptible to higher angulations of the labelling
plane. Secondly, the position of the neonatal head and neck in the scanner can be tilted to allow
space for a tracheal tubes used as part of breathing support, which makes the position difficult
to predict. A constant distance between the labelling plane and FOV could therefore result in
disadvantageous labelling plane position on parallel part of vertebral arteries.
6.3 Acoustic noise level of pCASL and its reduction
6.3.1 Motivation
Although pCASL offers higher signal-to-noise ratio (SNR) than pulsed ASL and provides better
quality CBF maps, concern has been raised about acoustic noise levels experienced by scanner
operators and patients undergoing the scan, leading to patient anxiety and discomfort. This is
especially a concern in imaging unsedated infants, where exposure to high levels of acoustic
noise might increase stimulation and chances of waking up [107], which in turn might result in
motion artefacts in the images and make diagnosis impossible. This chapter therefore addresses
the need to reduce the Sound Pressure Level (SPL) produced by the pCASL sequence. In this
section the theory of acoustic noise generation and reduction is introduced. This is then applied
to pCASL labelling trains and simulations are performed to find the best labelling train with
reduced SPL while maintaining labelling efficiency. The proposed labelling pulse train is then
tested on a healthy volunteer for in-vivo confirmation of the result.
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6.3.2 Theoretical background
Source of the acoustic noise in MRI
Acoustic noise duringMRI scan is produced by undesired vibrations of the gradient coils in their
assembly. This vibration is a consequence of the Lorentz forces ~FL acting upon the gradient coil,
generated by rapidly changing currents I in the coils in the presence of a static magnetic field
~B0. The magnitude of ~FL is described by 6.2 [108]:
~FL =
Z
l
I ~dl ⇥ ~B0 (6.2)
where~l is a vector of magnitude equal to the length of wire and its direction is along the wire and
⇥ is a cross product. The resultant force deflects the coil structure. Changes of the Lorentz force
with alternating electric currents cause the coil vibrations. These are then transferred through
the gradient coil assembly into the air, producing airborne acoustic waves with pressure P . The
measure of an effective sound pressure relative to the reference, Pref , is the SPL, expressed in
decibels (dB):
SPL = 10 log10
 
P 20
P 2ref
!
= 20 log10
✓
P0
Pref
◆
(6.3)
where P0 is the observed pressure in µ Pa and Pref is a standardised reference value of 20 µ Pa
(the threshold of human hearing).
Several methods for the acoustic noise reduction have been proposed, which can be broadly
divided in to two categories:
1. mechanical, by changes in the design of gradient coils structure [108], assembly [109] or
MR suite [110];
2. non-mechanical (altering the gradient output), by controlling the acoustic response of the
scanner by changing the gradient waveform shape [111] or frequency content of the pulse
sequence [112], [113], [114] .
Since manufacturers optimise mechanical methods, and further modifications via these methods
are not practically possible, non-mechanical methods were investigated.
Acoustic transfer function
Assuming a linear electromechanical system, for any arbitrary physical input g(t), G(f) the
system output p(t), P (f) is given by [112]:
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p(t) =
Z 1
0
h(⌧)g(t  ⌧)d⌧ (6.4)
or in frequency domain:
P (f) = H(f) ·G(f) (6.5)
where h(t),H(f) is the transfer function. This can be calculated as the complex ratio of output
response to an input excitation spectrum:
H(f) =
P (f)
G(f)
(6.6)
Once the transfer function is determined, it can be applied to any input signal to predict the
expected acoustic noise [112]. The input in the frequency domain can be computed using Fast
Fourier Transform of the gradient waveform.
Sources of acoustic noise in pCASL
The main source of acoustic noise in the pCASL labelling module is a long train (1.5-2s) of
rapidly changing gradient waveforms (that accompany RF pulses) (see figure 5.2) repeated
many times over a 4-6 minute scan. Here, the pCASL train is considered to be the input function
g(t). The elements of the pCASL train and their impact on the acoustic noise and the labelling
efficiency are as follows:
RF spacing  t. The spacing between pulses  t dictates the duration of the single gradient
module in the train, which in turn defines the fundamental the frequency f = 1/( t) and its
harmonics at multiples of the peak frequency: fn = nf [112], (figure 6.7). If the fundamental
frequency or any of the harmonics coincides with a peak of the transfer function H(f), the
system response P (f) and therefore acoustic noise will be increased. It is possible to adjust t
so that f and all fn avoid the maximum of H(f) and target H(f) minima.
RF duty cycle. Decreasing RF duty cycle (  t t ) has a significant effect on the noise levels
by reduction of the amplitude and the shape of the negative gradient lobe: there is more time
available to achieve the same gradient moment, which results in reduction of the slew rate and
therefore the gradient waveform is less sharp. This results in a spectrum with the lower relative
the harmonics contribution, as can be seen in figure 6.8 (G2(f)). For fixed Gmax and the same
spacing between the pulses  t, change in duty cycle from 50% to 33% reduces the acoustic
noise from 109.7dB to 107dB. However, to maintain the average B1 between the pulses, the
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flip angle (FA) of pulses in the train needs to be increased. Additionally, the condition in
equation 5.9, i.e. GmaxGave    t t is no longer fulfilled and to sustain the efficiency, Gmax/Gave
ratio needs to be increased, by either increasing Gmax or the amplitude of the negative lobe to
decrease Gave. Also, with more time between the pulses, the pCASL ’phase tracking’ error of
the phase shift between consecutive pulses from equation 5.11 increases and is more susceptible
to gradient or main magnetic field inhomogeneities (see section 5.2.3 in chapter 5).
Gradient amplitude. The amplitude of the selective gradient Gmax defines the width of the
labelling plane. The higher the gradient, the thinner the selectivity of the RF pulses and more
efficient aliasing reduction (equation 5.9). However, the amplitude of the gradient has a direct
implication in terms of the acoustic noise: the higher the gradient the higher the noise. Based on
Fourier Transform of the gradient train alone, reduction ofGmax from 1 to 0.6 G/cm can reduce
acoustic noise from 114.1 to 109.7 dB (more than 50 %). Increasing Gmax/Gave ratio while
keeping Gmax fixed, i.e. increasing the amplitude of the negative lobe, can have a marginal
influence on the acoustic noise, depending on the train design. If the negative gradient fills up
the whole time between 2 consecutive pulses, then increasing the ratio, resulting in increased
gradient moment, needs only a small increase in gradient amplitude.
Flip angle. The flip angle needs to be chosen to assure an adequate mean B1 as discussed
previously in section 5.2.3. This puts the constrains on the possible duty cycle.
6.3.3 Methods
Train design and simulations. To find the pCASL train designG(f) that results in the lowest
theoretical gradient system response P (f), the default pCASL gradient train (Gmax = 6mT/m,
Gave = 0.6 mT/m,  t = 1ms,  t = 0.5ms) was modified using different search strategies sum-
marised in table 6.2. For each strategy, ten  t values were considered, starting from 1 ms with
0.1 ms increment, while  t was either fixed or increased proportionally to  t. The average am-
plitude of RF pulse over  t was fixed, the amplitude of positive gradient lobe was always 0.6
G/cm and the amplitude of the negative lobe was matched so that Gmax/Gave was equal to 10,
15 or 20 depending on the strategy. Bloch equation simulations were performed as described in
chapter 5 to analyse changes in labelling efficiency as a result of changes in pCASL pulse and
gradient train design.
Next, theoretical total SPL for each design was calculated based on the FFT of the gradient
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Figure 6.7: Default pCASL gradient train g1(t) ( t = 1ms,  t = 0.5ms) and an example transfer
function with overlaid the G1(f) (FFT of g1(t)), normalised
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Figure 6.8: pCASL train g2(t) :  t = 1.8ms,  t = 0.6ms and an example transfer function with
overlaid the G2(f) (FFT of g2(t)), normalised. By changing  t the minima of a transfer function
are targeted, and by changing  t, the amplitudes of fn are reduced
train and the scanner transfer function provided by the manufacturer (Philips), according to
equation 6.3, where P0 was the power of system response spectrum calculated based on equation
6.5 for each train design. The flow chart presented in figure 6.9 summarises the method of choice
of the strategies to be tested on the scanner.
SPL measurements. Real system response was measured with a Brüel and Kjaer 2260 in-
tegrating sound level meter on a 3T Philips scanner for the 2 strategies that showed the best
theoretical SPL reduction and best labelling efficiency (i.e. strategy 3 and 6 in table 6.2) .
Measurements were performed at the location of the patient’s ear in the presence of a phan-
tom with linear frequency weighting (i.e. no weighting accounting for perceived ’loudness’ of
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Figure 6.9: Flow chart representing a method for strategy selection
different frequencies by the human ear was employed). The acoustic noise of the EPI readout
module was also measured for comparison.
Imaging. A healthy volunteer (27yrs) underwent a series of pCASL perfusion scans to evalu-
ate the labelling efficiency of four labelling train designs resulted from two best ’strategies’ in
vivo, chosen based on the lowest measured SPL with the highest simulated labelling efficiency
and compared to the scanner default setting. The labelling train parameters were:  t = 0.5ms,
Gmax/Gave = 20,  t = 1.3 with FA = 24 ,  t = 1.8 s with FA = 33  (strategy 3 design),
and Gmax/Gave = 15,  t = 0.5ms,  t = 1.5, with FA = 27 ,  t = 0.63ms,  t = 1.8, with
FA = 33  (strategy 6 design). The scanner default pCASL labelling train was also used for
comparison. Other pCASL parameters were: labelling duration: 1.65s, post labelling delay:
1.5s, GE-EPI readout: FOV 240x240mm, acq. matrix 64x64 TR/TE 4000/15ms, 30 averages.
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Post-processing. As described previously in 6.2.2, all data was motion corrected by register-
ing all raw images to the volunteer template using DTI-TK3 software. Each dataset was then
pairwise subtracted, averaged (all acquired repetitions for given acquisition), corrected for blood
T1 relaxation during the labelling delay with T1,a assumed to be 1.65s. A single mask including
brain tissue was created manually using ITK-SNAP4, which was then used to quantify mean
perfusion weighted signal for each labelling strategy. Next, relative labelling efficiency was
calculated by dividing the mean signal from each post-processed acquisition by the signal from
the standard acquisition:
↵rel,strategy = PWIstrategy/PWIdefault (6.7)
Stra-
tegy
 t [ms]  t [ms] Gmax/Gave Efficiency
min
Efficiency
max
1 1-2 0.5 10 0.53 0.89
2 1-2 0.5 -1 10 0.89 0.89
3 1-2 0.5 20 0.89 0.9
4 1-2 0.5 -1 20 0.9 0.91
5 1.5-1.95 0.5 15 0.85 0.9
6 1.5-1.95 0.5-0.65 15 0.89 0.9
Table 6.2: pCASL train design parameters used to find of the best search strategy; chosen
strategies are highlighted in bold.
6.3.4 Results
The results of the theoretical and measured SPL reduction is shown in figure 6.11. Analysis of
the system response spectra indicated that a reduction of up to 10dB in total SPL is possible
compared to the default scanner settings. A reduction of 6dB compared to the default scanner
setting was achieved for  t =1.8s (  t = 0.5ms for strategy 3 and  t = 0.6ms for strategy 6) and
4dB for t = 1.3s and  t = 0.5ms. Bloch equation simulation showed (table 6.2), that by choos-
ing high Gmean/Gave and/or adjusting the  t, the labelling efficiency was preserved. Relative
labelling efficiency is shown in Figure 6.12, suggest that there is a slight loss of labelling effi-
ciency for chosen strategies compared to default setting, however a larger number of volunteers
3http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
4http://www.itksnap.org/pmwiki/pmwiki.php
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should be scanned to establish statistical significance of this change. Additionally, no loss in the
quality of PWI was observed, as shown in figure 6.11.
 t = 1ms
 t = 1.3ms
 t = 1.8ms
 t = 1.5ms
 t = 1.8ms
 t = 0.63ms
 t = 0.5ms
 t = 0.5ms
 t = 0.5ms
 t = 0.5ms
A
B
C
D
E
Figure 6.10: PWI images: default (A), strategy 3 (B,C), strategy 6 (D,E).
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Figure 6.11: Measured SPL of pCASL label-
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Figure 6.12: Relative signal of each strategy
compared to the standard acquisition without
altering the labelling train
6.3.5 Discussion and conclusions
The study presented here shows that, acoustic noise level can be reduced and therefore patients’
comfort during scanning can be improved by adjusting the timing values of pCASL gradient
waveform, without compromising labelling efficiency. A small adjustment of  t and  t can
reduce the acoustic noise by 6dB and reduce labelling module noise levels to that of EPI readout.
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An important property of the presented approach is, as opposed to, for example, smoothing the
gradient shape, is that it does not require any sequence programming and the parameters can
be easily adjusted by any operator. However, smoother gradient forms might provide further
improvement.
In this work, the provided transfer function H(f) was used to identify best search strategy.
However, the differences between the calculated and measured SPL levels were found. This
discrepancy could be explained by the fact that H(f) depends, apart from the scanner design,
on the room acoustics and the position of the microphone [112]. In this case, a potentially better
approach would be to first identify the best fundamental frequency f by measurement with the
noise meter for variable  t and constant duty cycle, then probe different  t to  t and Gmax
to Gave ratios and finally, match the appropriate flip angle of RF pulse. Unfortunately, it was
impossible to test this approach due to the hardware changes in the scanner carried on by Philips
shortly after presentation of this work at the ISMRM Perfusion Workshop. This change reduced
the acoustic noise of the pCASL labelling module to the level of EPI readout (data not shown),
and therefore the project was discontinued.
Similar work was presented at the same ISMRM Perfusion Workshop and later published
by Meer et al. [115]. The authors carried out very similar experiments on 3T Philips Intera
system: SPL predictions, measurements and in-vivo tests on 9 healthy volunteers. The authors
were provided with response functions for five different spatial positions in the scanner bore and
incorporated it to simulate SPL levels as a function of the t depending on the labelling plane
position. Similarly to work presented here, they found a significant change of acoustic noise
levels with  t. Additionally, the authors also identified (simulated and measured) changes in
SPL levels with the position of the labelling plane from the scanner isocenter. This finding was
used to determine best t: 1.4ms which led to a SPL reduction of 6.5dB. In-vivo measurement
confirmed, that there was no statistical significant reduction of the labelling efficiency, although
the mean reported values were lower. In the final conclusions the authors recommend adjusting
 t to between 1.1 and 1.4ms, which is in line with the work presented in this chapter.
6.4 Summary
This chapter presented two important practical aspects of pCASL: labelling plane position and
acoustic noise reduction. Both aspects are very important for development of clinically feasible
and optimum neonatal protocol. However, the findings presented in this chapter also translate to
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other patient groups, in clinical or research studies, to achieve reproducible results and increase
patient comfort.
List of abstracts that benefited from work presented in this chapter:
M. Sokolska, X. Golay, and D. Thomas Effect of labelling plane angulation on pCASL labelling
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M. Sokolska, A. Oliver-Taylor, X. Golay, D. Thomas Theoretical and practical investigation
of acoustic noise level reduction in pseudo-continuous Arterial Spin Labeling. Proceedings of
ISMRM Perfusion Workshop 2012
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Development of in vivo imaging
framework for neonatal pCASL
7.1 Introduction
This chapter describes the development of the imaging framework for the neonatal pCASL.
This includes optimisation of the scanning protocol and development of an effective method
for motion correction. Sequence optimisation steps were performed as part of clinical neonatal
pCASL study, described in detail in chapter 8.
7.2 Development of scanning protocol
Readout choice
Ideal readout sequence for neonatal ASL would provide a rapid volume acquisition, with reso-
lution appropriate to neonatal brain anatomy sizes. However in practice, the voxel size in ASL
needs to be large enough to provide high perfusion signal relative to noise. Previous ASL studies
in neonates [58], [92] [49], have used voxels of the same size as in adults, which range between
3x3 and 4x4 mm2, with slice thickness of 5.5 to 6 mm. A recently published study [49] was car-
ried out on 3.0 Tesla Philips Achieva System (Philips Medical Systems, Best, The Netherlands),
where they used a quadrature body coil for transmission, an 8-element phased-array SENSE
head coil for reception and EPI readout. This set up is identical for the one available for this
project, and therefore the same EPI readout parameters were chosen as a starting point (matrix
64x64, FOV 240x240, 3.75x3.75 in plane resolution, 6mm slice thickness, 1mm gap, TE 20ms).
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SENSE factor was set up to 2.3. Tests with thinner slices resulted in reduction of SNR in PWI,
therefore this readout setup was kept throughout the study.
Positioning of the labelling plane
As shown in section 6.2 of the previous chapter, the labelling plane in pCASL should be posi-
tioned over parts of the feeding arteries where all vessels are straight in order to ensure minimum
variability of the labelling efficiency. On the other hand, labelling plane should be distanced
enough from the brain to avoid saturation artefacts. The best way to find straight parts of the
vessels is to perform a Time of Flight (ToF) sequence and use Maximum Intensity Projection
(MIP) reconstruction. An example of the labelling plane position overlaid on the ToF MIP
scans is shown in figure 7.1 (FFE, TE/TR 4.4/16ms, FOV 160x132x90mm, acquisition matrix
160x132).
Figure 7.1: Recommended position of the imaging volume (orange) labelling plane (white) on sagittal
view of T1 weighted image and MIP of ToF in sagittal and coronal projections.
Background suppression optimisation
To further improve the SNR and reduce the number of averages required, background suppres-
sion pulses can be used [116]. Background suppression pulses are a series of inversion pulses
following saturation, with a time delay in-between, chosen to suppress the signal from the static
tissue [117]. The evolution of magnetisation after saturation and 2 inversion pulses is illustrated
in figure 7.2 and can be found from the following equation:
Mz(T1) = 1 + ( 1)n+1 exp
✓
Tacq
T1
◆
+ 2
nX
i=1
( 1)i exp
✓
TIBS,i
T1
◆
(7.1)
Delays between the pulses can be found by solving the above equation using the function
"fsolve" in Matlab. Ideally, theMz of each tissue type should be equal to 0, in order to achieve
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best suppression of the background signal. However, any small deviation from expected T1
values or physiological noise could result with negative values ofMz . To avoid this, the target
value of Mz(T1) can be set to 20% of the original value. The T1 values should be appropriate
for the neonatal group [118]: 1.913 - 2.254s for grey matter and 2.556 - 2.934s for white matter.
The time for the first BS pulse should be fixed to the earliest possible time after labelling train.
Figure 7.2: Evolution of tissue longitudinal magnetisation with background suppression pulses
Fat/SENSE artefact
The fat artefact in an EPI based readout is a result of a chemical shift in the phase encoding
direction. Additionally, in cases of misalignment between the SENSE reference scan and ASL,
the SENSE reconstruction can introduce ’wrapping’ artefact. This is caused by the incorrect
coil sensitivity estimation due to motion. An example of the combination of Fat/SENSE artefact
and can be clearly visible in the further part of this chapter, in figures 7.11 and 7.12 (before
motion correction). To reduce this artefacts, two steps were undertaken:
1. Addition of fat saturation pulses (not used initially following the manufacturer’s advice)
2. When possible, and addition of SENSE reference scan before the ASL acquisition.
Additional SENSE acquisition extends the imaging protocol time and can only provide the
improvement if there is no more motion within ASL scan. Fat saturation is commonly used for
ASL experiments, but it might affect the CBF quantification [119],
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Post labelling delay
Identification of the optimal post labelling delay (defined previously in chapter 4), is crucial
for accurate CBF quantification. As discussed in section 4.2, if PLD is shorter than theATT ,
the traveling blood will still occupy arteries, producing bright signal and CBF around arteries
becomes overestimated, and underestimated in other regions, since the bolus duration in the
voxel would be different to that assumed. Therefore the PLD should be longer than the longest
ATT . On the other hand, when PLD is too long, the labelled blood would have relaxed (which
reduces SNR) and fewer repetitions are possible within the acquisition time, according to [70],
[120]:
SNReff =
PWIp
⌧ + PLD + tacq
(7.2)
where SNReff is an effective SNR of an ASL experiment and tacq - image acquisition time.
Establishing the optimal PLD in a neonatal group can be challenging, as there are many factors
influencing ATT , that vary between neonates, like velocity in the feeding arteries [57], [121],
sedation drug used, cooling or the overall condition of he neonate after HIE.
7.2.1 Methods
To better understand the spatial distribution and the range ofATT in neonates, two experiments
aiming to measure perfusion weighted signal at different PLD were performed:
1. Multiple, short and low resolution acquisitions at different PLDs, similar to [120] (long
acquisition)
2. An acquisition of a single slice at different PLDs in Look-Locker sampling scheme,
similar to [122] (short acquisition).
The main differences between the two protocols is their duration and coverage. Although ap-
proach 1 has a better coverage, it was found too lengthy and impractical to perform on all
neonates. Protocol 2 was proposed to offer shorter ATT survey, compromising the coverage.
Multiple PLDs in multi low-resolution acquisitions
Two neonates underwent the multiple low resolution scans at a range of PLDs in addition to
an acquisition with PLD = 1500ms (3 x 20 control-label pairs,2min48s each). The details of
the low resolution scans were as follow: 15 control-label pairs, acquisition matrix 64x64, voxel
size 4.5 x 4.5 x 6 mm (reconstructed voxel 3x3x6mm), labelling duration ⌧ = 1700ms, SENSE
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factor 2.3, 12-16 slices, TE = 20ms, TR = 3170 - 4678ms and 5 PLDs: 800ms, 1300ms,
1600ms, 1900ms, 2300ms, scan duration: 1.5min - 2.5min for each PLD. Before analysis, all
images were registered to the mean of the standard resolution image and the motion corrupted
data removed with the procedure described below in section 7.3. PWIs at each PLD were
computed. A histogram of all image intensities within a brain mask was also computed (30 bins
were used) to visualise the intensity composition for PWIs at each PLD.
An acquisition of a single slice at different PLDs with Look-Locker sampling
Look-Locker sampling with EPI readout [122] was used to acquire multi PLD information.
Here, only one slice was acquired, which was positioned at the level of thalamus and basal
ganglia. 15 PLDs were acquired, ranging from 50 to 3998ms after the end of labelling in
steps of 151ms, with TE/TR = 16/151 ms, flip angle ↵ = 30 . Two repetitions were acquired
in 24 seconds. Before analysis, the intensities of the images were corrected for T1 relaxation
and multiple excitation, by multiplying each voxel by exp(⌧/T1b) and (cos↵ 1)n 1 (where n -
number of pulses experienced by blood protons, T1b - T1 of arterial blood) respectively. It was
assumed, that the arterial protons during first five PLDs experience only one excitation pulse as
they move through the vasculature. The mask was created by applying a threshold to segment
the brightest voxels. The intensity of these voxels, with the mean and standard deviation was
also plotted to visualise the evolution of arterial signal over time.
7.2.2 Results
Multiple PLDs in multi low-resolution acquisitions. Three chosen slices of PWI acquired
at different PLDs are shown in figures 7.3 and 7.5 and the corresponding histograms of brain
PWIs in figures 7.4 and 7.6. For the first neonate, the quality of PWI at higher PLDs (1900
and 2300 ms) is much worse compared with others. This was due to the motion artefacts, which
persisted through the motion correction, as well as the lower signal due to the relaxation of
labelled blood. For both subjects, there is some signal coming from residual label in arteries in
image acquired at 800ms, however, this is not visible at the later PLDs. From PLD 1300 ms
onwards, a well perfused cortical ribbon is visible. The analysis of the histograms confirms this
- at PLD 800 there are many high intensity voxels compared to the late PLDs.
An acquisition of a single slice at different PLDs with Look-Locker sampling. Two ex-
amples of single slice Look-Looker sampling are shown in figures 7.7 and 7.8 for two neonates
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Figure 7.3: 3 slices of PWI acquired at different PLDs
(neonate 1)
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Figure 7.4: Histogram of masked PWI ac-
quired at different PLDs (neonate 1)
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Figure 7.5: 3 slices of PWI acquired at different PLDs
(neonate 2)
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Figure 7.6: Histogram of masked PWI ac-
quired at different PLDs (neonate 2)
with different ATT patterns. In the first neonate (figure 7.7), the vascular signal reduces much
more slowly compared to the second neonate (figure 7.8) and is still is visible in the image ac-
quired at PLD = 1.107s. For the second neonate the vascular signal reduces rapidly and is not
visible in the image acquired ad PLD 0.65s.
7.2.3 Summary
This section described the development of the imaging protocol in neonates and justified the
choices made:
1. Readout: although 2D, EPI readout has been used due to acquisition speed.
2. ToF scan: Given variable size of neonates and the inconsistent position of the head and
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Figure 7.7: Difference image of a single slice Look-Locker acquisition and arterial ROIs plotted for a
range of PLDs [ms]. Neonate with long ATT
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Figure 7.8: Difference image of a single slice Look-Locker acquisition and arterial ROIs plotted for a
range of PLDs[ms]. Neonate with short ATT
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neck in the incubator between babies, it is advantageous to find the best labelling plane
position using ToF MIP. In addition, the structural scans should also be used to ensure a
minimum distance between the labelling plane and brain tissue.
3. BS: For labelling duration of 1.7s and PLD 2s, optimised BS pulses were at 1750ms and
2974ms.
4. Optimum PLD: The method in which multiple, low resolution PLDs are acquired as
separate scans gave an initial insight into the temporal distribution of the blood to different
parts of the brain in neonates and guided the PLD change from the initial setting of 1.5
to 1.8s. However, due to the long acquisition time, this method was adopted in only
two neonates, one of which had an unusually high CBF value due to HIE. Since some
residual arterial signal was still observed in some neonates, PLD was increased to 2s.
The single slice PLDs with Look-Locker sampling benefits from very short acquisition
time and therefore can provide very useful information about arrival times before the
main scan. This can be used to choose the appropriate PLD for each baby. From these
limited examples it is clear, that ATT differs between babies. Therefore it might be that
estimating ATT for each neonate might add to clinical picture or help investigating the
treatment effects. However, the relevance of this, given a single slice acquisition, has yet
to be established.
7.3 Motion and motion correction
Motion correction and elimination of any intensity differences between control and label images
that do not represent perfusion is a crucial part of ASL image processing. In ASL, multiple
repetitions of the control-label pairs are acquired to improve the SNR. This assumption is only
true if all the voxels correspond to a fixed location in the brain which does not change during the
duration of the scan. However, this is usually not the case and given that the difference of the
signal between a single control and labelled images is relatively small, the difference in signal
due to motion can be significantly larger and produce artefactual perfusion values.
The amount of motion during an ASL scan in neonates can vary substantially, depending
on the baby’s preparation. Some babies are ’fed and wrapped’ without any sedation, but some
are administered an oral dose of chloral hydrate or intravenous morphine (in case of ventilated
babies). None of these methods, however, guarantees motion free scans. Examples of different
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extent of motion are shown in figures 7.9 and 7.10, showing translation and rotation computed
from the transformation matrix after rigid registration. If the baby did not move throughout the
duration of the scan, motion correction might not be necessary, given the magnetic field drift
is not large (the scanner drift is demonstrated here as the smooth and consistent translation in
the phase encoded direction y, as seen in [123]). In some cases, when the baby is unsettled or
awake, the amount of motion makes it impossible to create a meaningful perfusion weighted im-
age without additional data processing steps: identification of corrupted data and its exclusion,
image registration, or a combination of both.
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Figure 7.9: Translation in x, y and z direction computed from the transformation matrix after rigid
registration for different amount of motion: from the left: severe intermittent motion, drift of magnetic
field during the scan, very severe motion. Please note different distance scales
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Figure 7.10: Rotations around x, y and z axis computed from the transformation matrix after rigid
registration for different amount of motion: from the left: severe intermittent motion, drift of magnetic
field during the scan, very severe motion. Please note different distance scales
There is a limited literature on the best strategy in neonates with severe motion artefacts,
and therefore a detailed analysis was performed.
137 of 212
Chapter 7. Development of in vivo imaging framework for neonatal pCASL
7.3.1 Background
Outlier exclusion
Existing intensity based methods. One of the methods for improving the quality of PWI is
based on identifying and discarding the corrupted images from the data series. This can be done
based on a visual inspection, however, due to an impracticality and potential bias, an automated
method is preferred. Most commonly, after pairwise subtraction, a mean difference between
control and labeled image mi is calculated for each pair i = 1 : N , where N is the number of
averages:
mi =
1
K
KX
j=1
vij (7.3)
where K is the number of voxels within a mask, and vij - intensity of the jth voxel of the ith
difference image within the mask. Next, the mean µm and standard deviation  m over allm are
computed:
µm =
1
N
PN
i=1mi and  m =
q
1
N 1
PN
i=1 (mi   µm)2 (7.4)
The pairs for which the condition:
|mi   µm| > p ·  m (7.5)
is fulfilled, are discarded from the final averaging. The constant p; when set to 2 [124] it means
that the 95% of the data is kept. An extension to this method proposed by Tan et al. [125], is to
calculate both themi as well as the standard deviation for each subtracted pair:
si =
vuut 1
K   1
KX
j=1
(vij  mi)2 (7.6)
and the mean µs and standard deviation  s across all si, where:
µs =
1
N
PN
i=1 si and  s =
q
1
N 1
PN
i=1 (si   µs)2 (7.7)
Similarly, if
|mi   µm| > p ·  m
or
si   µs > q ·  s (7.8)
with q empirically found to be 1.5 [125], such volume is classified as an outlier. If
ln (max(si) min(si)) < 1 (7.9)
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all the pairs were considered ’stable’ and included in the final PWI. This step is design to min-
imise over-filtering, i.e. exclusion of good data since a certain number of si will always fall
outside µs ± q ·  s. Constants p, q and exclusion criterions are empirically chosen, and can
be adjusted to better remove motion corrupted volumes for given dataset. The main drawback
of this method is the fact that, especially in the presence of severe motion, the calculated stan-
dard deviation will be artificially increased by the presence of the outliers and therefore not all
corrupted data will be correctly identified.
Investigated new intensity based methods.
1. The first proposed method of outlier detection is to further extend the method proposed by
[125] and use criterion 7.9 as a stopping criterion, i.e. keep excluding difference images
until 7.9 is fulfilled.
2. An alternative approach is to identify volumes - control or labels - that are not aligned
with the mean image using sum of square differences (SSD) - commonly used similarity
measure. The SSD is very sensitive to voxels with large intensity differences, which
makes it a good candidate to identify volumes that are not aligned with the rest. The
procedure of finding outliers can be designed in a similar way than above, but instead of
calculating a difference image mi, SSD between the acquisition Ii and the mean of all
acquisitions I¯ is calculated instead, as defined below:
SSDi =
1
K
X
j
|Ij   I¯|2 (7.10)
The rejection of the data is performed until an empirically found exit criterium is reached,
such as:
ln (max(SSDi) min(SSDi)) < 5 (7.11)
3. The extension of the above approach is to restrict the analysis to the regions of the biggest
motion, rather than the brain mask. For this purpose, the use of Robust Principal Com-
ponent Analysis (RPCA) [126] was investigated. If the motion artefact in the SSDi is
sparse, RPCA can separate sparse and low rank components in the image. The assump-
tion is that the high intensity due to motion can be decomposed and used to identify the
most corrupted volumes better.
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Registration based methods. The final method of identifying the outliers is to register all the
images together and use the given transformation matrix as a guidance. In [127],[58], if the
absolute translations or rotation between successive volumes was greater than 2 mm and 1.5 
respectively, such volumes were discarded.
Registration
The relative motion between acquired volumes can be represented by a geometrical transforma-
tion, that maps the corresponding anatomy from the one image to the another. This transfor-
mation can be determined by image registration. The transformation is then used to transform
one image into the coordinate system of the other one by resampling, which requires interpo-
lation. Image registration is a common approach in reduction of motion artefacts, however due
to the big voxel sizes and low contrast between different tissue types in ASL data, it can be
challenging.
In a typical implementation of ASL data registration, the first image is chosen as a com-
mon space and the remaining images from that dataset are registered to that common space.
However, this can give rise to interpolation asymmetries: the target image will not be resam-
pled and therefore will have a different amount of blurring compared to the rest of the volumes
[128],[129]. This might especially be an issue if the chosen common space happens to be
significantly missaligned relative to all other volumes. Additionally, the performance of the reg-
istration algorithm might be compromised due to large transformation needed for the alignment,
which will then affect negatively all the volumes. The solution to these problems is to create
an unbiased, common space template so that all the volumes can be treated the same way and
the transformation needed is minimised. Such computed common template will represent an
"average" head position.
7.3.2 Methods
Outlier exclusion. To find the best method of outlier exclusion, two datasets, one with severe
and one with moderate motion between scans, were used to assess and compare the performance
of methods described above (see list below). Each dataset consisted of 40 control - label pairs
(80 volumes). Mean and standard deviation of PWI was computed alongside mean SNR, de-
fined as PWI divided by SD across the all the difference images (tSD). The calculations were
performed within the region of the brain defined by the mask. "inexact_alm_rpca" 1 function
1http://perception.csl.illinois.edu/matrix-rank/sample_code.html#RPCA
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was used for RPCA computation. Two slices with the most pronounced artefact were chosen to
demonstrate the change in perfusion image after discarding the data points identified. All the
tested methods of outliers detection are listed as follows:
(A) No outlier identification
(B) Outlier identification based on visual inspection
(C) Outlier rejection based on equation 7.5 only with p = 2 [124]
(D) Outlier rejection based on equation 7.5 and 7.8, with restriction 7.9 with p = 2 and q = 1.5
[125]
(E) Method D extended by repeating it until 7.9 is fulfilled
(F) Identification of misaligned volumes based on SSD
(G) Identification of misaligned volumes based on the combination of SSD and RPCA
(H) Identification of misaligned volumes based on the transformation matrix from rigid regis-
tration to the mean
Registration. Two different registration strategies were tested:
(A) Registration to the first image
(B) Registration to refined mean image
The same two datasets with variable amount of motion were chosen to assess the performance of
these approaches. A rigid transformation with normalised mutual information [130] was used.
Rigid transformation only alters the image orientation, preserving object’s size and shape and is
therefore best suited for alignment of ASL data. Normalised mutual information was chosen as
a similarity measure to accommodate the intensity differences in control and labelled images.
The refined mean image was computed by first creating a mean image, next registering all
volumes to the mean image and iterating the process 3 times (established empirically as the
number of iteration that do not reduce tSD of registered images significantly). This was done
using "scalar_rigid_population" implemented in the DTI-TK software package 2. To reduce the
computational time, every other control image was used to create a mean.
2http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
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Registration with outlier rejection. To further reduce the contribution of motion to the
final PWI image, the combination of the registration and outlier rejection was also tested. Two
methods of outlier rejection that performed best in the previous section were identified and
added as as step after registration. Additionally, a motion free dataset was chosen to assess the
influence procedure on the image SNR.
Validation Twelve neonatal datasets were used to validate the motion correction and rejection
regime. Each dataset consisted of 40 control-label pairs. Similarly, mean and standard deviation
of PWI and mean SNR, as defined above. This was computed for all datasets without any
motion correction, standard data rejection and best rejection regime, for both non-registered
and registered data. The amount of motion was assessed visually and the datasets were divided
in three categories: motion free, moderate and severe motion to assess the motion correction
and rejection regime in each category. Resulted PWIs were also visually assessed in terms of
artefacts and definition of grey and deep grey matter.
7.3.3 Results
Outlier exclusion. Table 7.1 presents the results of the analysis. All the methods were capable
of improving PWIs for both datasets, in terms of reduction in SD and increase in SNR for case
of severe and moderate motion. The change of the quality of the PWI maps for data with severe
motion can be observed in figures 7.11, 7.12 and 7.13. The bright rim around the brain observed
in PWI and tSD before discarding corrupted data, indicating misalignment of volumes, are
much reduced after exclusion. Although the number of volumes contributing to the final PWI
decreased, the reduction of tSD resulted in increase in SNR. Method C and D - rejection based
on the deviation from the mean signal or in combination with deviation in standard deviation,
resulted in the smallest amount of improvement, both qualitatively and quantitatively. This is
the result of significant inflation of both SD of the mean  m and SD of the standard deviation  s
in case of big motion artefacts. This seems to be solved by iterating the rejection of the data until
all difference imagesm are considered ’stable’ by meeting the condition 7.9. In case of method
H, the improvement of PWI in terms of SNR is similar to method C and D. This is due to the
limitations of the registration algorithm, namely, some of the volumes get mis-registered and
therefore the registration transformation does not always reflect the amount of rotation and/or
translation necessary for the perfect alignment. The PWI, SD and SNR for moderate motion
is shown in figures 7.14, 7.15 and 7.16. Visually, the improvement provided by all methods is
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similar. However, quantitatively, method E provides the highest SNR, even though the lowest
number of repeats are used to create the PWI. Method F and G identified the same volumes as
outliers and produced the same results of Mean PWI and SNR. This indicates that there are no
benefits in restriction of calculations to the motion affected regions using RPCA.
Method No Pairs
Used
Mean PWI ( SD) SNR = PWI / tSD
Severe motion
A. None 40 0.7644 (1.0860) 0.1835
B. Visual rejection 28 0.4273 (0.4013) 0.3457
C. Mean 37 0.6074 (0.7524) 0.2436
D. Mean + SD 35 0.5130 (0.5729) 0.2748
E. Mean + SD + loop 26 0.4263 (0.4100) 0.3599
F. SSD 29 0.4467 (0.4668) 0.3505
G. PCA 29 0.4467 (0.4668) 0.3505
H. Rigid transf. mat 33 0.5305 (0.5800) 0.3307
Moderate motion
A. None 40 0.6624 (0.5325) 0.5619
B. Visual rejection 34 0.6412 (0.4895) 0.8659
C. Mean 37 0.6602 (0.5136) 0.7417
D. Mean + SD 36 0.6655 (0.5155) 0.8285
E. Mean + SD + loop 31 0.6550 (0.4809) 0.9041
F. SSD 37 0.6537 (0.5062) 0.8057
G. PCA 37 0.6537 (0.5062) 0.8057
H. Rigid transf. mat 39 0.6458 (0.5207) 0.6837
Table 7.1: Summary of mean, standard deviation and SNR of the whole brain PWI for each exclusion
method. The best performer highlighted in bold.
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HF GEDCBA
Figure 7.11: 2 slices of PWI with severe motion; A - G different method of outliers detection (see text
for more details)
HF GEDCBA
Figure 7.12: 2 slices of tSD with severe motion; A - G different method of outliers detection (see text for
more details)
HF GEDCBA
Figure 7.13: 2 slices of SNR with severe motion; A - G different method of outliers detection (see text
for more details)
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HF GEDCBA
Figure 7.14: 2 slices of PWI with moderate motion; A - G different method of outliers detection (see text
for more details)
HF GEDCBA
Figure 7.15: 2 slices of tSD with moderate motion; A - G different method of outliers detection (see text
for more details)
HF GEDCBA
Figure 7.16: 2 slices of SNR with moderate motion; A - G different method of outliers detection (see text
for more details)
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Registration with outlier rejection. Method E and F were found to be most effective in
identifying motion corrupted volumes and were selected for further testing with registrations.
The performance of the registration before and after outliers exclusion for severe motion can be
visualised in figures 7.17 and 7.18 for the registration to the first and to the mean respectively.
The qualitative data are also given in tables 7.2, 7.3 and 7.4 for severe, moderate and motion
free data sets respectively.
It can be seen in figures 7.17 and 7.18, that SD reduces after the registration compared with
images 7.12 and 7.15 before registration, however, the misalignment is still present, causing
changes to the mean and SD of images contributing to PWI.
For both severe and moderate motion, a further improvement in SNR was achieved after
registration, but only after exclusion of mis-aligned data was also performed (see tables 7.2 and
7.3). Registration to the mean paired with SD rejection seems to improve the quality of the PWI
as well as SNR the most. For moderate motion, the choice of the target image doesn’t seem to
influence the PWI. In both cases, the registration paired with SD rejection produced higher SNR
of PWI compared to no registration. In case of the data without any motion, the registration
slightly reduced the SNR, however there was no difference in the mean PWI value.
A B C A B C A B C
Figure 7.17: 2 slices of PWI, SD and SNR with severe motion after registration to the first volume and
before outlier rejection (A), mean + SD + loop rejection (B) and SSD rejection (C)
A B C A B C A B C
Figure 7.18: 2 slices of PWI, SD and SNR with severe motion after registration to themean volume and
A: before outlier rejection (method A), B:mean + SD + loop rejection (method E) and C: SSD rejection
(method F)
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Method No Pairs
Used
Mean PWI ( SD) SNR = PWI / tSD
Registration to the first
No exclusion (A) 40 0.5930 (0.7679) 0.1744
Mean + SD + loop (E) 24 0.3936 (0.3807) 0.3588
SSD (F) 31 0.4118 (0.3922) 0.3420
Registration to the mean
No exclusion (A) 40 0.6362 (0.7942) 0.1863
Mean + SD + loop (E) 23 0.4634 (0.4219) 0.4279
SSD (F) 31 0.4295 (0.3982) 0.3340
Table 7.2: Severe motion: summary of mean, standard deviation and SNR of the whole brain PWI
for 2 registration methods.
Method No Pairs
Used
Mean PWI ( SD) SNR = PWI / tSD
Registration to the first
None (A) 40 0.6462 (0.4938) 0.5727
Mean + SD + loop (E) 31 0.6556 (0.4646) 0.9434
SSD (F) 37 0.6421 (0.4715) 0.8275
Registration to the mean
None (A) 40 0.6365 (0.4790) 0.5727
Mean + SD + loop (E) 31 0.6386 (0.4520) 0.9246
SSD (F) 37 0.6361 (0.4638) 0.8213
Table 7.3: Moderate motion: summary of mean, standard deviation and SNR of the whole brain
PWI for 2 registration methods.
Method No Pairs
Used
Mean PWI ( SD) SNR = PWI / tSD
No Registration 40 0.6253 (0.4673) 0.9145
Registration to the first 40 0.6228 (0.4523) 0.8532
Registration to the mean 40 0.6203 (0.4454) 0.8570
Table 7.4: Motion free: summary of mean, standard deviation and SNR of the whole brain PWI for
2 registration methods.
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Validation. Method E for outlier exclusion was chosen for validation against previously pub-
lished method D, with and without registration to refined mean image. The results of analysis
averaged across all 12 datasets are given in table 7.5. In terms of motion, three datasets were
categorised as motion free, 5 as mild and 4 as severe. The break-down for mean, SD and SNR
for each motion category are shown in figures 7.19, 7.20 and 7.21, showing mean, SD and SNR
respectively.
No Pairs
Used
Mean PWI ( SD) SNR=
PWI / tSD
No
loops
Accepted
datasets
No registration
No exclusion (A) 1.95 ( 2.93 ) 0.49 7
Mean + SD (D) 41.25 1.85 ( 2.70 ) 0.53 1.00 9
Mean + SD + loop (E) 31.75 1.89 ( 2.35 ) 0.58 3.75 11
With registration
No exclusion (A) 1.95 ( 2.29 ) 0.51 7
Mean + SD (D) 41.25 1.90 ( 2.17 ) 0.55 1.00 9
Mean + SD + loop (E) 33.67 1.89 ( 2.07 ) 0.61 2.58 12
Table 7.5: Summary of mean, standard deviation and SNR of the whole brain PWI for the full
dataset
The findings after analysing 12 datasets were consistent with those described above. Data
exclusion significantly reduced presence of big motion artefacts, which was especially visible
in datasets included in ’moderate’ and ’severe motion’ group. This is reflected in reduction of
mean SD and increase SNR in figures 7.20 and 7.21 respectively for these categories. The best
improvement was achieved for proposed method E. In all cases, registration improved definition
of the anatomy, i.e. cortical ribbon and deep grey matter and in some cases reduced some motion
artefacts, which resulted in reduced SD and improved SNR in ’moderate’ and ’severe motion’
groups.
Out of all different methods motion correction, only a combination or registration and pro-
posed method E allowed inclusion of all twelve datasets to the study (based on visual inspec-
tion). Using method D with or without registration, would have resulted in exclusion of 3
datasets (25%).
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Figure 7.19: Mean PWI averaged across different motion groups for 3 meth-
ods with and without registration. (A): no outlier exclusion, (D): mean + SD,
(E): mean + SD + loop; error bars represent standard error.
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Figure 7.20: Mean SD of PWI averaged across different motion groups for 3
methods with and without registration. (A): no outlier exclusion, (D): mean +
SD, (E): mean + SD + loop; error bars represent standard error.
Figure 7.21: SNR averaged across different motion groups for 3 methods with
and without registration. (A): no outlier exclusion, (D): mean + SD, (E): mean
+ SD + loop; error bars represent standard error.
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7.3.4 Discussion
The above analysis shows, that identification and exclusion of motion corrupted data signifi-
cantly improves the quality of the data in case of both severe and moderate motion. Reduction
in number of averages used to compute PWI did not result in decreased SNR, confirming, that
the data removed from analysis had undesired effect on PWI. All proposed methods resulted in
improved quality of PWI, with proposed method E performing the best qualitatively and quan-
titatively. There are two advantages of using this method. Firstly, it does not require rejection
of any dataset if the motion is not present (condition 7.9). Secondly, it performs rejection until
all datasets are considered stable. This allows to overcome the issue of increased standard de-
viation in a presence of outliers. With this additional condition the number of images rejected
was similar for both severe and moderate motion.
The registration paired with misaligned data exclusion improves the quality and SNR of
PWI, especially in case of severe and moderate motion. The choice of the template for the
registration is important when a severe motion is present the "average head position" should be
chosen as a common space for the registration. However, this choice is less important for less
severe motion. The registration algorithm is not always able to align the volumes, and therefore
additional exclusion is necessary.
Both improvements: first, it the image registration and second, in identification of corrupted
data resulted in 100% success rate, which compares favourably with previously published re-
search.
An additional improvement of the registration performance could be achieved for the regis-
tration of control and images separately and this will be investigated in the future work. Another
improvement might be to perform a distortion correction using acquired B0 map. However, this
might be not practical for 2 reasons: first, in case of large motion the acquired map might not
match the image to be corrected and secondly, it requires additional time for acquisition.
However, in some cases the registration might not result in a good alignment. This is because
of the low resolution of ASL images in combination with poor contrast and non-isotropic voxels.
Therefore, after the registration, those images that are still not aligned, should be identified and
excluded.
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7.4 Summary and conclusions
This chapter presents development and optimisation of ASL protocol for neonatal scanning and
motion correction. Two main issues that can significantly alter the estimated CBF have been
identified:
1. Arterial Transit Time range: ATT
Arterial Transit time varies between the babies. This variation might be visualised by
acquisition of a single slice image at multiple delay times. This might be then used to
adjust the PLD appropriately to avoid arterial artefacts.
2. Motion correction with outlier rejection
Motion correction is essential to compute meaningful PWI for neonates that moved dur-
ing acquisition. This can be achieved by efficient rejection of corrupted datasets or image
registration. The best performance is achieved when these two techniques are combined.
Creating an "average head position" as a common space improves the registration. How-
ever, this improvement is more subtle than data rejection.
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Chapter 8
Clinical application of pCASL in
neonates with hypoxic-ischaemic
encephalopathy
8.1 Introduction
In this chapter, a detailed analysis of CBF maps acquired from neonates who experienced a
peri-natal hypoxic-ischaemic event will be presented. This will be combined with brain MRS
data acquired during the same scanning session in order to compare the abnormal regionalCBF
values to the outcome biomarker derived fromMRS and investigate the added value of ASL and
to link the physiological and biochemical changes after hypoxia-ischaemia in neonatal brain.
8.2 Background
Perinatal hypoxia-ischemia (HI) can cause severe alteration of brain metabolism and physiol-
ogy [17], resulting in neonatal encephalopathy. Metabolic changes detected using magnetic
resonance spectroscopy (MRS) have been used as a reliable predictor of clinical outcome [131].
Abnormalities in cerebral blood flow (CBF ), reflecting cerebral physiology, have also been
linked to HI [34]. Our group proposed combining these two MR biomarkers [132], which was
subsequently shown by another group to increase the predictive power of MRS in deep grey
matter (DGM) [133]. The CBF analysis in [133] was limited to DGM; extending this analysis
to other brain regions might provide further insights into different patterns and severity of the
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pathology resulting from HI.
Regional CBF analysis can be achieved by manually placing regions of interest (ROI) di-
rectly on theCBF map, using high resolution scans used as a guidance. However, this approach
requires an expert knowledge of neonatal brain anatomy. Additionally, it is likely that this ap-
proach will produce biased CBF values if identification of the regions is based only on voxels’
intensity in theCBF maps. A different solution to this problem is to define ROIs on high resolu-
tion structural images, either manually [134] or automatically, using available atlases, and then
propagate the labels to the perfusion maps. Recently, two new neonatal atlases have become
available: one containing probabilistic tissue segmentation of 5 tissue classes1 [135] and one
consisting of manual segmentations of neonatal brain into 50 regions called ALBERT2 [136].
They have been shown to be useful for segmentation and percellation of high resolution data for
volumetric studies [135],[137], but their potential for ASL has not yet been explored.
The aim of this work was to develop an automated framework for regional analysis of CBF
and to investigate the added value of combining thalamicMRSwith such detailed regionalCBF
analysis as a potential biomarker of outcome in HIE.
8.3 Methods
Arterial Spin Labelling is a part of the ongoing "UCH Baby Brain Study", led by Prof Nicola
Robertson and Dr Cristina Uria-Avellanal, who received ethical approval for the study from
the NRES Committee London - Bloomsbury (Research Ethics Committee (REC) Reference
number: 13/LO/0225) and from UCLH. Written consent was obtained from the parents before
enrolment of any neonate in the study. The MR images were scored by Dr. Maïa Proisy, UCL
honorary clinical research fellow (now Centre Hospitalier Universitaire de Rennes-Hôpital Sud,
Rennes, France). The clinical MR report on the scans was provided by a consultant neonatolo-
gist as part of clinical care and management.
Subjects. Neonates that fulfilled the following criteria were considered eligible for the study:
"All term and pre-term babies born at UCH or transferred to UCH for treatment of acute brain in-
jury without life threatening congenital malformations and considered likely to survive". Some
of the neonates were also recruited to the Total Body with Xenon gas (ToBy Xenon) clinical trial
(REC reference: 10/H0707/33) and, apart from the standard care, were administered Xenon dur-
1http://biomedic.doc.ic.ac.uk/brain-development/index.php?n=Main.Neonatal2
2http://biomedic.doc.ic.ac.uk/brain-development/index.php?n=Main.Neonatal3
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ing the first days of life. The detailed inclusion criteria were defined for the ToBy Xenon trial
and were followed in all cases 3:
1. Infant is 36 to 43 weeks gestation with at least one of the following:
• Apgar score of < 5 at 10 minutes after birth;
• Continued need for resuscitation, including endotracheal or mask ventilation, at 10
minutes after birth;
• Acidosis defined as pH < 7.00 and/or base deficit > 15mmol/L in umbilical cord
blood sample or any blood sample within 60 minutes of birth (arterial or venous
blood).
2. Moderate to severe encephalopathy consisting of altered state of consciousness (reduced
or absent response to stimulation) and hypotonia, and abnormal primitive reflexes (weak
or absent suck or Moro response).
3. At least 30 minutes duration of amplitude integrated EEG (aEEG) recording that shows
moderately abnormal or suppressed background aEEG activity or seizures.
Twenty two neonates with suspicion of acute brain injury were enrolled in the study. The data
from one neonate were excluded due to severe motion artefacts. The characteristics of all ac-
cepted neonates are given in table 8.1. Although four neonates: two pre-term (N 18 and 19)
and two with neonatal seizures (N 20 and 21) presented a different clinical picture and were not
included in the final HIE cohort analysis, the data contributed to the development of the final
protocol.
Classification. Neonates admitted to the neonatal unit were assessed by the clinical team and
initially scored in terms of severity of the injury based on the clinical history, blood pH, EEG
(electroencephalography) signal. The final classification was given based on the improvement
in terms of EEG, imaging and spectroscopy results.
MR protocol and processing. The infants were appropriately prepared for the MRI exam-
ination, placed in an MR-compatible incubator, equipped with ear protection and monitored
throughout the scan. Scanning was performed on a 3T Philips Achieva. Twenty out of 21 in-
fants were sedated either with an oral dose of chloral hydrate (n = 10) or intravenous morphine
3https://www.npeu.ox.ac.uk/toby-xe
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N GA
(weeks +
days)
Gender Birth
Weight
[g]
PNA
(days)
Initial
classifica-
tion
Treatment
1 39 + 2 F 2814 7 HIE 1 Cooling
2 41 M 3670 3 HIE 1 Cooling
3 41 F 3800 4 HIE 1 Cooling + Xenon
4 36 + 3 M 2440 7 HIE 1 Cooling
5 38 + 2 F 3034 5 HIE 1 Cooling
6 40 + 3 F 3930 5 HIE 2 Cooling
7 40 + 2 F 3020 4 HIE 2 Cooling
8 38 + 6 M 2850 4 HIE 2 Cooling
9 41 + 6 F 3630 6 HIE 2 Cooling
10 39 M 2250 3 HIE 2 Cooling
11 40 + 2 M 3110 6 HIE3 Cooling + Xenon
12 39 + 2 M 3060 7 HIE3 Cooling + Xenon
13 38 F 1770 4 HIE3 Cooling + Xenon
14 39 + 5 M 3640 4 HIE3 Cooling
15 40 M 3310 13 HIE 1 Cooling
16 36+3 M 3034 9 HIE 1 Cooling
17 41 + 1 M 3140 2 HIE 3 Cooling + Xenon
18 26 F 890 64 pre-term
19 32 + 5 F 1890 24 pre-term
20 41 F 3775 7 neonatal
seizures
21 40 + 3 M 3186 8 neonatal
seizures
Table 8.1: Summary of subjects. N - neonate number, GA - gestational age, PNA - postnatal age,
HIE - hypoxy-ischemic encepalopathy grade[13] (grading details given in table 2.2 in chapter 2).
Neonates 18-21 were excluded from HIE cohort analysis.
in the case of ventilated babies (n = 10). Blood testing was also performed around the time of
the MRI examination. In addition to standard structural imaging, 19 neonates underwent MRS
and 21 underwent the ASL protocol.
1. Structural scans. The standard protocol included T1, T2 weighted (axial and coronal)
high resolution and diffusion weighted structural scans. Neonates that were also enrolled
to the Toby Xenon trial additionally received a T2 weighted Pseudo 3D scan. Apparent
diffusion coefficient (ADC) and exponential ADC, eADC (calculated as exp(-b*ADC))
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maps were generated on the scanner. In case of motion, structural scans were repeated
using single shot, motion resistant sequences. All sequence parameters are given in table
8.2. Images were scored by trained neuroradiologist using the Barkovich scoring system
(see table 2.4 in the chapter 2 details of the scoring system).
2. MRS. The MRS voxel was positioned in the left thalamus as shown in figure 8.1. Water-
suppressed spectra were acquired using point resolved spectroscopy (PRESS, 64 aver-
ages, TR/TE = 2288/288ms, voxel size 15x15x15mm, scan time s7 min). The spectra
were manually corrected for phase and frequency shifts and fitted using the AMARES
algorithm as implemented in the jMRUI4 software package. Lactate to N-acetylaspartate
(Lac/NAA) peak-area ratio were calculated.
3. ASL. A pseudo-continuous ASL (pCASL) scans and post processing were performed
as described in 4.2. The labelling plane was positioned based on ToF angiography im-
ages to ensure that it was perpendicular to the feeding arteries, as shown in figure 8.1.
The labelling duration was 1.7s with a post-labelling delay of 1.5-2s. A proton density
(PD) image was also acquired (19 neonates), with the same acquisition parameters as the
pCASL readout. Since the protocol was under development, some improvements (longer
PLD, fat saturation and background suppression pulses) were introduced during the du-
ration of the study and therefore not present in scans for all subjects. Motion Correction
was performed as described in chapter 7.3.1. In short, images were first rigidly regis-
tered using normalised mutual information based rigid registration to a subject template
created from every other control image using DTI-TK5. Next, pairwise subtraction was
performed and any outliers were removed before averaging using method E described in
section 7.3.1. The schematic of motion correction procedure is shown in figure 8.1. The
single compartment kinetic model was used for CBF quantification (equation 4.10 [71])
using Matlab and was calculated for each baby based on measured hematocrit values ac-
cording to equation 4.11: 1/Tblood = 0.5*Hct +0.37[89]. Labelling efficiency was set to
0.77, as estimated by numerical simulations of Bloch Equations in chapter 5, or 0.69 if the
background suppression was used (i.e. accounting for the efficiency of two background
suppression pulses assumed to be 0.95 each). All ASL parameters for each baby are given
in table 8.3.
4http://sermn02.uab.es/mrui/mrui_Overview.shtml
5http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
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pCASL*Labelling*
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Figure 8.1: Acquisition: positioning of the thalamic voxel, ASL FOW and the labelling plane (left) and
motion correction procedure: a - registration and b - automated rejection of the corrupted data (right).
4. Regional CBF quantification. Regional CBF was calculated in Regions of Interest
(ROIs) defined automatically based on both an atlas based probabilistic tissue segmen-
tation of 5 tissue classes6 and on a joint multi-atlas label propagation and fusion of 50
neonatal brain7 [136]. After affine and non-linear registration (Nifty-Reg8) of the T2-
weighted atlas images to the T2-weighted image of each neonate, the probabilistic maps
and parcellations were propagated to individual subject space. Probability maps were
used to segment T2 images using AdaPT algorithm [137] (Nifty-Seg9). The segmenta-
tions were reviewed and manually corrected when necessary. Finally,T2-weighted subject
images were co-registered to the CBF maps using rigid registration, with the tissue seg-
mentations and brain parcellation propagated to CBF space. Global grey matter (GM)
and deep grey matter (DGM) CBF were quantified in the regions using tissue segmen-
tations. Subsets of the parcellated areas were combined to create larger regions, corre-
sponding to the main cerebral lobes (frontal, temporal, occipital, parietal) plus cingulate
cortex and insula. Left and right sides were added together to create a single mask for
each region. The ROIs were then used together with the GM mask to determine cortical
regions. Similarly, the left and right parcellation of the deep grey matter nuclei (thalami,
caudate and lentiform nuclei) were combined and CBF quantified within the DGM seg-
6http://biomedic.doc.ic.ac.uk/brain-development/index.php?n=Main.Neonatal2
7http://biomedic.doc.ic.ac.uk/brain-development/index.php?n=Main.Neonatal3
8http://sourceforge.net/projects/niftyreg/
9http://sourceforge.net/projects/niftyseg/
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N LD
[ms]
PLD
[ms]
Fat
Sat
BS Reps Hct
[%]
T1 [s] Sedation
1 1700 2000 Yes 1750 / 2974 29 46 1.67 Chloral
2 1700 1500 No n/a 44 60 1.49 Chloral
3 1700 1700 No 1750 / 2674 38 39 1.77 Morphine
4 1700 2000 Yes 1750 / 2974 38 35 1.84 Morphine
5 1700 2000 Yes 1750 / 2974 33 36 1.82 Morphine
6 1700 1700 No n/a 45 40 1.75 Morphine
7 1700 2000 Yes 1750 / 2974 32 45 1.68 Morphine+ Chloral
8 1700 2000 Yes 1750 / 2974 36 45 1.68 Chloral
9 1700 1500 No n/a 23 45 1.68 Chloral
10 1700 2000 Yes 1750 / 2974 45 32 1.89 Morphine+ Chloral
11 1700 2000 Yes 1750 / 2974 45 46 1.67 Morphine
12 1700 2000 Yes 1750 / 2974 23 33 1.87 Morphine
13 1700 2000 No 1750 / 2974 30 35 1.84 Chloral
14 1700 2000 Yes 1750 / 2974 40 36 1.82 Morphine
15 1700 2000 Yes 1750 / 2974 40 46 1.67 Chloral
16 1700 2000 Yes 1750 / 2974 35 41 1.74 Chloral
17 1700 1500 No n/a 60 42 1.72 Morphine
18 1700 1500 No n/a 20 30 1.92 Chloral
19 1700 2000 Yes 1750 / 2974 14 36 1.82 None
20 1700 1700 No n/a 17 45 1.68 Chloral
21 1700 1500 No n/a 42 29 1.94 Chloral
Table 8.3: Summary of ASL parameters. N - neonate number consistent with table 8.1 Hct and sedation
agents administered during the scan. LD - labelling duration, PLD - post-labelling delay, BS - background
suppression, Reps - number of control-label pairs accepted for final averaging, Hct - haematocrit, T1
calculated from Hct based on equation 4.11.
mentation mask. The generated segmentations and parcellations were checked for the
quality and manually edited if necessary.
Analysis. The analysis was performed in three steps: i. general analysis (all subjects), ii.
qualitative analysis (case study), iii. regional analysis (chosen subgroup).
The aim of the general analysis was to find different patterns in regional CBF visually
and quantitatively for all neonates. Additionally, an analysis was performed to investigate any
dependencies that could influence the finding, such as PLD, days of life at scan (DOL), admin-
istered sedation.
160 of 212
Chapter 8. Clinical application of pCASL in neonates with hypoxic-ischaemic encephalopathy
Next, cases with imaging findings (Barkovich score > 0) were qualitatively analysed. CBF
maps were compared with the structural scans (T1, T2 and diffusion weighted) to assess the
correspondence of the pathology observed in the anatomical scans and CBF maps.
Finally, a subgroup of 14 neonates (indicated by N = 1 to 14 in table 8.1) was chosen for
in depth analysis. The criteria for the choice included: PNA (4-7), gestation age at birth ( >
38), and initial classification (excluding neonates diagnosed with neonatal seizures and without
clinical presentation typical for HI). Subjects were divided into two groups based on Lac/NAA
peak-area ratio: below 0.3 = likely favourable outcome (n=9) and above 0.3 = high risk of poor
outcome. T-tests and F-tests were computed to investigate the statistical differences in mean and
variance of CBF values between low- and high-risk groups in terms of prognosis.
8.4 Results
All CBF maps and MR spectra were successfully produced in all neonates. On average, 20%
(range: 0-70%) of motion corrupted data was rejected. An example of MR spectra showing low
and high level of lactate relative to NAA is shown in figure 8.2 and an example segmentation and
parcellation is shown in figure 8.3 and 8.4 respectively, whereas figure 8.5 shows an example of
segmentation and parcellation combined which was used for the final analysis.
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Figure 8.2: Examples of MRS spectra from two neonates showing normal (left) and abnormal (right)
levels of lactate and NAA. Blue arrow indicate direction of change
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Figure 8.3: Example
of GM and DGM seg-
mentation overlaid on a
CBF map
Figure 8.4: Example of
GM and DGM parcella-
tion overlaid on a CBF
map
Figure 8.5: Example of
the ROI used for the
analysis overlaid on a
CBF map
8.4.1 General analysis findings
TheCBF maps for all neonates are presented in figure 8.6. The order of the images is consistent
with the order in tables 8.1 and 8.3.
Visual analysis. Upon visual inspection of the maps, two main observations can be made.
First, the distribution of CBF varied considerably between neonates with different degrees
of HIE. Second, some parts of the brain were more likely to be characterised by high CBF .
Specifically:
• Most of the CBF maps showed:
1. High CBF in basal ganglia / thalamus in relation to the average cortical CBF (see
8.7 a);
2. High signal in the area of MCA (see 8.7 b);
3. High signal in the area of Circle of Willis, indicating arterial artefact originating
from the posterior circulation; this usually coincided with high signal from occipital
lobe and low signal in the PCA/MCA watershed regions (see 8.7 c);
• Some of the CBF maps showed:
1. High signal in the region of ACA and pericallosal artery; this coincided with high
signal in cingulate cortex and low signal in pericallosal/MCA borderzone (see 8.7
d);
2. Unevenly distributed signal in the basal ganglia, i.e. some nuclei perfused more than
others (see 8.7 e);
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3. High signal in cingulate and perirolandic cortex (see 8.7 f and g);
a"
b" c"
d"
e" f" g"
Figure 8.7: Example images representing common (a-c) and less common (e-
h) findings. CBF maps of neonate 2 and 17 displayed on the high resolution
structural scans for easier localisation
Quantitative analysis. The findings from the visual analysis were confirmed quantitatively
in figures 8.8, 8.9 and 8.10, which show the CBF values in the various regions of interest in
the whole brain, grey matter (GM) and deep grey matter (DGM) (figure 8.8), in sub-regions of
the cortex expressed as percent of the CBF value in GM (figure 8.9) and in deep grey matter
sub-regions, expressed as percent of the CBF value in DGM (figure 8.10). Two outliers seen in
figure 8.8: neonate 14 and 17 are two out of three neonates with the highest Lac/NAA peak-area
ratios in this cohort, suggesting the most severe effect of the hypoxia-ishaemia (Lac/NAA = 1.32
and 1.94 for neonate 14 and 17 respectively). This dramatic increase in CBF was most likely
caused by vasoparalysis and loss of the vessel tone. Neonate 17 passed away a day after the scan
(neonate 14 was transported to a different hospital and their final outcome is unknown). In the
cortical sub-regions in some neonates,CBF in cingulate, parietal cortex and insula is noticeably
increased. In deep grey matter, CBF in caudate nuclei is consistently lower compared to the
mean DGM and the other nuclei and lentiform nucleus has the highest CBF . All the CBF
values for each region, subregion, Lac/NAA peak-area ratio, detail Barkovich scores and the
final classification are given in table 8.4.
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Figure 8.8: CBF in the whole brain, mean cortical grey matter (GM) and the deep grey matter (DGM)
by subject
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Figure 8.9: CBF in cortical sub-regions expressed as a percent of the CBF value in the mean cortical
GM, by subject
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Figure 8.10: CBF in sub-regions of deep grey matter expressed as a percent of the CBF value in the
whole DGM by subject
Dependencies of CBF on other factors. The initial analysis of the dependencies did not
show any significant correlation between CBF and sedation agents administered (figure 8.11)
gestation age (GA) at birth (figure 8.12), GA at scan (figure 8.13), postnatal age at scan (figure
8.14, 8.15 and 8.16 for whole brain, grey and deep grey matter respectively). The high spread
of CBF values for the neonates receiving morphine during the scan, as seen in the figure 8.11,
is likely to be explained by the severity of the HI. Babies receiving morphine were the most
affected and required ventilator support.
Figure 8.11: Whole brain CBF vs seda-
tion agent
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Figure 8.12: Whole brain CBF vs. gestation
age at birth
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Figure 8.13: Whole brain CBF vs. gesta-
tion age at scan
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Figure 8.14: Whole brain CBF vs postnatal
age
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Figure 8.15: Grey matter CBF vs. postnatal
age
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Figure 8.16: Deep grey matter CBF vs. post-
natal age
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8.4.2 Cases with abnormalities in imaging
CBF maps of six neonates with imaging findings (Barkovich score > 0) were compared to
standard structural scans (T1, T2 and diffusion weighted) to assess the correspondence of the
pathology observed in the anatomical scans and CBF maps. These neonates also had increased
thalamic Lac/Naa peak-area ratios and regional CBF values, which is provided in description
of each subject for convenience. All results are given in table 8.4. Direct citations from the
radiology report is given in quotation marks.
Case 1 (Neonate 10)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.17. Lac/NAA peak-area for this neonate was 1.8, mean whole brain
(WB) CBF = 27 ml/100g/min and CBF in the lentiform nucleus = 48 ml/100g/min.
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Figure 8.17: Neonate 10. Matching slices of structural scans and CBF map. From the top: T1 weighed,
T2 weighted, eADC, ADC, CBF [ml/100g/min].
Structural imaging shows widespread abnormal signal intensities (Barkovich score 7: BG =
4 and BG/W = 3). All regions of the cortex are clearly visible in the CBF map, which results
from both high contrast between grey and white matter and homogenous distribution of the label
across and within grey matter, reflecting increased perfusion. Regions of low mean diffusitivity
in the ADC map coincide with increased CBF . An expert radiologist also noted that "the white
matter changes are quite extensive for an isolated acute hypoxic ischaemic event. The image
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findings would be associated with a poor outcome with both motor and cognitive impairment.
[...] There may be prolonged feeding difficulties."
Case 2 (Neonate 11)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.18. Lac/NAA peak-area for this neonate was 0.39, mean WB CBF
= 13 ml/100g/min and CBF in the lentiform nucleus = 30 ml/100g/min.
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PA239$Figure 8.18: Neonate 11. Matching slices of structural scans and CBF map. From the top: T1 weighed,
T2 weighted, eADC, ADC, CBF [ml/100g/min].
Structural scans show widespread abnormal signal intensities (Barkovich score 10: BG =
4, WM = 3 and BG/W = 3). It was reported that "The multifocal cortical involvement is not
typical of an isolated acute hypoxic ischaemic encephalopathy secondary to a sentinel event.[...]
These imaging findings are likely to be associated with later motor and cognitive impairment."
Cingulate cortex and lentiform nucleus show restricted diffusion (decreased ADC), which co-
incides with elevated CBF . There seems to be decrease in the CBF in anterior and posterior
watershed grey matter regions.
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Case 3 (Neonate 12)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.19. Lac/NAA peak-area for this neonate was 0.76, mean WB CBF
= 27 ml/100g/min and CBF in the lentiform nucleus = 53 ml/100g/min, para sagittal cortex
CBF = 60 ml/100g/min, Barkovich score 10: BG = 2, WM = 5 and BG/W = 3.
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Figure 8.19: Neonate 12. Matching slices of structural scans and CBF map. From the top: T1 weighed,
T2 weighted, eADC, ADC, CBF [ml/100g/min].
The structural scans showed "widespread abnormal signal intensities consistent with severe
hypoxic ischaemic brain injury and likely to be associated with severe neurodevelopmental im-
pairment. The white matter changes are atypical for an isolated acute hypoxic ischaemic event,
particularly the anterior cerebral artery changes". Decreased ADC in the regions supplied by
ACA and MCA are consistent with increased CBF in these regions.
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Case 4 (Neonate 13)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.20. Lac/NAA peak-area for this neonate was 0.77, mean WB CBF
= 17 ml/100g/min and CBF in the lentiform nucleus = 36 ml/100g/min and Barkovich score 2
(BG = 2).
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Figure 8.20: Matching slices of structural scans andCBF map. From the top: T1 weighed, T2 weighted,
eADC, ADC, CBF [ml/100g/min].
Abnormal signal intensity was found "within the basal ganglia and thalami, PLIC, brain-
stem and the white matter, and within the cortex of the medial temporal lobes . This is con-
sistent with a perinatal hypoxic ischaemic injury. These imaging findings would be associated
with neurodevelopmental impairment in both motor and cognitive domains". CBF maps show
increased CBF mainly within the lentiform nucleus, which is coincides with decreased ADC.
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Case 5 (Neonate 14)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.21. Lac/NAA peak-area for this neonate was 1.32, mean WB CBF
= 67 ml/100g/min and in the lentiform nucleus = 93 ml/100g/min and Barkovich score 11 (BG
= 4, W = 3, BG/W = 3).
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Figure 8.21: Neonate 14. Matching slices of structural scans and CBF map. From the top: T1 weighed,
T2 weighted, eADC, ADC, CBF [ml/100g/min].
There are "widespread abnormal signal intensities consistent with severe perinatal hypoxic
ischaemic injury involving the white matter, cortex, basal ganglia and thalami, PLIC and the
brainstem. (...) The diffusion weighted ADC map shows widespread low signal intensity with
reduced ADC values consistent with infarction.These image findings would be associated with
significant motor and cognitive impairments.(...) We also noted a splitting of the choline peak [in
MR spectra, shown in figure 8.22] which we see in severe HIE and is consistent with membrane
breakdown as part of axonal and neuronal injury."CBF map shows very highCBF throughout
the brain, with high values in the basal ganglia and thalami, occipital and cingulate cortex,
concurrent with decreased ADC.
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Figure 8.22: MR spectroscopy for neonate 14 showing splitting choline
peak.
Case 6 (Neonate 17)
CBF maps and matching slices of the structural scans: T1 weighed, T2 weighted, eADC and
ADC are shown in figure 8.23. Lac/NAA peak-area for this neonate was 1.94, meanWBCBF =
50 ml/100g/min and in the lentiform nucleus = 51 ml/100g/min, occipital cortex 71 ml/100g/min
and Barkovich score 11 (BG = 4, W = 5, BG/W = 4).
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Figure 8.23: Neonate 17 (excluded). Matching slices of structural scans and CBF map. From the top:
T1 weighed, T2 weighted, eADC, ADC, CBF [ml/100g/min].
The radiology report noted "marked diffuse swelling and oedema of the basal ganglia, tha-
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lami and PLICS in keeping with profound, severe HIE. There is diffuse cerebral hemisphere
swelling of the cortex and white matter. Some oedema is seen within the midbrain, pons and
medulla and there is definite restricted diffusion within the midbrain." CBF maps shows in-
creased CBF in occipital and peri-Rolandic cortex as well as basal ganglia and cortex.
8.4.3 Subgroup analysis
The analysis of the subgroup data showed that the whole brain CBF values for neonates with
low Lac/NAA peak-area ratio and low Barkovich score are all below 40 ml/100g/min, whereas
in some neonates with elevated Lac/NAA peak-area ratio can reach much higher values, as
presented in figures 8.24 and 8.25.
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Figure 8.24: CBF vs Lac/NAA peak-area ra-
tio for the selected cohort
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Figure 8.25: CBF vs Barkovich score for the
selected cohort
After division of the neonates into two groups based on the Lac/NAA peak-area ratio (below
or above 0.3), the difference in the distribution of the CBF values across different brain regions
can be clearly seen (see figure 8.26). The boxes represent the 25th and 75th percentile, the band
the median and the whiskers the spread of the data. In the low risk group, all CBF estimations
are within a tight range for all brain regions (8-47ml/100g/min), whereas in the high-risk group,
the range is much broader: (7-128ml/100g/min). In this group, the CBF of lentiform nuclei and
cingulate cortex have the most elevated values. There were statistical differences for CBF in
the lentiform nuclei between the high- and low-risk groups (t-test, F-test p<0.05) but not in the
cingulate cortex (t-test p=0.07, F-test p<0.05), suggesting that CBF in the lentiform nucleus has
good potential for outcome prediction in HIE neonates.
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Figure 8.26: Results of detailed regional CBF analysis; neonates with thalamic Lac/NAA peak ratio
below (black) and above (red) predictive value of 0.3
8.5 Discussion
This study presents a detailed analysis of regional CBF in conjunction with Lac/NAA peak-
area ratio. ASL provides a window to the physiology of the brain, over and above the infor-
mation from structural, T1 / T2 / diffusion weighted scans. Generally, an increase in CBF
accompanies an increase in Lac/NAA, most notably within the lentiform nuclei and cingulate
cortex. This increase in CBF could be related to the loss of autoregulation in severely affected
babies, and this information has the possibility to further separate this group of patients from the
moderately affected, usually evenly split by current imaging and clinical criteria between mild
and severe HIE.
8.5.1 Acquisition and processing
ASL Protocol and CBF quantification.
For each neonate, quantification was done according to the performed protocol and hematocrit
measured on the day of the scan. The protocol used here evolved through the study, therefore not
all neonates were scanned with identical parameters (e.g. PLD, background suppression and fat
saturation). For later scans, PLD was increased to avoid suspected artefacts from large arteries
whereas the fat saturation was added to reduce the fat artefact arising from incorrect SENSE
encoding of the fat frequency due to the chemical shift. However, the CBF quantification
accounted for all the changes and no relation between the parameters and CBF was found.
It is therefore believed that any artificial variation of CBF due to to the protocol adjustment
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was much smaller than the genuine variation of CBF between neonates. Some quantification
error could have been introduced by the uncertainty of the Hct measurement. In this study, a
constant labelling efficiency was assumed for all babies. Please see section 5.5 for more details
and further discussion on this topic.
In some cases, the signal seemed to originate from arteries, even after 1.5-2s PLD, which
indicates very low blood velocities in the main supplying arteries or dispersion of the labelled
blood bolus. This could have given rise to overestimation of flow in the voxels including the
large arteries, while at the same time underestimating the CBF in the voxels containing the
terminating branches of these large arteries. This could explain the regions of low CBF in
the arterior and posterior cortex coinciding with high signal in the regions of ACA and PCA
respectively.
Very high CBF values were found in the brainstem. For the majority of the neonates, this
was the highest value in the brain and was much higher than in other brain ROIs. This could
be the reflection of the damage done to that structure. However, it is more likely that the origin
of the high signal lies in the arterial artefact in the PCA, i.e. the presence of the labelled blood
that still occupied the posterior circulation at the time of scan. For that reason, the quantitative
values for that region were not included in the graphs and were not commented on in the case
analysis.
Motion correction
Registration and outlier rejection were essential to produce good quality maps for the majority of
subjects. However, some residual motion artefacts could still be present, especially at the edges
of the brain in the region of frontal cortex, where motion correction is the most challenging.
This could have affected CBF quantification in those regions.
Automated segmentation and parcellation
Although challenging, a good match was achieved between atlases and structural subject scans,
and between the structural and CBF maps, resulting in good quality ROIs.
Segmentation. Good quality segmentations were produced, despite using a priori tem-
plate created from the scans of the pre-term babies. The anatomical features of pre-term brain
at birth equivalent age differ from that of a term infant, mainly in the CSF spaces around the
brain tissue at the top of the brain. In the brains of HIE neonates, especially the badly affected
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ones, tissue is swollen, leaving little or no space for CSF. Additionally, the tissue contrast of
the basal ganglia and thalamus differ from that of healthy (pre-)term babies. These differences
influenced the accuracy of the registration, i.e. finding the spatial correspondence between the
template and the subjects’ structural images. To overcome this, a relaxed prior segmentation
AdaPT algorithm was used, and most of the DGM structures were manually corrected. The
relaxation of the prior has been shown to significantly improve the success of segmentations in
babies with structural abnormalities like ventriculomegaly and has proven to improve the seg-
mentations compared to no-relaxation approach [137]. All segmentations were guided by the
T2 weighted images as they were found to be of better quality across the cohort compared to the
T1 weighted images (less motion artefacts), and are thought to provide better contrast [138].
Parcellation. The propagation of a manually segmented atlas of a term infant was suffi-
cient to provide multiple ROIs within grey and deep grey matter.
Registration. The accuracy of the registrations between the high resolution structural im-
ages and low resolution perfusion maps was carefully checked for all cases and it was found
to be satisfactory based on visual inspection. Finding the geometrical correspondence between
structural and perfusion scans can be challenging due to the non-linear distortions of EPI im-
ages. This could be improved if aB0 field map was used to reduce distortions of the EPI images
[139]. This is a common practice in fMRI studies [140], where the final activation mask is dis-
played on the high resolution anatomical image to identify the activated brain regions. In the
present study, however, acquisition of the field maps was not possible due to restricted proto-
col time. Additionally, any movement between the acquisition of the map and EPI images will
reduce the efficacy of the method.
8.5.2 Clinical findings
General findings
Overall, the CBF maps showed large variability between neonates. The CBF findings were
consistent with those previously reported in neonates in terms of range and location, as shown in
table 8.4. No clear relationship between CBF values and GA at birth, GA at scan or postnatal
age at scan was found. The relationship between CBF and PNA was reported in healthy term
neonates over a period of 7 [141] and 20 days [121] of life using Doppler ultrasonography and
during the first days of life in pre-terms measured with NIRS [142]. The changes in CBF
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with GA were reported in pre-term neonates between pre-term age, term age and three months
equivalent age using ASL [143] and in the first weeks [144] and months of life [48] using PET.
The lack of this relationship in this study suggests, that any CBF changes due to maturation
are likely to be much smaller compared to that resulting from the perinatal brain injury, and
therefore the CBF values reported in this study reflect perfusion abnormalities.
Case study
The case studies showed the extent of variability of brain damage as a result of HI, as can be
seen from the structural images as well as the CBF maps. Most of the imaging findings, i.e.
abnormal signal intensities seen in the structural scans, correspond to elevated CBF values.
AbnormalCBF and its distribution coincides with abnormal tissue appearance in DWI/ADC
images. This is consistent with the previous findings in HIE neonates [93]. The behaviour of
DWI signal in neonates is very different from that of a typical adult arterial ischaemic stroke.
In stroke, the ADC is reduced rapidly after the artery occlusion and the volume of the lesion
seen in DWI is closely related to the volume of the final lesion, indicating an acute necrosis.
In contrast, in HIE neonates cell death is a dynamic process [145] lasting days after the injury,
which results in constant changes of DWI signal [146]. The relationship between CBF and
ADC is also very different when comparing stroke and HIE. In adult stroke, the decrease in
ADC is usually explained by cytotoxic oedema, caused by complete reduction in the blood flow
by a focal arterial occlusion. In neonates at the time of the scan, the flow is usually fully restored
and usually increased in the affected tissue.
Subgroup analysis
This study has found a statistically significant difference in the CBF levels of the lentiform
nuclei between neonates with elevated and normal levels of Lac/NAA ratio, which can be con-
sidered consistent with the very recent findings found in [133]. In [133], the low Lac/NAA
ratio were also linked to low CBF in the majority of cases. However, there are a number of
differences between [133] and the study presented here. In [133], a PASL technique was em-
ployed, as opposed to pCASL that was used here. It is reassuring that both ASL approaches
used in neonates led to similar quantitative results, regardless of differences in the method for
ROI placement. In [133], a manual method was used. Here, an automated method was chosen
for two reasons: (i) the ability to define a larger number of regions quickly and (ii) avoidance of
the segmentation bias. The segmentation bias could result in ROIs being chosen based on the
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high CBF , therefore not representing the underlying anatomy and potentially overestimating
the findings. Lastly, in [133] the one year outcome of all the neonates was available, which is
the most important measure from the clinical perspective. Here, the Lac/NAA peak-area ratios
were used as a surrogate measure of outcome predictor, as the 1 year outcome data was not
yet available. However, the findings presented here are consistent with [133], when consider-
ing only CBF and Lac/NAA data, i.e. the increase of the Lac/NAA peak-area ratio generally
follows increased CBF values.
Only a limited number of cases were available for the sub-group analysis (n=14) with
unknown long term clinical outcomes. It is expected that long-term follow-up data of these
neonates will enable correlation between CBF findings and clinical outcome.
8.6 Summary
This chapter presents an in depth analysis of cerebral blood flow in neonates with perinatal brain
injury and its relation to thalamic metabolic changes. The study takes advantage of an optimised
acquisition protocol and image processing pipeline, which enabled non-biased regional CBF
quantification. The proposed automated method of segmentation and parcellation increases
the objectivity of ROI placement, making it user-independent. It is less labour intensive and
time consuming, and therefore more appropriate for implementation in clinical practice. It also
allows for the objective analysis of a much larger number of regions.
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Conclusions and future work
9.1 Thesis summary
The aim of this thesis was to develop a clinically feasible framework for non invasive mapping
of cerebral blood flow in neonates with presumed hypoxy-ischemic encephalopathy.
The following objectives have been achieved:
pCASL labelling efficiency in neonates was estimated in chapter 5, which described the the-
ory, implementation, validation and usage of the Bloch equation simulator for pCASL labelling.
Implementation of the simulator enabled estimation of labelling efficiency for measured blood
velocities in neonates, as well as enabled estimation of labelling efficiency for not perpendicular
labelling plane orientations and in renal pCASL.
The effect of labelling plane angulation was studied in details in chapter 6. It was shown in
healthy adult volunteers, that pCASL labelling is robust against the angulation of the labelling
plane, even as high as 30  and that labelling plane positioned on parallel part of vertebral arteries
resulted in a large data variation. It was therefore recommended that while positioning the
labelling plane, the highest attention should be given to avoid kinks on the vertebral arteries.
Since the velocities of blood in neonates are much lower than these of adults, especially in
posterior circulation, this indicated that an extra care should be taken when planning neonatal
scan to avoid deterioration of the labelling efficiency. Additionally, the position of the neonatal
head and neck in the scanner can be tilted to allow space for a tracheal tubes used as part of
breathing support, which makes the position difficult to predict. Therefore a constant distance
between the labelling plane and FOV could result in disadvantageous labelling plane position
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on parallel part of vertebral arteries.
pCASL acoustic noise reduction of 6dB achieved without significant change in labelling
efficiency and described in chapter 6. This was done by predicting the acoustic noise using the
scanner transfer function and adjustments of labelling train module parameters.
In vivo imaging framework was developed for imaging neonates using pCASL in chapter
7. First, differences in arterial transit times depending on HIE severity were identified. This in-
cluded optimisation of ASL protocol for neonatal scanning, motion correction and identification
and exclusion of corrupted data. The best performance was achieved when motion correction
was combined with extended identification and exclusion of motion corrupted data. The com-
bination of these approaches proposed in this thesis improved the success rate and allowed all
acquired datasets to be included in the final study.
pCASL was successfully applied in clinical study presented in chapter 8. This chapter
showed potential benefits of using pCASL in neonates with perinatal brain injury and its relation
to thalamic metabolic changes. The study took advantage of an optimised acquisition protocol
and image processing pipeline, which enabled non-biased regional CBF quantification.
Renal application of pCASL in healthy adult volunteers will be presented Appendix A.
This study demonstrates the feasibility of using pCASL with gradient-echo EPI in a wide bore
3T scanner to measure renal perfusion in healthy volunteers. The technique is quick to acquire
and both tissue contrast and spatial resolution suggest likely utility in the clinical setting. Two
important challenges are addressed: estimation of labelling efficiency and motion correction.
9.2 Future directions
The research presented in the previous chapters leaves many promising avenues open for future
research. This section looks at some of the future directions in the development and applications
of the framework.
1. Outcome, dataset extension and clinical practice
A natural extension to the work presented here is further data collection and clinical follow
up at one and two years of age for neonates with HIE. This will allow further investigation
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of the sensitivity and specificity of pCASL for outcome prediction. Once the outcome
prediction of the CBF maps is clearly demonstrated, the standard clinical protocol could
easily be extended to include pCASL and CBF maps can be generated for radiological
reporting.
2. New research
Two new studies already take advantage of the proposed framework and combine infor-
mation provided by pCASL with other modalities: phosphorous MRS and NIRS in HI
neonates. The first study might further the understanding of HIE (measuring pH in the
brain with MRS); the second might enable bedside CBF monitoring (NIRS). Although
the framework was developed for HIE cohort, it could be extended to include pre-term
neonates to, for example, study the relationship between regional CBF and localised
cortical folding.
A more ambitious new research direction could involve perfusion measurement in neona-
tal kidneys using pCASL. Renal failure can occur within 24 hours of a HI episode and
can be difficult to diagnose in neonates [147]. Although renal ASL in still a relatively
uncommon technique, it has been shown to be useful in evaluating renal blood flow after
transplantation [148] and it might become a valuable tool in clinical practice (see Ap-
pendix A for renal pCASL study in healthy volunteers).
3. Arterial transit times
CBF maps used in this project were calculated using a single post labelling delay. How-
ever, measuring an ATT reliably could provide additional information about the vascu-
lar response to HIE. Therefore, future work will focus on optimisation of time encoded
pCASL (e.g. [141]) to enable estimation of arterial transit time in addition to CBF .
4. Imaging framework
Further improvements to the regional CBF estimation will be made by using more so-
phisticated methods for automated ROI definition, by using multimodal data and using the
Similarity and Truth Estimation for Propagated Segmentations (STEPS) approach [142].
5. Motion reduction
Currently, the timing of background suppression pulses pulses was chosen to reduce the
signal from the white and grey matter (WM, GM) and cerebrospinal fluid (CBF) in order
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to enhance SNR. However, the manipulation of the BS pulses can be used to enhance
the contrast between the tissues instead, which might improve the performance of image
registration. This will be tested first in healthy volunteers. The data will be acquired
with carefully controlled motion and the temporal SD of difference images will be used
to assess the alignment after registration.
6. CBF and MRS
The detailed regional analysis of CBF could provide additional information of patho-
physiology, if it could be combined with regional MRS data. This could be achieved by
using MRS imaging instead of a single voxel.
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Renal pCASL: reproducibility study
A.1 Introduction
This chapter presents an application of pCASL quantification of renal blood flow, which takes
advantage of the knowledge and experience gained during development of the neonatal imaging
framework described in chapter 7. Although this work was not directly motivated by investiga-
tion of neonatal HIE at this stage, it might lead to future development in neonatal renal failure.
A.2 Motivation
Renal perfusion is an important indicator of renal function and its abnormalities are associated
with a range of diseases [149]. Therefore measuring renal perfusion is particularly important
for assessment of renal damage, recovery from the desease or transplantation. Commonly used
methods for renal perfusion quantification, such as PET, CT and contrast enhanced MRI, are
invasive. Furthermore, they might not be well tolerated by the patient due to nephrotoxicity
or might be contraindicated in certain patient group, for example gadolinium based agents in
renal failure. ASL offers a truly noninvasive alternative, therefore it has attracted attention of
researchers interested in the renal function in recent years. Additionally, ASL offers quantifica-
tion of renal blood flow (RBF ) which may be a useful imaging biomarker.
Renal ASL using pseudocontinuous labelling has been shown feasible in 1.5T [150] and 3T
[151], but it presents itself with different challenges compared to that of the brain. One of the
biggest challenges in renal imaging is motion and motion related artefacts. As shown in chapter
7 in brain and by other researchers in kidneys, motion correction can increase SNR and improve
reproducibility of the technique [152]. However, standard motion correction approaches devel-
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oped for brain do not always produce expected results. Another challenge in renal pCASL and
RBF quantification is estimation of labelling efficiency. In renal pCASL, the labelling plane is
positioned on the descending aorta, where a large velocity distribution within the cardiac cycle
is expected and, as seen in section 5.3.2, the labelling efficiency depends on the velocity of the
moving spins. In reported studies using pCASL in kidneys at 3T [151], the labelling efficiency
was estimated only based on simulations. However, it is not clear how the different velocities of
blood in the descending aorta during the cardiac cycle affect the labelling efficiency.
For renal perfusion imaging with pseudo-continuous ASL (pCASL) to become a clinically
useful tool, the above challenges need to be addressed and its reliability assessed. Therefore in
this study the labelling efficiency for different velocities in the cardiac cycle is estimated and
a new motion correction framework proposed. This is then followed by an assessment of a
test-retest reproducibility in healthy volunteers.
A.3 Methods
Study design. Institutional and Research Ethics Committee approval was obtained for this
study. Ten healthy volunteers were recruited to this study (3 females, age 25-35). All volunteers
underwent within session scan-rescan. Additionally, seven had the scan repeated on two separate
occasions (between sessions scan-rescan, at least one week apart). The schematic of the study
design is shown in figure A.1.
Imaging. All subjects underwent a renal pCASL perfusion protocol in a 3.0T Phillips Ingenia
wide-bore MR scanner. Volunteers were positioned with their arms extended on dedicated arm-
rests above their heads. This allowed a reduction of the FOV in the phase encoding direction and
the number of phase encoding steps, which in turn reduced the acquisition time of each frame.
Respiration and cardiac cycles were monitored with respiratory bellows and pulse oximetry. The
main protocol consisted of localiser scans, pCASL and phase contrast scans. A coronal-oblique
ASL imaging volume was positioned along the long axis of both kidneys to reduce in and out
of plane motion. The labelling plane was carefully positioned above the kidneys, perpendicular
to the descending aorta and far away from the lungs to reduce B0 inhomogeneities at the level
of labelling. An example of planning for pCASL including FOV: labelling plane an shim box
is shown in figure A.2. Labelling duration was 1.65s, post labelling delay 0.9s. The pCASL
labelling train consisted of 0.5ms Hanning RF pulses with FA=18 , a maximum gradient of
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Figure A.1: Study design.
0.6 G/cm and Gmax/Gmean equal to 10. Gradient-echo EPI was chosen for the readout mod-
ule which enabled multi-slice acquisition. EPI parameters were: 108x99 acquisition matrix,
320x320x5mm3 FOV,10 slices (2mm gap), SENSE factor of 3, FA=90  and TE/TR = 7/4000ms
and spectral adiabatic inversion recovery (SPAIR) pulses were applied for fat suppression. 20
control-label pairs were acquired for each full pCASL acquisition. To reduce motion between
acquisitions, two pairs were acquired within a 16s breath-hold. M0 proton density images were
also acquired in a separate acquisition with the same readout as pCASL scans, but with TR=9s.
QFlow acqisition and velocities estimation. Quantitative cardiac-gated phase contrast scan
was acquired at the exact position of labelling plane for all volunteers. The velocities of the
flowing blood were measured using a flow sensitive multi-shot TFE sequence, with the following
parameters: TFE factor = 9, TR/TE = 5.6/3.3ms, FOV 210x267x5 mm3, matrix size 104x129,
FA=10 , SENSE factor = 1.5, VENC = 90 or 100 cm/s, phase encoding direction: AP. All data
was acquired within a single breath-hold and PPU retrospective synchronisation was used to
reconstruct PC images for twelve cardiac phases.
Magnitude images from all cardiac phases were segmented using Snake ROI region growth
implementation in ITK-SNAP 1. The intensity threshold for ROI growth restriction was set to
1http://www.itksnap.org/pmwiki/pmwiki.php?n=Main.Credits
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Figure A.2: Position of the FOV (green), labelling plane (white)
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Figure A.3: Motion correction
pipeline
include the whole lumen of the artery. Such created segmentations were then used to quantify
mean and maximum velocity in phase images, as well as the lumen for each cardiac phase. An
example segmentation overlaid on the magnitude and phase images is presented in figure A.4.
Figure A.4: Magnitude (left) and phase (right) images acquired with QFlow sequence with overlaid
manual segmentation of descending aorta.
Labelling Efficiency estimation. Based on measured velocities across different cardiac cycle
phases, laminar flow weighted labelling efficiency was estimated using a Bloch equation simu-
lator (described previously in chapter 5). Two methods were considered. In the first method, all
velocities across all cardiac cycles across all volunteers were averaged, and labelling efficiency
for that velocity ↵vave was computed. In the second method, the velocities and artery lumen for
each cardiac cycle phase were averaged across all volunteers, and a total flow and total labelling
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efficiency was computed using equations similar to 5.30 and 5.31 from chapter 5:
Ftotal =
12X
i=1
vmean,i · si (A.1)
↵total =
12X
i=1
vmean,i · si
Ftotal
· ↵weighted(vmax,i) (A.2)
=
12X
i=1
wi · ↵weighted(vmax,i) (A.3)
where si is the artery lumen, i = 1 : 12 here representing each cardiac cycle and ↵weighted
5.28. Weighting factor wi was introduced here to reflect different volumes of blood delivered to
the kidneys at different cardiac phases. The resulting estimated efficiencies were compared and
used for RBF quantification.
Motion Correction. Although the images were acquired during multiple breath-holds, the
frames acquired during different breath-holds were not aligned. To reduce this misalignment
between consecutive pairs, a new post-processing motion correction procedure was developed.
First, the images were cropped to restrict FOV to the region of left and right kidneys separately,
which allowed for independent registration. Next, a mask was drawn manually on each kidney
and used to constrain the rigid registration to the region of interest. Control and labelled images
were registered to a template created by refined registration of control images using DTITK2,
similarly to that described in detail in chapter 7. Pairwise subtraction was then performed, and
these were averaged to create a perfusion weighte image. A summary of the motion correction
steps is shown in figure A.3.
Quantification. The general kinetic model was used to quantify RBF using equation 4.10,
with blood T1 set to 1.65s and partition coefficient   = 0.9. The mean value of M0 within the
whole kidney mask was used for calibration. Cortical RBF was calculated by averaging signal
within a manually segmented cortex mask created for each kidney.
Statistical analysis. The mean and SD for all measurements of whole kidney and cortex ROIs
was calculated, and a Student’s t-test was used to evaluate the reproducibility of the technique. A
standard deviation of the differences between repeated measurements (both within and between
sessions) within and between subjects (SDws, SDbs) as well as coefficient of variation (CVws,
CVbs) and interclass correlation coefficient ICC were computed, using analysis of variance
2http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
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(ANOVA) [153]. Coefficient of variation is defined as a ratio of SDws or SDbs to the appropri-
ate mean of repeated measurements. ICC is a measure of reliability; it typically ranges between
0-1, with 1 indicating the highest reliability (zero measurement error) [154]. It is defined as:
ICC =
MSbs  MSws
MSbs + (k   1) ·MSws (A.4)
whereMSbs andMSws are the mean square between and within subjects, and k is the number
of repeated scans. To visualise the agreement within and between session measurements, a
Bland-Altman plot [16] was provided. The 95% limits of agreements were calculated as the
mean difference ±1.96 · SD of the scan-rescan difference. This represents the range within
which 95% of the future scan-rescan differences will lie [155]. This was done for an average of
left and right kidneys within cortex and whole kidney ROIs.
A.4 Results
Labelling Efficiency estimation.
The maximum velocity, lumen and weighted labelling efficiency for each cardiac phase for all
volunteers as well as a mean across volunteers is shown in the figure A.5. Details of average
cardiac cycle across all volunteers are presented in table A.1.
Labelling efficiency for average blood velocity, ↵vave was 0.87, whereas the total efficiency
↵total averaged across all cardiac cycle phases and volunteers was 0.81, SD = 0.18 (ranging
from 0.77 to 0.84) and was used to quantify RBF .
RBF qualification
A typical renal perfusion map is shown in figure A.6. The mean RBF within the whole kidney
ROI was 187[ml/100g/min] (range: 98-291[ml/100g/min], SD:52 [ml/100g/min] ) and within
the cortex: 234[ml/100g/min] (range: 86-399[ml/100g/min], SD 70). The RBF values are
in agreement with previously reported renal ASL studies. There was no statisticaly significant
difference between left and right kidney RBF , both whole and cortex (Student t-test p>0.05).
Reproducibility
Results of the reproducibility analysis are given in table A.2. Within-session scan-rescan co-
efficient of variance, was lower than that between between sessions, both within and between
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Figure A.5: Maximum velocity (top), lumen (middle) and weighted efficiency (bot-
tom) for each cardiac phase. The mean for all volunteers is marked in red.
subjects. The Bland-Altman plot is shown in figure A.7. There is a small negative bias: -3.7 and
-5.9 [ml/100g/in] for within and between session differences, respectively.
A.5 Discussion
This study demonstrated the feasibility of using pCASL with gradient-echo EPI in a wide bore
3T scanner to measure renal perfusion in healthy volunteers. The technique was quick to acquire
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phase vmean [cm/s] vmax [cm/s] s [mm2] wi ↵(vmax)
1 10.3 17.1 2.51 0.04 0.77
2 9.9 16.6 2.46 0.03 0.76
3 13.8 20.7 2.41 0.04 0.79
4 30.4 44.2 2.39 0.07 0.85
5 52.6 71.8 2.59 0.13 0.83
6 55.7 80.0 2.84 0.18 0.81
7 43.2 66.4 2.94 0.17 0.84
8 22.9 39.3 2.92 0.12 0.86
9 10.7 21.3 2.88 0.08 0.81
10 9.2 17.3 2.77 0.05 0.78
11 10.1 17.7 2.68 0.05 0.79
12 10.9 17.9 2.59 0.04 0.78
Table A.1: Results of estimated labelling efficiency, averaged across all volunteers
Figure A.6: Example of renal blood flow map. Tissue contrast and spatial resolution of the
imaging allowed for differentiation between cortex, medulla and renal columns
and both tissue contrast and spatial resolution suggest fiseable utility in the clinical setting. Two
important challenges were addressed: estimation of labelling efficiency and motion correction.
Labelling efficiency. Labelling efficiency of pCASL was estimated successfully for an av-
erage velocity and for all cardiac cycle phases. Additionally to laminar flow weighing, the
additional weight wi for each cardiac cycle was added to put more importance on the cardiac
cycle phase that provides the highest volume of the label. This weighting was driven by the
wide range of velocities and lumen within a cardiac cycle. For an average heart rate of 75 beats
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Whole Kidney Cortex
scan - rescan SDws[ml/100g/min] 14.8 20.14
CVws 7.90% 8.60%
SDbs [ml/100g/min] 71.7 97.8
CVbs 38.30% 41.70%
ICC (scan-rescan) 0.92 0.92
session1 - session 2 SDws[ml/100g/min] 60.4 80.1
CVws 31.30% 33.00%
SDbs[ml/100g min] 48.9 70.5
CVbs 25.30% 28.90%
Table A.2: Results of statistical analysis. SDws,SDbs - within subject and between subjects
standard deviation CVws,CVbs - within subject and between subjects coefficient of variation,
ICC - Interclass Correlation Coefficient
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Figure A.7: Bland-Altman plot for scan-rescan (red) and between sessions (black)
variability of cortical and whole kidney perfusion (dashed lines represent 95% limits
of agreement, calculated as the mean difference ±1.96 ·SD of the difference between
repeated measurements.
per minute (1.25 per second) two full cardiac cycles are covered within the labelling duration
of 1.65 seconds and therefore all cardiac cycle phases should be equally represented in the total
acquisition of 20 controls and labels. However, using the mean flow across the cardiac cycle
would result in an overestimation of renal perfusion of almost 7%, which emphasises the im-
portance of efficiency estimation for all cardiac phases. In this study of healthy volunteers, one
value of labelling efficiency was used. If the method was to be used in a patient population, it
could be beneficial to estimate efficiency on a patient by patient basis.
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One limitation of the estimation of ↵total presented here is the lack of B0 estimation from
the field maps. The inhomogeneities are expected to reduce efficiency, especially for the fastest
spins, as discussed in chapter 5. This will be addressed in future work.
Motion correction. The motion correction pipeline consisting of registration of each kidney
separately as well as adding a mask significantly improved the quality of RBF maps. Motion
artefacts could be further reduced with the use of background suppression pulses. Additionally,
breath-holds could be replaced by a timed breathing - a method in which the subject synchro-
nises their breathing with the sequence, breathing during post-labelling delay and at the end of
a single frame acquisition. This method is currently being tested in a new study investigating
usability of pCASL in the liver.
RBF quantification. The RBF values are in agreement with previously reported renal ASL
studies [156].
Reproducibility. The within sessions ICC was high, indicating good reliability of the method.
Between sessions limits of agreements were high, however they were similar to values previ-
ously reported at 1.5T using multiple inversion times FAIR [156]. This might have resulted
from a natural variance in renal perfusion driven by food and drink (especially caffeine) uptake
before the scans, which was not controlled for. Another reason for increased variance between
the sessions could have been deviations of the labelling efficiency from that estimated based on
measured velocities and simulations due to B0 and B1 inhomogeneity.
A.6 Summary
In summary, pCASL can be successfully used for RBF estimation. The biggest application of
the method would be in cases when an asymmetricalRBF is expected, like in kidney transplan-
tation. The scanning protocol can be easily adapted for perfusion quantification in other organs,
like a liver or prostate.
List of abstracts that benefited from work presented in this chapter:
M. Sokolska, D. Thomas, A. Bainbridge, X. Golay, S. Taylor, S. Punwani, D. Pendse Renal
Perfusion Imaging with Pseudo-continuous Arterial-Spin Labelling (pCASL) at 3.0T: Repeata-
bility in Healthy volunteers. Proceedings of 22nd ISMRM 2014
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M. Sokolska, D. Thomas, A. Bainbridge, X. Golay, S. Taylor, S. Punwani, D. Pendse "Renal
Pseudo- continuous Arterial Spin Labelling (pCASL) MRI: A Repeatability Study". ERC 2014
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